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Abstract 
 
The synthesis of luminescent metal complexes is a very challenging task since they can be regarded 
as the starting point for a lot of different areas. Luminescent complexes, in fact, can be used for 
technological, industrial, medical and biological applications. During my PhD I worked with 
different metals having distinguishing intrinsic properties that make them different from each other 
and, in particular, more or less suitable for the different possible uses. Iridium complexes show the 
best photophysical properties: they have high quantum yields, very long lifetimes and possess easily 
tunable emissions throughout the visible range. On the other hand, Iridium is very expensive and 
scarcely available. The aim of my work concerning this metal was, therefore, to synthesize ligands 
able not only to form luminescent complexes, but also able to add functionalities to the final 
complex, increasing its properties, and therefore its possible practical uses.  
Since Re(I) derivatives have been reported to be suitable as probes in biological system, and the use 
of Re(I) reduces the costs, the synthesized bifunctional ligands containing a pyridine-triazole and a 
biotin unit were employed to obtain new Re(I) luminescent probes.  
Part of my work involved the design and synthesis of new ligands able to form stable complexes 
with Eu(III) and Ce(III) salts, in order to obtain an emission in the range of visible light: these two 
metals are quite cheap and relatively non-toxic compared to other heavy metals.  
Finally, I plan to synthesize organic derivatives that already possessed an emission thanks to the 
presence of other many chromophoric groups and can be able to link the Zinc (II), a low cost and 
especially non-toxic “green” metal. Zinc has not its own emission, but when it sticks to ligands, it 
increases their photophysical properties.  
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1) The importance of synthesizing luminescent metal complexes  
The design and synthesis of luminescent substances is definitely a very current topic of interest for 
scientific research. In fact many publications can be found in chemical journals, but also in medical, 
biological and technological reviews, demonstrating how this topic can be considered as a starting 
point for completely different fields of study. 
Today, for example, we witness an impressive expansion of the literature on the luminescence of 
Ir(III) complexes, as illustrated in Figure 1. 
 
Figure 1: Representative number of papers (full points) dealing with the luminescence of 
iridium(III) complexes in the indicated years; updating is set at August 2006 (empty point) 
From this diagram, it can be noticed that ca. 90% of the known luminescent Ir(III) complexes, 
mostly containing cyclometalating ligands, have been reported only since 2000.1 
Despite the considerable interest, the obtainment of substances for the developing of new materials 
or devices still presents many problems due to the costs and the poor durability of the finished 
products. For this reason, it is necessary to continue the research, trying to synthesize organic 
functionalized molecules, which can be used as ligands for metal cations at low cost and high 
availability, to form luminescent complexes. 
Especially cyclometalated Iridium (III) complexes, but also Rhenium (I), Europium (III), Cerium 
(III) and Zinc (II) complexes now, can be employed in a lot of different applications. Typically, 
such complexes are used as sensitizers for outer-sphere electron-transfer reactions,2,3 
photocatalysts,4 photoreductants,5 pH sensor,6,7 biological luminescent probes and assays,8 medical 
diagnostics and optical imaging devices,9,10 but in particular as emissive dopants in multicolor 
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electroluminescent displays based on organic light emitting devices (OLEDs) and light-emitting 
electrochemical cells (LECs). 
It is now accepted in the electroluminescent displays industry that phosphorescence-based OLEDs 
offer many advantages over existing display technologies. The most common display technology 
used for portable applications to flat panel display (FPD) TVs is liquid crystal displays (LCDs). A 
non-organic LCD display does not emit light; a white fluorescent backlight sitting behind the LCD 
panel is filtered by switchable polarizers in order to generate the pixel colors and to create the 
image on the screen. Individual liquid crystals allow light to pass or block it. Since the polarizer 
filter is employed in LCD, this leads to a loss in efficiency since most of the light is absorbed by the 
color filters, and creates viewing angle problems due to the polarized emission. On the other hand, 
OLED displays do not need a backlight since the organic material self-generates light, requiring 
very low external power and showing, generally, more efficient than LCDs. Additionally, OLEDs 
do not suffer from viewing angle problems, thus they always display sharp quality images 
independent of viewing angles. In contrast to conventional inorganic LEDs, OLEDs can result 
flexible, transparent, and lightweight. The basic structure of an OLED consists of a stack of two or 
more thin organic layers with a total thickness of about 1000 Ǻ sandwiched between a transparent 
anode and a metallic cathode (Figure 2). The organic layers consist of a hole transporting layer 
(HTL), an emissive layer containing a dopant and a host material, and an electron transporting layer 
(ETL). When an external driving voltage is applied, the introduced positive and negative charges 
are injected into the organic materials. The positive (holes) and negative (electrons) charges migrate 
through the device and recombine to form excitons in the emissive layer. The device lights up 
(produces electroluminescence) as excitons decay radiatively. The emission color depends on the 
energy of the exciton. Particular structures of the organic layers and the choice of anode and 
cathode should be considered to highly maximize the recombination process in the emissive layer, 
thus maximizing the light output from the OLED device. 
    
Figure 2: Typical OLED Structure  
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The earliest OLEDs work was reported in 1987 by Tang and Van Slyke from Eastman Kodak labs. 
They made the first double heterostructure device in which its structure comprised of ITO / diamine 
HTL / Alq3 / Mg:Ag.11 A glass substrate was coated with a transparent indium tin oxide (ITO) 
acting as the anode.  
A diamine was used as the hole transporting material and Alq3 (tris(8-hydroxyquinoline) 
aluminum(III)) served as both an electron transporting layer (ETL) and an emissive layer. Electrons 
were injected from a Mg:Ag alloy cathode with an additional layer of Ag to protect the Mg from 
oxidation. In this double layer device, electrons and holes combined at the diamine/Alq3 interface 
(Figure 3a). This double layer device utilized HTL and ETL to confine excitons and prevent 
dispersion. The utilization of HTL and ETL could lead to efficient charge carrier injections. The 
significant problem with this double layer device is that the excitons emitting from a dense and pure 
matrix typically go through significant self-quenching that leads to poor external quantum 
efficiency (~1%).11 In 1989, Tang, Van Slyke and Chen showed that it was possible to add small 
quantities of a highly fluorescent dye (green Coumarin 540 or red DCM (4-(Dicyanomethylene)-2-
methyl-6-(4-dimethylaminostyryl)-4H-pyran) fluorescent dyes) to a charge transporting material 
(Alq3) in the double layer device to easily tune the OLED emission color. By introducing the 
fluorescent dopant, they were able to improve the device efficiency up to 2.5%.12 Inside the 
emissive layer, energy will transfer readily from the host (Alq3) to a dopant with a smaller optical 
gap resulting in efficient emission from the dopant (Figure 3b). The self-quenching of excitons is 
also suppressed by lowering the concentration of excitons and the device efficiency is improved. An 
additional benefit of doping is to control emission colors of OLEDs by doping with different 
emissive dyes. 
 
(a)                                                    (b) 
Figure 3: (a) Double Layer OLED; (b) Doped-double Layer OLED 
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Excitons in OLEDs are created in a ratio of about 3:1 (Figure 4), i.e., approximately 75% triplets 
(spin parallel) and 25% singlets (spin antiparallel).13 A fluorescence device only utilizes singlet 
excitons, while the energy of triplet excitons is generally lost to non-radiative decay processes that 
heat up the device. This inefficient utilization of triplet excitons limits the internal quantum 
efficiency of fluorescence-based devices to only 25%. Contrary to fluorescence-based devices, 
OLEDs utilizing phosphorescent materials that emit from triplet excited states are expected to result 
in higher internal quantum efficiency. 
 
Figure 4: Exciton Formation by Hole-Electron Recombination 
OLED displays can be fabricated on different types of substrates ranging from rigid glass to flexible 
polymers which are usually coated with a transparent conductive anode material, indium tin oxide 
(ITO). Since most organic molecules have low charge transport mobilities (<10-2cm2/Vs),14 the 
films are required to be very thin (~1000 Å) in order to pass enough currents at low operating 
voltages. Organic films comprised of small molecules are usually grown by vapor deposition 
(sublimation) onto the substrate under high vacuum conditions (< 10-6 torr). On the other hand, high 
molecular weight polymers, that are not volatile enough for vapor deposition, are typically spin-
coated or printed onto the substrate. A low work function metal (e.g. Ca, Al, or Mg) is vapor 
deposited on top of the organics to serve as the cathode.  
To improve the device performance, multi-layered materials are used, each of which serves 
different functions, i.e. hole carrier, emissive layer, or electron carrier. The most commonly used 
hole-transporters consist of an organic triarylamine-based compound. A series of metal quinolates 
are widely utilized as electron transporting materials. The chemical structure of several typical HTL 
and ETL molecules, i.e. 4,4'-(cyclohexane-1,1-diyl)bis(N,N-di-p-tolylaniline) (Cta), N,N’-bis-(1-
naphthyl)- N,N’-diphenylbenzidine (α-NPD), aluminum tris(8 hydroqunilonate) (Alq3), are shown 
in Figure 5. 
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Figure 5: Structures of Typical HTL and ETL Materials Used in OLEDs. 
OLEDs and LEECs have attracted also a great deal of attention due to their potential use in lighting. 
Notably, they are acquiring an increasing market share in ambient illumination thanks to the 
consolidation of white LED concepts.15 In fact, the diffusion of artificial lighting is one of the 
greatest achievements of the past century, in fact for millennia artificial lighting was generated by 
the open fire. In 1879, taking advantage of the work of many other inventors and after having tested 
hundreds of different materials as filaments, Thomas Edison patented the incandescent carbon 
filament lamp, a milestone of modern lighting. Edison’s device converted just 0.2% of electricity 
into light, but it was 20-times more efficient than a candle in converting chemical energy into useful 
photons.16,17 In the following decades, electric lighting devices underwent substantial progress in 
terms of efficiency and all the systems that are still used nowadays were introduced: the tungsten 
lamp (1906), that dominated residential lighting for one century, the sodium vapor lamp (1930s) 
and the fluorescent tubes (1940s).18 The evolutions of these three fundamental designs were 
introduced in relatively recent times: the halogen lamp, an advanced filament system, entered the 
market in the 1960s and the compact fluorescence lamp, a sort of hybrid between bulbs and 
fluorescent tubes, appeared in the 1980s. The tremendous progress made during the 20th century in 
improving the quality and availability of artificial lighting was accomplished through the use of two 
main technologies: incandescent- and discharge-based lamps.19 There is a variety of both type of 
lamps, but these two traditional lighting concepts have been exploited near to their limit; thus, new 
lighting approaches have emerged in the last two decades.20 The emerging concept for illumination 
is solid-state lighting (SSL),21 in which selected semiconductor materials are stimulated to produce 
visible light under the action of an electrical field (electroluminescence). Through this approach, the 
primary product of these lighting devices is the photon itself, unlike traditional sources where 
visible light is essentially a byproduct of other processes, such as heating or discharging. As a 
result, SSL (OLEDs or LEECs) creates visible light with reduced heat generation or parasitic 
energy dissipation, while its solid-state nature provides for greater resistance, increasing 
significantly the lifespan of appliances. 
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2) Different metals for different properties 
2.1 - Iridium (III) 
Iridium(III) is a 5d6 metal center and its d orbitals are split by the interaction with the octahedral 
ligand field into three stabilized t2g (dxy, dxz, dyz) and two destabilized eg orbitals (dz2, dx2-y2), 
(Figure 6a). In general the energy difference between these two levels (o) depends on:  
1) the oxidation state of the metal center: the higher the oxidation state, the higher the o splitting;  
2) the size of the d orbitals: o is smallest for 3d metals and progressively increases with 4d and 5d 
metals;  
3) the field strength exerted by the ligands, following the so-called spectrochemical series.  
Ir(III) exhibits a high o splitting because of the presence of a highly charged ion belonging to the 
third row of the d-block of the periodic table. As a result, the electronic configuration of the metal 
center is always in a low-spin state (t2g 6, eg 0, Figure 6a) and the ligand-field stabilization energy is 
maximized, which means that Ir(III) complexes are generally stable and rather inert toward 
substitution. Accordingly, the configuration of the metal orbitals is closed-shell (A1g) and, since the 
ligand orbitals are fully occupied, the ground-state of the complexes is a singlet (S0). Other 
transition-metal ions have the same d6 low-spin configuration of Ir (III) (e.g., Os (II), Ru (II) and in 
the presence of particular ligands, even Fe (II)), however their complexes do not exhibit such 
remarkable photophysical properties (e.g., emission color tunability, high photoluminescence 
quantum yields (PLQYs), good photostability, etc.) because the scenario in the excited states is very 
different (Figure 6b). The reasons are as follow: 
a) Fe (II), 3d6 configuration: the o splitting is very small, hence the lowest-lying excited state is 
1MC in nature (i.e., centered on eg metal orbitals) and, therefore, not emissive.22 
b) Ru (II), 4d6 configuration: the o splitting is increased and the lowest (emissive) excited state is a 
metal-to-ligand charge transfer triplet (3MLCT), relatively close to 3MC states that can be thermally 
populated and open a competitive radiation less deactivation pathway to either the ground state or to 
degradation products; accordingly, the PLQY of Ru (II) complexes increase substantially with 
decreasing temperature.23 
c) Os (II), 5d6 configuration: the o splitting is considerable and the 3MC states are usually too high 
to affect emission properties, but the emissive 3MLCT excited state has lower energy compared to 
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Ru (II) analogues (emission bands typically peaking in the red/infrared edge of the spectrum) and 
this favors radiationless pathways thanks to the “energy gap law”;24 accordingly, PLQYs of these 
complexes are typically low, often below 1–2%.25 
 
Figure 6: a) Low-spin d6 orbital configuration in octahedral field. b) Qualitative electronic excited 
states description for Fe(II), Ru(II), and Os(II) metal complexes. c) Electronic energy-level diagram 
for a generic Ir-complex. MC is metal-centered, LC is ligand-centered, LLCT and MLCT are 
ligand-to-ligand and metal-to-ligand charge transfer, respectively. 
The emission colors from Ir (III) complexes are strongly dependent on the choice of the 
cyclometalating ligand, with room temperature lifetimes on the order of µs, high quantum 
efficiencies and good stability. The emission color can be readily tuned from blue to red by 
judicious modification of the cyclometalating ligands and/or ancillary ligands. In general, multi-
color display applications require efficient and stable blue, green and red OLEDs. OLEDs have 
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been manufactured with (C^N)2Ir(L^L) phosphor dopants, giving efficient green, yellow or red 
emission (Figure 7).26 
 
 
Figure 7: Green to Red Emission Ir Phosphors (from http://www.sigmaaldrich.com/technical-
documents/articles/material-matters/achieving-high-efficiency.html) 
 
It is interesting to note that red and green iridium complexes have been well developed to be used in 
OLEDs, while blue iridium complexes are still less common. 
Most Iridium complexes are synthesized in two steps according to the strategy depicted in Figure 8. 
Commercially available IrCl3·nH2O reacts with a slight excess of the desired cyclometalating ligand 
(C^N), the most popular of which are substituted 2-phenylpyridines (Hppy). The reaction is usually 
carried out in 2-ethoxyethanol heating overnight at around 120° C under argon atmosphere.27 The 
product of this reaction is the cyclometalated Ir(III) -dichloro bridged dimer [{(C^N)2Ir(-Cl)}2]. 
In Iridium dimer complexes, the Ir_C/Ir_C’ bonds are stereochemically cis to each other, whereas 
the Ir_N/Ir_N’ are mutually in trans position.28 Tris-cyclometalated iridium(III) complexes are 
minor byproducts that can be easily separated from the main dichloro-bridged dimer.29 The 
[{(C^N)2Ir(-Cl)}2] dimers undergo facile reactions with a variety of monodentate and bidentate 
neutral imine type chelating ligands (Figure 8) to yield a plethora of different cationic mononuclear 
complexes in high yields30 as chloride salts. Subsequently, these can undergo an ion exchange 
reactions with less-coordinative and less-reactive anions, for example (PF6- or BF4-, to improve the 
performance of the complex under the electric field in operating devices. When the direct addition 
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of the neutral ligands to the dimer affords low yields, an alternative synthetic route can be utilized, 
carrying out removal of chlorides by treating the -dichloro-bridged dimer with silver triflate or 
other silver based chloride-abstracting agents.31 The chloride-free intermediate, for example, 
[(C^N)2Ir(H2O)2][CF3SO3], can then be treated with the desired neutral ligand under mild reaction 
conditions.32 It is even possible to avoid this two-step procedure by directly treating the 
[{(C^N)2Ir(-Cl)}2] dimer with a stoichiometric amount of neutral ligands in the presence of Ag2O, 
to promote the removal of chloride during the reaction.33 
C
N
Ir
N
C Cl
C
N
Ir
N
C
Cl+ IrCl3C N
OH
EtO / H2O
rfx, overnight
C N
N
=
Ir
N
NCH2Cl2/EtOH
N
N N
N
{(C^N)2Ir( -Cl)}2
 
Figure 8: Typical two-step synthesis of a heteroleptic bis-cyclometalated iridium(III) complex. 
 
2.2 - Rhenium (I) 
The photochemistry of Rhenium complexes occupies a prominent position in the photochemistry of 
transition metal complexes. Along with early preparative studies on photosubstitution of carbonyl 
species like Re(CO)5X, the preparation of the remarkably stable yellow complex fac-
Re(CO)3(phen)Cl (phen= 1,10-phenanthroline) foreshadowed the discovery of the a large class of 
related luminescent materials by Wrighton and co-workers in the 1970s.34 As pointed out by Vogler 
and Kunkley, the current photochemistry of Rhenium complexes is rich, spanning eight oxidation 
states from formal Re(0) (for example, Re2(CO)10) to formal Re(VII) (for example MeReO3).35 
Complexes of Re(I) containing polypyridine or diimine donors, usually with three carbon monoxide 
co-ligands, continue to be an intense area of interest. The most popular Re(I) family of complexes 
studied for their luminescent properties is the fac-[Re(N^N)(CO)3-(L)]n+,36,37 where N^N represents 
a neutral conjugated diimine ligand such as 2,2’-bipyridine (bipy) or 1,10-phenanthroline (phen), L 
is an ancillary ligand, and n = 0 or 1 depending on the respective anionic or neutral charge of the 
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ligand L. Some of these complexes exhibit exceptional luminescence properties with quantum yield 
(Φ) values up to 0.6 and extended excited state lifetimes (τ) ranging from the nano to microsecond 
scale. Manipulation of the photophysical properties is achieved by changing the relative energy of 
the π* orbitals of the diimine system with the introduction of electron withdrawing (EWGs) or 
donating groups (EDGs) and/or by varying the crystal field strength of the ancillary ligand L.38 
Generally, cationic fac-[Re(N^N)(CO)3(L)]n+ complexes, for example, when L is a pyridine-type 
ligand, possess superior photoluminescence properties compared to their analogous neutral ones 
where L = Cl-, Br-. These improved properties have been rationalized in terms of a reduced non-
radiative decay constant, knr, due to the larger gap between the highest occupied molecular orbital 
(HOMO) and the lowest unoccupied molecular orbital (LUMO), in agreement with the energy gap 
law.39 
Figure 9 illustrates two models used to explain the photochemical properties of rhenium carbonyl 
complexes. The MLCT absorption band often lies at lower energy on the shoulder of the π →π* 
diimine ligand centered transition (LC); hence, both the 1MLCT and 1LC levels are often populated 
simultaneously. Further, the 3MLCT and 3LC* vary in energy relative to one another. Consequently, 
emission spectra are often found to occur in the 500 nm region with strong vibronic character 
consistent with a large 3LC* contribution; in other cases the spectra occur near 600 nm and are 
structureless and assignable to a 3MLCT state. Because the emission envelope of the coordinated 
diimine ligand is red-shifted from that of the free ligand, a combination 3LC, 3MLCT state is often 
employed to account for the emission behavior. Emission spectra are also temperature dependent. 
At 77 K in a frozen matrix, the 3MLCT state in some cases is found to rise above the 3LC state 
resulting in ligand centered emission in some systems.40 For the “parent complexes”, 
[Re(bpy)(CO)3Cl] and [Re(bpy)(CO)3(py)]+, the highest occupied molecular orbital contained 50% 
or greater Red character along with ∼20% contributions each from CO and Cl for [Re(bpy)(CO)3Cl] 
and ∼20% contributions from CO for [Re(bpy)(CO)3(py)]+. The lowest unoccupied molecular 
orbitals consisted of 80% or greater diimine ligand π* character in both cases. Thus the lowest 
energy optical transition was assigned as a metal-ligand-to-ligand charge transfer transition 
(MLLCT).41 
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Figure 9: Jablonski Diagrams for [Re(diimine)(CO)3L] Complexes: A MLCT Model; B Ligand-
Centered Model 
Re(I) complexes have been employed for various applications, for instance carbonyl derivatives 
were used as probes in biological systems. [Re(diimine)(CO)3La,b,c]+ complexes, where La,b,c are 
shown in Figure 10; diimine = phen, 3,4,7,8-(CH3)4-phen, 2,9-(CH3)2-4,7-Ph2phen and 
dipyrido[3,2-f:2,3-h]quinoxaline, contain the ligand L with the coordinating pyridine linked to 
biotin. Biotin binds to the protein avidin and upon binding enhanced the emission of the rhenium 
chromophore; hence, the complex served as a recorder for the presence of avidin.42 
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Figure 10: Pyridine ligands 
Although not necessarily involving photoactive complexes, a variety of approaches have been used 
to design radiopharmaceuticals for imaging central nervous system receptors. Ultimately, such 
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studies are an important extension of photochemical applications of Re (I) complexes since the 
design of radiopharmaceuticals that luminescence (for detection) and are therapeutic (by radiation) 
is a topic of current interest.43 Re (I) complexes are usually studied prior to the preparation of Tc 
(VII) derivatives since their chemistries are so similar, although the use of Re isotopes for therapy is 
also possible. 
Rhenium complexes have been used as a pH sensor, as the emitting layer in organic light emitting 
diodes (OLEDs) and exploiting their luminescence sensing, was also used for anion recognition.44 
 
2.3 - Europium (III) and Cerium (III) 
 
Complexes of rare earth metals with organic ligands present an astounding class of emissive 
materials for OLEDs due to peculiarities of their luminescence properties.45 As defined by IUPAC, 
rare earth metals are a collection of seventeen chemical elements in the periodic table, namely 
scandium, yttrium, and the fifteen lanthanides.46 Most of the studies on these electroluminescent 
complexes have been limited to lanthanide compounds thanks to their unique ability to emit narrow 
line-like emission bands in the visible and near-infrared spectral regions. Their most stable 
oxidation state is +3, particularly in water, with a [Xe]4f n configuration. These properties of Ln3+ 
ions are permitted by the existence of 4f electrons which are efficiently shielded from external 
influences by the overlaying 5s2 and 5p6 orbitals. It is well known that the ligands in the first and 
second coordination sphere perturb the electronic configurations of the lanthanide ions only to a 
limited extent. The f–f transitions are parity and, sometimes, spin forbidden and consist mainly of 
weak magnetic dipole and induced electric dipole parts. The intensities of the first type are 
practically not influenced by the coordinating surroundings of the ion, whereas those of the second 
one are quite sensitive to it.47 Therefore, selection of organic ligands for luminescent lanthanide 
complexes is particularly important, considering that they can coordinate to a variety of ligands 
with different coordination numbers, most typically eight to ten. In most cases this role is played by 
O-O or O-N chelating groups with extended conjugated systems. In such compounds the 
luminescence of lanthanide ions is explained commonly by the ligand-to-metal energy transfer from 
the lowest triplet level of the ligands to a resonance level of the lanthanide ion.48 The simplified 
diagram in Figure 11 shows the energy migration paths in rare earth complexes. The metallo-
complex may undergo a radiative transition from the singlet state S1 to the ground state S0 
(molecular fluorescence). The excited S1 state can be non-radiatively deactivated to the triplet T1 
and then radiatively to the ground state S0 (molecular phosphorescence). The complex may undergo 
non-radiative transitions from the singlet or triplet states to an excited state of the metal ion (in the 
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case of lanthanide). Additionally, recent theoretical computations indicate that the ligand-to-metal 
energy transfers also include the ligand-to-metal charge transfer (LMCT).49 Due to the competition 
of radiative and non-radiative transitions, it is possible to observe some combination of ligand- and 
metal-centered emissions. 
 
 
Figure 11: Simplified diagram of energy migration paths. 
In general, for rare earth compounds three main types of electronic transitions are considered. The 
first one is the metal-centered f–f transitions of the lanthanide ions. The block of these metals can 
be divided in two parts: fluorescent (e.g. Pr(III), Nd(III), Ho(III), Er(III) andYb(III) emitting in the 
NIR region), and phosphorescent ones (e.g. orange Sm(III), red Eu(III), ultraviolet Gd(III), green 
Tb(III), yellow Dy(III) and blue Tm(III)). The second one, also involving metal-centered f–d 
transitions, interests the promotion of a 4f electron into the 5d subshell, meaning all transitions 
become spin-allowed. Generally, they occur at energies which are much higher than those of f–f 
transitions. Their energy depends largely upon the metal environment because the 5d orbitals are 
external and interact directly with the ligand orbitals.50 In addition, it has been pointed out (for Ce3+ 
complexes) that the metal-centered f–d transition can be viewed also as a metal-to-ligand charge 
transfer (MLCT) transition.51 Finally, ligand-centered or charge-transfer transitions represent the 
third type of electronic conversions. As a general rule, LMCT states are considered for the 
complexes of lanthanide ions, having high electron affinity, with organic ligands, which have low 
oxidation potentials. These transitions are allowed and as the p* ligand orbital is mainly delocalized 
over the acceptor ligand, the charge-transfer states may cause minimum structural distortion and 
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facilitate the energy transfer efficiency from ligands to the metal ion. An intermixture of various 
transitions in the complexes with complicated molecular structures is common and can play a 
crucial role for good luminescence efficiency.  
The relative ordering of these transitions may be changed in several ways: by the selection of the 
metal, by the choice and modification of the ligand, or by changing the geometry of the complex. 
Generally speaking, to achieve an efficient emission, a rare earth ion needs a carefully tailored 
environment consisting of organic ligands that simultaneously provide a rigid and protective 
coordination shell for minimizing non-radiative deactivation and ensuring effective population to 
the metal ion excited states through the energy transfer. 
As explained above, the lanthanide f–f transitions (electric dipole transitions) are “Laporte-
forbidden”, therefore, the generation of fluorescence from the lanthanide ion can be difficult. Direct 
excitation of the lanthanide ion can be achieved, but this only becomes practical with the use of 
lasers or at high ion concentrations. However, such inherent disadvantages can be overcome by 
using sensitization techniques52 (Figure 12). These involve the use of indirect excitation of the 
lanthanide ion with a sensitizing chromophore (often termed as an antenna), commonly an aromatic 
system,53 usually through an intramolecular energy transfer process.54 The antenna needs to be in 
close proximity to the lanthanide ion, therefore, generally, a ligand containing an antenna directly 
coordinates the lanthanide ion. 
 
Figure 12: Sensitisation techniques 
 
The presence of coordinated O–H, N–H and C–H oscillators (also in the solvent), associated with 
unsaturated complexes, has significant implications because non-radiative quenching of the 
lanthanide excited states can occur through vibrational harmonics of these oscillators. 
The hard Lewis acidity of the lanthanide ions results into a specific preference towards ligands 
incorporating atoms that can act as hard Lewis bases or can be easily polarized. Therefore, 
combinations of amines and carboxylic groups are commonly used in lanthanide complexation.55 In 
16 
 
order to fully coordinate a lanthanide ion, either a high-level polydentate ligand such as a cryptate 
(Figure 13a) or a number of smaller ligands (such as 1,3-diketones, Figure 13b) working in 
cooperation are required. Both (a) and (b) are two of the simplest coordination complexes possible 
for lanthanide ions. In both cases there are no antennae present. However, the number of bound 
solvent molecules is decreased considerably from nine (for lanthanide ions in solution) to one or 
two for the cryptate and three for the 1,3-diketone complexes.  
 
                                (a)                                                        (b) 
Figure 13: Lanthanide complexes 
 
There are many examples of “podand-type” ligands56 and the bypyridyl (bpy)-based podand ligand 
has been used to form lanthanide complexes. These can be considered as ligands with integrated 
antenna as shown in Figure 14. 
NN
N
NN N
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Figure 14. An example of a “podand-type” ligand 
 
Considering the energy level schemes, it can be assumed that there are only three trivalent 
lanthanides (Ce3+, Pr3+, Nd3+) for which allowed f–d emission can be observed. This three metals 
exhibit a broad emission band in the UV-vis region, but really only Ce3+ is characterized by strong 
f–d transitions. This indicates that the overlap between the 4fn-1 core and the delocalized 5d 
electron decreases with n. Generally, the emission of Ce3+ ion occurs in the UV and/or in the blue 
spectral region and can be red-shifted depending on the ligand environment.57 However, in some 
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cases the organic ligands in cerium complexes quench the luminescence of metal ion, and this is 
why the design of efficient electroluminescent cerium complexes is a very complicated task and 
examples of such compounds are limited. 
Europium complexes have attracted considerable attention as red emitting materials, due to the 
strong metal-centered luminescence of Eu3+. This emission is explained by electronic transitions 
from the lowest excited state, 5D0, to the ground state manifold 7FJ (J = 6–0) level. The most 
intense emission line corresponding to 5D0→7F2 is observed at 614 nm.  
A large variety of europium complexes have been synthesized during the last decade with the aim 
of exploiting their electroluminescent properties. It is well known that the simple homoleptic -
diketonate europium complexes show a highly efficient photoluminescence, but due to the poor 
carrier transport ability they do not satisfy the requirements for OLED materials. To improve these 
properties, two strategies have been developed: (i) introduction of charge transport substituents in 
the ligands and (ii) introduction of ancillary ligands enhancing an emission of a metal atom. 
In recent years a few examples of mixed f–d metal complex have been developed. One of the 
driving forces for such work has been that the excited states of NIR-emitting ions such as Yb(III), 
Eb(III), and Nd(III) in particular, can be formed by excitation in the visible region.58 As many 
transition metal complexes often have strong MLCT absorption bands in the visible region, then 
these are ideal as antennae for the population of these ions. This has been elegantly shown by many 
researchers.59 This is of particular interest as it opens up new potentials for sensing of biological 
systems in the NIR. Moreover, the photophysics of transition metal complexes is well established 
and explored, and many varieties of ligands are available that can be used to construct mixed f–d 
metal complex (Figure 15).  
 
Figure 15: Examples of mixed metal complexes 
In an analogues manner, other examples of such mixed complex have been developed.60,61 For 
instance, De Cola et al.61 developed a the system consisting in a heterotrimetallic complex, in which 
the excitation of the Eu(III) occurs via energy transfer from a Ir(III)-based metal-based antenna. 
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Interestingly, the emission of almost-white light can be observed if there is only partial energy 
transfer fromthe excited Ir(III)-based chromophore. If this occurs, the Eu(III) red emission 
combined with the residual blue emission from the iridium complex gives rise to a global white 
light emission (Figure 16). 
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Figure 16: White light emitting mixed complex 
 
2.4 - Zinc (II) 
No other metal has as many functions in living organisms as zinc.62 In one of the early reviews on 
its biochemistry Vallee63 noted that it occurs in all six groups of the IUBMB (International Union of 
Biochemistry and Molecular Biology) enzyme classification. The number of enzymes known to 
contain zinc in the active center now exceeds 1000.64 In mid 2007 the Brookhaven protein data 
bank lists some 40 000 structures of proteins, out of which almost 5000 contain zinc, and it has 
been found that 3% of the human genome contain the code for zinc finger proteins.65 All this 
despite the fact that the zinc ion neither possesses color, magnetism or redox properties, nor 
provides stability or inertness to its complexes: all these characteristic have made zinc considered 
the “boring element” in teaching and research for decades. In the majority of cases the role of zinc 
ions in proteins is structural, comparable to that of hydrogen bonds.  
The uniqueness of zinc is well-hidden. Unlike iron, present in the blood or in the meat, we do not 
see it. Unlike cobalt, nickel, copper or cadmium, we can hardly poison ourselves with its 
compounds. It is only appropriate in this scenario that one has a hard time finding zinc in the 
textbooks. Thinking about this, one can concluded that when there are no characteristic features 
leading the way to the unique properties of zinc in biology, their absence may be the clue. Namely, 
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the non-properties of zinc are the secret of its success. Whether zinc with its filled d shell is a 
transition metal or not may be a semantic question, but of course its properties resulting from the 
filled d shell are essential. A rather trivial consequence of the electronic configuration of zinc and 
hence its chemical properties is its bioavailability. Definitely the redox inertness and the hard-soft 
properties of zinc play an important role. The intermediate nature of zinc in this respect, not really 
hard and not really soft, certainly makes it suitable to be bound to and to act in all available donor 
environments in living organisms.  
These non-properties make zinc what it is: available, mobile and versatile.  
Recently, there has been growing interest in the photochemistry of luminescent Zn(II) coordination 
complexes in the form on monomeric, multinuclear, and polymeric species.66 The zinc(II) ion can 
be used to assemble different units and build up long rod-like linear structures which can be 
considered coordination polymers.67 Zinc complexes with nitrogen ligands display interesting 
optical properties for LED devices and sensors,68 but also for application in imaging techniques69 
and as fluorescent sensors in biological systems.70 
As colourless d10 metal ion, Zn(II) can assume coordination geometries from tetrahedral through 
trigonal-bipyramidal and square-pyramidal to octahedral, hence suitable for the construction of 
luminescent coordination complexes. In fact, some of the monomeric or multinuclear complexes are 
electroluminescent materials and used in organic light-emitting diodes (OLEDs). 
A 4-oxo-bridged tetranuclear Zn(II) complex, Zn4O(prp)6, prp=1H-pyrrolo[2,3-b]pyridine,71 was 
suggested to be one of the white electroluminescent materials which may be used in OLEDs. In 
particular, research on Zn (II) complexes as emitting as well as electron transport materials has 
recently improved advanced.72 The electron transport layer plays an important role in transporting 
electrons and blocking holes, thus preventing holes from moving into the electrode without 
recombining with electrons.73  
Moreover Zn(II) ion is highly promising with respect to cost and toxicity, therefore a variety of 
systems with high photoluminescence (PL) quantum yields and electroluminescence performance 
has already been synthesized.74 Zn(II) has received attention because of its ability to enhance the 
emission of the ligands and tune some of the properties67 (Figure 17). Due to the d10 electron 
configuration of Zn(II) ions, metal-to-ligand charge-transfer (MLCT) processes do not occur in 
such systems.75 Only Intraligand Charge Transfer (ILCT) is observed. 
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                                                       H2L                                              ZnL 
Figure 17: Qualitative states diagram of H2L and ZnL compounds. Solid line:allowed radiative 
transitions; dotted line: forbidden (or weak) transitions; curves: non radiative decays. 
 
After the ligand coordinates with Zn(II) ion, as a result of perturbation of the lowest unoccupied 
molecular orbital (LUMO), the absorption maximum at the longest wavelength is shifted 
bathochromically, compared to the free ligands. Since MLCT has to be excluded for Zn(II) because 
of its d10 electron configuration, this shift can be explained by ILCT processes.76 After 
complexation of the ligand with Zn(II), the emission is usually red-shifted and strongly increases in 
intensity.77 Several reports on the structure, photoluminescence and theoretical studies of Zn(II) 
coordination complexes have been published recently, exploring the relationship between the 
structure and the photoluminescence properties. These large shifts suggest an enhancement of the π-
conjugation due to the bidentate complexation of the ligand to the d10 spectroscopically inactive 
Zn2+ ion, giving rise to a decrease in the π*-π energy gap of the ligand molecular orbitals 
responsible for the transitions.78 The bidentate coordination imposes a planar conformation in the 
ligands by restricting the rotation about the C bonds. 
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3) Luminescence and luminescent materials 
3.1- Luminescence 
The emission of light is a physical phenomenon which occurs in response to an external stress, 
which may be in the form of thermal, electrical or chemical energy. This phenomenon is called, in 
general, luminescence, and, depending on the nature of the external stimulus, it assumes different 
designations, as reported in Table 1: 
Name Stimulus 
Bioluminescence Enzymatic reaction 
Chemiluminescence Chemical Reaction 
Electrochemiluminescence Chemical reaction electrochemically induced  
Electroluminescence Electricity 
Photoluminescence Photons 
Radioluminescence Ionizing 
Sonoluminescence Sound Waves 
Thermoluminescence High temperature 
Triboluminescence Mechanical efforts  
Table 1. Types of luminescence according to the excitation source. 
 
The most well-known phenomenon is the photoluminescence and, in this case, the substance able to 
emit light after absorbing the luminous radiation is called fluorophore.  
According to the Boltzmann distribution, at room temperature the population of higher electronic 
levels is negligible compared to the one of the lowest energy level, the ground state. For this reason, 
it is assumed that almost all of the molecules are in the lower electronic state, with orbitals occupied 
by pairs of electrons with paired spins (antiparallel), in order to have total spin equal to 0 and 
multiplicity equal to 1 (singlet ground state S0). When subjected to excitation, most of the 
molecules are promoted from the S0 state to an Sn electronic excited state. Regardless of the type of 
energy provided, the excited state is not stable, therefore exited molecules will return to the ground 
state through radiative or non-radiative decay mechanisms. The non-radiative decay mechanisms 
take place without the emission of photons and consist mainly of the following processes: 
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- vibrational relaxation: the excited molecule transfers vibrational energy through collisions 
with the surrounding molecules of solvent (time ≈ 10-12 s); this mechanism is favored at high 
temperatures; 
- internal conversion: transitions between two electronic states of the same multiplicity (time 
≈ 10-13 s); 
- conversion between systems (intersystem crossing): transition between two electronic states 
of different multiplicity, for example from singlet to triplet (time ≈ 10-8 s). 
The radiative decays occur as emission of photons, and are named in the following ways: 
- fluorescence: transition from the lowest excited singlet state S1 to the ground state S0 (time ≈ 
10-9 s); 
- phosphorescence: transition from the triplet lowest excited state T1 to the singlet ground 
state S0 (time ≈ 10-6 s); 
- radiation of resonance: emission with a frequency equal to that absorbed. Occurs only for 
low pressure gas (time ≈ 10-8 s). 
Observing the specific lifetime of the processes listed above, it can be noted that the non-radiative 
mechanisms are always competing with the radiative ones, so that the latter may not be displayed at 
all. This can be due to several factors such as, for example, the great flexibility of the molecular 
structure, the high temperature, which favors the collisions, or the presence of a solvent able to 
absorb the energy of the excited molecule.79 Accordingly, the fluorescence or phosphorescence 
phenomena are rarely observed, and most of the substances does not present these phenomena at all. 
The Jabloski diagram is the best way to summarize the above listed mechanisms80 (Figure 18). 
Generally, a molecule excited to a Sn state decays to the excited state S1 (the lowest of the excited 
states) through internal conversion.81 Therefore, the fluorescence can be observed only for the 
decay from S1 to S0,82 but remaining in competition with the internal conversion. 
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Figure 18. The Jablonski diagram. 
The phosphorescence emission occurs only when the intersystem crossing is efficient enough to 
compete with other mechanisms, allowing the triplet states to become populated, because a 
transition with a change of spin would not be permitted by the selection rules. Furthermore, on the 
basis of the maximum multiplicity principle, the triplet states have lower energies of the 
corresponding singlet states, therefore the phosphorescence emission is observed at longer 
wavelengths than fluorescence.  
A further mechanism that can lead to the deactivation of an excited state is the quenching, which 
can be: 
- collisional quenching: a bimolecular process that occurs when a fluorophore and a 
substance, said quencher, able to receive the excess energy possessed by the excited 
molecule, hit each other.; 
- static quenching: occurs when a non-fluorescent fluorophore-quencher complex is formed; 
- self-quenching: a phenomenon which occurs when molecules of the same fluorophore act as 
a quencher, or in the presence of substances that absorb at the wavelength of emission of the 
fluorophore. 
In particular, the substance that can more easily cause the phenomenon of collisional quenching is 
molecular oxygen,83 which has a triplet ground state at lower energy than the singlet state. 
The ability of a given substance to emit is quantified with a magnitude, called quantum yield, which 
is calculated as the ratio of the energy emitted by radiation and the total absorbed energy: 
 Qkkk
k
QNRR
R

  
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where kR, kNR and kQ are the rate constants of radiative, non-radiative and quenching processes, 
respectively. It is evident that to maximize the fluorescence, the speed of the other processes that 
lead to deactivation of the excited state, i.e. the concentration of quencher, should be reduced as 
much as possible. 
Another parameter which is evaluated in photophysical studies is the lifetime, also called decay 
time (τ), which is the average time that the molecule spends in the excited state before decaying in a 
radiative way. 
 Qkkk QNRR 

1
  
This parameter is essential for the evaluation of the possible applications of different luminescent 
compounds. The fluorescence and the phosphorescence are distinguished by their lifetime: the first 
has an average lifetime of the order of nanoseconds, while for the second the lifetimes are usually of 
the order of microseconds. 
 
3.2 - Luminescent materials 
 
Over recent years, materials with luminescent properties have attracted increasing interest thanks to 
their applications in science and technology. They are mainly used in devices such as light emitting 
OLEDs (Organic Light-Emitting Diodes) and LEECs (Light-emitting Electrochemical Cells), which 
is the next-generation technology used in computers, televisions and cell phones flat displays.84,85 
In these devices, the electroluminescent layer usually consists of a semiconductor film of an organic 
compound able to emit light as a result of an electrical stimulus. This phenomenon is made possible 
by the presence of emitters (cationic or neutral), incorporated in the organic matrix. 
In this context, it has been observed a significant increase of interest in the synthesis of transition 
metal complexes (Ir(III), Re(I), Ru(II), Pt(II) and Os(II)) with organic ligands;86 the reason for such 
expansion can be attributed to their unique luminescent properties together with high photochemical 
and thermal stability and a potential internal quantum efficiency of 100%. These complexes are able 
to exploit the fluorescence emission from singlet excited states as well as the phosphorescence from 
triplet states, generated by a high spin-orbit coupling, typical of the elements belonging to the 
second and third transition series, which allows an efficient intersystem crossing. 
In particular, Ir(III) complexes exhibit high electroluminescence,87 electrochemical reversibility and 
synthetic versatility; in addition they are also characterized by an internal quantum efficiency higher 
than that shown by the other transition metals complexes,88,89 which makes them ideal candidates 
for devices. 
25 
 
The luminescent Ir(III) complexes present an octahedral symmetry and can be divided into two 
categories: 
• homoleptic: contains three identical cyclometallated ligands  
• heteroleptic: contains two cyclometallated ligands and one ancillary ligand. 
Despite the neutral complexes are the object of intense study by the scientific community, since 
they are the most common dopants used in OLEDs, recently electrically charged derivatives are 
receiving increasing attention for their applications in LEECs.90,91,92 
A further reason since the iridium complexes are considered excellent candidates for forming bright 
materials resides in the possibility of easily tune the wavelength of the emitted radiation, by 
appropriately varying the ligands.93,94,95 Indeed, it is possible to obtain stable and efficient emitters 
in the ranges of the three primary colors,96 blue (450-470 nm), green (500-550 nm) and red (650-
700 nm) (Figure 19), obtaining thus devices that emit throughout the visible spectrum. 
 
Figure 19: Blu (a), green (b) and red (c) emitting iridium complexes. 
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4) Purpose of the work 
As illustrated in the previous sections, the synthesis of luminescent metal complexes is a very 
challenging task since they can be regarded as the starting point for a lot of different areas. 
Luminescent complexes, in fact, can be used for technological, industrial, medical and biological 
applications. They consist of two main parts: the central core of the complex, a metal atom, and 
organic ligands of various nature bonded to it.  
During my PhD I worked with different metals having distinguishing intrinsic properties that make 
them different from each other and, in particular, more or less suitable for the different possible 
uses, considering the key strength of each metal. 
For example, Iridium complexes show the best photophysical properties: generally, they have high 
quantum yields, very long lifetimes and possess easily tunable emissions throughout the visible 
range. On the other hand, Iridium is very expensive (IrCl3·x H2O, 99.9%, 258.5 €/g, Sigma-Aldrich, 
2013) and scarcely available, and therefore its use for industrial purposes is not practicable. The aim 
of my work concerning this metal was, therefore, to synthesize ligands able not only to form 
luminescent complexes, but also able to add something to the final complex, increasing its 
properties, and therefore its possible practical uses. In detail, I synthesized new bifunctional ligands 
good to complex Iridium(III), but that at the same time, containing a functional group (FG) able to 
perform an additional purpose, i.e. to bio-conjugate particular proteins or suitable to co-polymerize, 
forming luminescent polymers (Figure20).  
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Figure 20: Functionalized Iridium complexes.  
 
In addition, exploiting the iridium properties, new complexes emitting in the blue spectral region, 
color still difficult to be achieved by reported iridium complexes, were synthesized. 
Since Re(I) derivatives have been reported to be suitable as probes in biological system, even if the 
photophysical properties of its complexes are less impressive than those of Iridium ones, and the 
use of Re(I) reduces the costs (ReCO5Br, 98%, 115 euro/g Strem Chemicals), the synthesized 
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bifunctional ligands containing a pyridine-triazole and a biotin unit were employed to obtain new 
Re(I) complexes able to recognize a specific protein (Figure21). 
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Figure 21: Biotinylated Rhenium complexes 
 
Europium and Cerium belong to the family of lanthanides, and they show their own characteristic 
emissions when linked to specific ligands. Eu(III) and Ce(III) salts I used are quite cheap (average 
cost of about 20/25 euro/g) and relatively non-toxic compared to other heavy metals. The aim of my 
work was to design and synthesize new ligands able to form stable complexes with these two 
metals, in order to obtain an emission in the range of visible light. Furthermore, owing to the high 
coordination number displayed by lanthanides, these ligands had to be sufficiently chelating to 
protect the central metal atom by external agents such as moisture or solvents, which can turn off 
the final complex emission. 
Finally, my work focused on the synthesis of ligands able to link Zinc. Zinc is a low cost 
(Zn(ClO4)2·6H2O, 39.4 euro/100g Sigma-Aldrich) and especially non-toxic “green” metal. Zinc has 
not its own emission, but when it sticks to ligands, it increases their photophysical properties, 
forming luminescent complexes, that can be used for many purposes. 
Therefore I plan to synthesize organic derivatives able to link the Zinc atom through a terpyridine 
unit, which already possessed an emission thanks to the presence of other many chromophoric 
groups, such as carbazole (Figure 22). 
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Figure 22: Carbazole-terpyridine derivatives. 
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6) Bifunctional ligands  
6.1 - Luminescent Ir(III) methacrylic copolymers 
In order to be employed in luminescent devices, the low molecular weight organometallic 
compounds are usually dispersed in a conductive polymer matrix, necessary to transfer the energy 
generated by an external electric field to the fluorophore, which, after photoinduced excitation, 
emits phosphorescent light. However, one of the limitations that can affect the performance of the 
devices is the high tendency of fluorophores to aggregate or to migrate toward the surface of the 
emissive layer, difficultly maintaining homogeneous dispersions, required to avoid quenching 
phenomena. 
To overcome these problems, some examples of fluorophores covalently bonded to a polymer 
chain, and not simply dispersed, are reported in literature.[1-5] Many efforts have been made in order 
to obtain homogeneous, stable and easily processable material in which the fluorophore is also 
protected from oxygen and moisture. Among copolymers containing iridium complexes in the side 
chain, polyethylene oxide (PEO) and polystyrene (PS) functionalized with Ir(ppy)2(tpy) and Ir(ppy-
CHO)2(tpy) (where ppy = 2-phenylpiridine, tpy = terpyridine, ppy-CHO = 4-(2-pyridyl) 
benzaldehyde) are reported.[1] These materials, prepared by spin-coating, emit yellow light; in 
addition the AFM analysis showed that these thin films are homogeneous and free from defects, 
such as crystal formation or holes, demonstrating their potentials for electroluminescent devices. 
Examples of copolymers of N-vinyl carbazole and styrene, functionalized with various iridium (III) 
complexes,[3-6] are also reported. The photophysical characterization of these products showed an 
improvement of their performances, if compared to the ones containing the respective “free” 
complexes. 
Part of the research carried out during my PhD lies in this framework. In fact, I plan to obtain a 
copolymer in which a photoactive iridium complex is covalently linked to a macromolecular chain 
and to study its luminescence properties in comparison with those of the corresponding low 
molecular weight emissive compound. 
For this purpose, the bifunctionalized ligand 9-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl) undecyl 
methacrylate (ptuma) was synthesized. It is capable, on one hand, to chelate an Ir(III) unit forming 
a luminescent complex and, on the other hand, to polymerize in the presence of methyl 
methacrylate (MMA). This ligand was then coordinated to the metal center to obtain the Ir-
luminescent monomer Ir(ppy)2(ptuma)Cl which was subsequently copolymerized in the presence 
of different amounts of MMA, (Figure 3). 
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Figure 3: Ir(ppy)2(ptuma)Cl monomer. 
Easily filmable and transparent methacrylic copolymers were then obtained: they are characterized 
by variable composition and contain an Iridium complex Poli[Ir(ppy)2(ptuma)-co-MMA] in the 
side chain (Figure 4). The presence of the covalent bond between the Ir(III) complex and the main 
chain ensures a homogenous dispersion of the fluorophores throughout the material, precluding it 
migration towards the surface and avoiding the formation of aggregates. Furthermore, by varying 
the amount of fluorophores, it is possible to minimize the quenching phenomenon caused by an 
eventual proximity of various complexes. 
 
Figure 4: Copolymer Poli[Ir(ppy)2(ptuma)-co-MMA] structure. 
6.1.1 - Results and discussion 
6.1.1.1 -Ligand synthesis 
In detail, ligand ptuma was obtained following the synthetic strategy reported in Scheme 1. The 
azide derived from the reaction of 11-Br-undecanol 1 with NaN3 underwent to a “click reaction” to 
form the 1,4-disubstituted 1,2,3-triazole 2 (85% yields from 1) when treated with 2-alkynylpyridine 
under CuAAC conditions. The hydroxyl pyridine-triazole 2 was transformed into the methacrylate 
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ester ptuma by reaction with freshly distilled methacryloyl chloride in presence of hydroquinone to 
prevent possible polymerization side reactions. 
Br OH
9
1) NaN3, DMSO, rt, 24h
2) 2-ethynylpyridine,
Cu(SO4)2, Na-ascorbate,
tBuOH/H2O, rt, overnight
3) NH3 aq, DCM
N
N
N
N
OH
9
TEA,
THF dry, N2, rt, 24h.
N
N
N
N
O
91
2 ptuma85% yields 74% yields
OH
HOO
Cl
,
O
 
Scheme 1 
 
6.1.1.2 – Ir(III)-monomer synthesis and characterization. 
The monomer bis-(2-phenylpyridine)-9-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)undecyl 
methacrylate-Ir(III), (Ir(ppy)2(ptuma)Cl) was synthesized by reacting the iridium dimer 
{[(ppy)2Ir(µ-Cl)]2},[7, 8] with the ancillary ligand ptuma (Scheme 2). 
N
N
N
N
O
9
ptuma
O
N
N
N
N
O
9
O
Ir
N
N
Cl
N
N
Ir
Cl
2
+
DCM/EtOH 3:1
r.t., 24h.
[(ppy)2Ir(-Cl)]2
[Ir(ppy)2(ptuma)]Cl
 
Scheme 2: Ir-monomer synthesis. 
6.1.1.3 - Synthesis and characterization of polymeric compounds. 
The Ir-monomer [Ir(ppy)2(ptuma)Cl] was copolymerized through a radical reaction with methyl 
methacrylate (MMA) as a co-monomer in different molar ratios, in order to obtain copolymers with 
variable composition, as reported in Scheme 3. All polymerizations were conducted in a sealed vial 
at 60 °C, for 72 hours under vacuum, using dry THF as solvent (1 g of monomer in 15 mL of 
solvent) and 2-2'-azo-bis-isobutyronitrile (AIBN) (2% in weight with respect to the monomer) as a 
thermal initiator. 
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Scheme 3: Copolymers synthesis. Poli[Ir(ppy)2(ptuma)-co-MMA] 
n=1, m=130, 150, 450, 820, 850, 1100, 2000, 12100. 
 
The obtained copolymers were purified by precipitation, using a methanol/hexane = 3:1solution to 
remove the unreacted monomer. In Table 2 the data of the synthesis of several polymers and their 
average molecular weight determined by gel permeation chromatography (GPC) in THF at 25 ° C, 
using monodisperse polystyrene samples as standard, are reported 
 
Feeding reaction (mol) Polymer 
Ir(ppy)2(ptuma) MMA Ir(ppy)2(ptuma)
a MMAa Yield (%)b 
Mn 
(g/mol)c
Mw/Mn
c Tg (°C)
d 
1 50 1 130 42 18800 1.7 120 
1 100 1 150 45 20100 1.8 122 
1 200 1 450 40 23000 1.7 123 
1 400 1 820 60 21300 1.7 103 
1 500 1 850 60 37000 1.3 123 
1 1000 1 1100 68 22500 1.7 123 
1 2000 1 2000 65 32000 1.8 122 
1 10000 1 12100 64 38900 1.6 112 
 
Table 2:  Copolymers data. a Determined by UV-Vis analysis, b Calculated as (g of polymer / g of 
monomer) x 100, c Determined by GPC in THF at 25 ° C d Glass transition temperature determined 
by DSC (10 ° C / min) in nitrogen. 
 
The polymerization was confirmed by 1H-NMR spectra, in which the signals enlargement and the 
disappearance of the vinylic protons at 6.10 and 5:55 ppm can be observed. However, it was not 
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possible to determine the final composition of the copolymers by 1H-NMR analysis, due to the low 
intensity of the signals of the co-monomer containing the iridium complex. 
For this purpose, the absorption spectra of all polymers and the monomer [Ir(ppy)2(ptuma)Cl] 
were recorded. Since the molar absorption coefficient of the complex at 257 nm (the area in which 
the MMA does not absorb) is known and assuming that it remains unchanged even when the 
chromophore is attached to a macromolecular chain, it was possible to determine the final 
composition of the different copolymers (Table 2). From the obtained data, it can be noted that the 
final composition does not reflect the initial feed: the methacrylic monomer [Ir(ppy)2(ptuma)Cl] 
has, in fact, a low reactivity compared to MMA, probably because of its steric hindrance. 
Nevertheless, it was possible to obtain copolymers with variable amount of iridium complex. 
From the DSC measurements, performed in a temperature range between 25 and 200 ° C, it can be 
noted that all synthesized polymeric derivatives have only thermal transitions of the second order, 
typical of glass transitions (Table 2). Endothermic crystalline melting peaks do not appear, in 
agreement with the substantially amorphous character of these macromolecules in the solid state. 
UV-Vis analysis. 
All the synthesized copolymers and the monomer containing the iridium complex, were 
characterized by UV-Vis spectroscopy in chloroform solution. 
All obtained spectra have two characteristics absorption bands: one in the ultraviolet region, very 
intense (molar absorption coefficient 4·104 L mol-1 cm-1), centered at about 257 nm and attributable 
to the  * transitions of ligand aromatic rings.[9, 10] The second one, less intense and enlarged 
compared to the first, is centered at about 290 nm, and it is due to the metal to ligand charge transfer 
(MLCT).[9-11] 
From the comparison of copolymers and monomer UV-Vis spectra (Figure 5), it is observed that the 
position of the absorption maxima ( max) does not change. 
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Figure 5: poly[Ir(ppy)2(ptuma)Cl-co-MMA] 1:820 () and monomer [Ir(ppy)2(ptuma)Cl] (• • •) 
UV-vis spectra in chloroform. 
 
This behavior, already reported in literature,[4,5,12] shows that the transition from single isolated unit 
to the macromolecular system does not involve effects on the energy difference between the ground 
state and the excited state of the chromophoric system. From the absorption spectra, it was possible 
to determine the final composition of synthesized copolymers (Table 2), not determinable by 
1HNMR analysis. Given the molar extinction coefficient of the unit containing the iridium complex 
as a constant and equal to that of the low molecular weight monomer, it was possible to calculate 
the relative amount of the two co-monomers in each polymer by absorbance measurements. 
 
Photophysical properties 
The photophysical properties of the luminescent monomer [Ir(ppy)2(ptuma)] have been studied 
under the following conditions: 
- Solution at 298 K (Sol 298 K); 
- Degassed solution at 298 K (Sol deg); 
- Frozen solution at 77 K (Sol 77K). 
The excitation (Ex) and emission (Em) maxima, the determined lifetimes () and quantum yields 
() are reported in Table 3. 
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Figure 6: Monomer emission spectra. 
 
As shown in Figure 6, the emission spectrum of the degassed solution is found to have a higher 
intensity than that of the solution in the presence of oxygen; this is due to the phenomenon of 
collisional quenching caused by the presence of molecular oxygen dissolved in the solution when it 
is not degassed. This phenomenon is characteristic of species whose emission originates from a 
triplet excited state. The spectrum of the frozen system at 77 K shows an increase of the emission 
intensity due to the decrease of the not competitive radiative processes, and a shift of the emission 
maximum towards higher energies, in accordance with the nature of MLCT excited state. The data 
of  the monomer, shown in Table 3, also put into evidence as both the lifetimes and the quantum 
yields improve significantly when the samples is degassed. The lifetime of the frozen solution is 
even greater. 
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Monomer Ex Em  (ns) 
          
Sol. 298K 266, 382 478, 508 175 6% 
          
Sol.Deg. 298K 266, 382  480, 510 1646 33% 
          
Sol 77K 268, 290, 310 
470, 506, 
536 4195 x 
          
solid 348, 430 488, 530 91 (34%),  0,7 
      630 (66%)   
         
POLI 1:130 Ex Em  (ns) 
        
  290, 380 478, 508 2780 20,1 
        
POLI 1:150 Ex Em  (ns) 
        
  290, 380 478, 508 2800 27,1 
        
POLI 1:450 Ex Em  (ns) 
        
  290, 380 478, 508 2730 35,2 
        
POLI 1:700 Ex Em  (ns) 
        
  290, 380 478, 508 2785 45,4 
        
POLI 1:820 Ex Em  (ns) 
        
  290, 380 478, 508 2915 52,3 
        
POLI 1:850 Ex Em  (ns) 
        
  290, 380 478, 508 2780 49,7 
        
POLI 1:1100 Ex Em  (ns) 
        
  290, 380 478, 508 2765 54,7 
        
POLI 1:2000 Ex Em  (ns) 
        
  290, 380 478, 508 2641 60,3 
        
POLI 1:12100 Ex Em  (ns) 
        
  290, 380 478, 508 2646 59,7 
          
 
Table 3: Photophysical properties. 
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The emissive properties of the copolymers have been investigated in the solid state, on films of 
thickness of about 1 m, obtained by spin-coating. As can be seen from the obtained data (Table 3), 
the emission maximum [Em ()] remain unchanged for all compounds, because the emissive 
component is only the cyclometallated iridium complex. The lifetimes obtained for all the 
copolymers, instead, are lower than those of the monomer frozen at 77 K, but higher than those of 
the monomer in solution. This data are encouraging for a possible application of these materials in 
devices. The quantum yields exhibited by these films are interesting too. In fact, it can be observed 
as  increases with decreasing the dilution of the iridium complex present in the polymer, reaching 
an asymptotic value of around 60% for poly [Ir(ppy)2(ptuma)-co-MMA] 1:2000 and 1:12100 
(Figure 7). 
 
 
Figure 7: Trend of the quantum yield  depending on the amount of MMA in the copolymers. 
 
From these data it can be deduced that the lower concentration, hence the greater dispersion of the 
iridium complex in polymers, avoids the formation of emissive component aggregates, which would 
lead to a decrease of the quantum yields and lifetimes, for self-quenching. Given the obtained 
results, the synthesized materials show promising features to be processed into thin films and used 
as emissive systems in devices LEECs and / or OLEDs. 
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6.1.2 - Conclusions 
In this work the possibility to synthesize polymeric materials containing an organometallic 
luminescent complex covalently bound to the side chain, in order to improve the performance of the 
emissive compound has been studied. These new materials being transparent and easily filmable, 
allow the polymer to increase the photophysical properties of the iridium complex. In fact, it 
combines the advantage of working in the solid state and in "degassed" environment, to the fact that 
the iridium complex is located in a diluted matrix which limits any quenching phenomena which 
should be to lower its emission intensity and consequently lifetimes and quantum yields. The fact 
that the complex is covalently linked to the polymer chain and not simply mixed with it allows to 
have homogeneous dispersions and to avoid self-aggregation phenomena (Figure 8). 
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Figure 8: Schematic representation of the polymers. 
Specifically, a new cyclometallated iridium complex, bis-(2-fenilpiridina)-9-(4-(pyridin-2-yl)-1H-
1,2,3-triazol-1-yl)undecylmethacrylate-iridium(III) [Ir(ppy)2(ptuma)Cl], was synthesized and 
characterized which has been copolymerized in the presence of MMA in different amounts. The 
final composition of the so obtained new polymeric materials, determined by UV-Vis spectroscopy, 
showed a lower reactivity of methacrylic monomer containing the iridium complex compared to 
MMA, probably due to its steric hindrance. Thermal analysis of the copolymers showed their 
amorphous character in the solid state. The position of the absorption and emission maximum, of 
the monomer [Ir(ppy)2(ptuma)Cl] and polymeric compounds is unchanged, regardless of the 
amount of complex present, indicating that the emissive component does not undergo variations 
after the copolymerization. By the analysis of the lifetimes and quantum yields promising results 
were obtained, showing a clear improvement in polymeric compounds compared to the luminescent 
monomer in solution. In addition, the upward trend of the quantum yields with decreasing 
concentration of the complex, suggests a progressive decrease in the self-quenching effects. 
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6.1.3 - Experimental section 
Solvents and materials 
The methyl methacrylate (MMA) was distilled at reduced pressure (P = 260 mmHg) at 60 ° C under 
a stream of dry nitrogen before use. The tetrahydrofuran (THF) (Aldrich) was left a few hours 
onKOH, then distilled on Na-K alloy under an atmosphere of dry nitrogen and subsequently 
redistilled of Na-K alloy and benzophenone.[13] 2-2'-azobis-isobutyronitrile (AIBN) (Aldrich) was 
crystallized from absolute ethanol before use. Other commercial reagents and solvents (Aldrich) 
were used without further purifications. 
 
Products characterization 
The NMR spectra were obtained at room temperature with a spectrometer Varian MercuryPlus VX 
400 (1H, 399.9) using, when possible, to 5-10% solutions in CDCl3. The chemical shifts are 
expressed in ppm from tetramethylsilane (TMS) as an internal reference. The UV-Vis spectra (250-
700 nm) were recorded at 25° C in CHCl3 solutions with a spectrophotometer Perkin Elmer 
Lambda 19, using quartz cells. The DSC measurements were carried out using a Thermal Analysis 
DSC Q2000 calorimeter modulated, equipped with a cooling system RCS, adopting a temperature 
program consisting of three heating from ambient temperature and two coolings with speed 10 ° K / 
min in nitrogen. The average molecular weights of the polymer samples were determined from 
solutions of THF using a HPLC Lab Flow 2000, equipped with a Rheodyne injector 7725th, column 
Phenomenex Phenogel 5 MXL and a refractive index detector RI Knauer K-2301. The calibration 
curve was constructed with standard monodisperse polystyrene samples. The emission spectra in 
the steady state were recorded with a spectrofluorimeter Edinburgh FLS920P equipped with a 
xenon arc lamp, double excitation monochromators and single issue, a Hamamatsu R928P 
photomultiplier tube (185-850 nm) with Peltier cooling. The excitation and emission spectra were 
corrected for intensity of source (lamp and grating) and emission spectral response (detector and 
grating) by means of the calibration curve supplied with the instrument. The emission lifetimes 
were determined on the same instrument Edinburgh with the technique Time Correlated Single 
Photon Counting (TCSPC), using pulsed LEDs (EPLED EPLED 295 or 360, FHWM <800 ps, 
repetition rate between 10 kHz and 1 MHz) as a source of excitation and the photomultiplier tube as 
a detector. The quantum yields of emission were determined on dilute solutions, with reference to 
standard solutions of Ru(bpy)3Cl2 in acetonitrile (r)[14]: 
2
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where I is the area of the emission peaks of the complex and the reference sample, A is the 
absorbance and n is the refractive index of the solvent. 
 
Ligand and Ir-monomer synthesis  
 
Synthesis of azide 2: In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, 11-
bromo-1-undecanol 1 (0.75 g, 3.0 mmol) and NaN3 (0.39 g, 6.0 mmol) was dissolved in 10 mL of 
DMSO. The reaction mixture was stirred under at room temperature for 24 h. Then water (15 mL) 
was added and the aqueous phase was extracted with ethyl acetate (3X 10 ml). The organic layer 
was dried over MgSO4 and the solvent evaporated to give brown oil (98% yields). The product was 
used in the next step without further purification. 
1H NMR (CDCl3, 300 MHz) δ 3.58 (dt, JT = 6.5 Hz, JD = 1.4 Hz, 2H), 3.22 (t, J = 7.0 Hz, 2H), 
1.62 - 1.47 (m, 4H), 1.39 - 1.21 (m, 14H). 
Synthesis of ligand 3: In a 100 ml-two-necked round-bottom flask equipped with a stirring bar, the 
crude azide 2 (3 mmol) was dissolved in a mixture of tBuOH/H2O=1:1 (20 ml), and 2-ethynyl 
pyridine 10 (0.45 g, 4.4 mmol), sodium ascorbate (86 mg, 0.4 mmol) and CuSO4 (0.30 g, 1.2 mmol) 
were added. The reaction was left to stir overnight at room temperature. Then the solvent was 
removed by vacuum and 35 ml of CH2Cl2 and 35 ml of aqueous NH3 were added. The mixture was 
left to stir overnight. The aqueous layer was washed twice with 30 ml of CH2Cl2, and the organic 
phase was dried over MgSO4. The solvent was removed and the crude was purified by column 
chromatography on silica gel (EtOAc/CH2Cl2 = 6/4, CH2Cl2/MeOH = 9:1, 85% yields). 
1H NMR (CDCl3, 300 MHz) δ 8.57 (dq, JD = 5.0 Hz, JQ = 0.9 Hz, 1H), 8.19 (dt, JD = 8.0 Hz, JT = 
1.13 Hz, 1H), 8.13 (s, 1H), 7.78 (td, JT = 7.7 Hz, JD = 1.9 Hz, 1H), 7.23 (ddd, J = 6.1 Hz, J = 4.9 Hz, 
J = 1.3 Hz, 1H), 4.41 (t, J = 7.3 Hz, 2H), 3.68 - 3.60 (m, 2H), 2.01 - 1.90 (m, 2H), 1.60 - 1.50 (m, 
2H), 1.40 - 1.22 (m, 14H). 13C NMR (CDCl3, 101 MHz) δ 150.6 (C), 149.5 (CH), 148.4 (C), 137.2 
(CH), 123.0 (CH), 122.1 (CH), 120.5 (CH), 63.1 (CH2), 50.7 (CH2), 33.0 (CH2), 30.4 (CH2), 29.6 
(CH2), 29.50 (CH2), 29.48 (CH2), 29.42 (CH2), 29.08 (CH2), 26.6 (CH2), 25.9 (CH2). 
 
Synthesis of ptuma: In a 50 mL three-neck, round bottom flask equipped with a stirring bar, ptuma 
(0.7 mmol) and 0.2 mL of freshly distilled triethylamine was dissolved in 10 mL of dry THF. The 
reaction mixture was cooled to 0° C. Methacryloyl chloride (3 equiv.) and hydroquinone (0.02 
equiv.) dissolved in 3 mL of dry THF were added dropwise. The reaction mixture was stirred 
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overnight at r.t. under N2 protection. Then the solvent was removed by vacuum and the crude was 
dissolved with an aqueous solution NaHCO3(sat) and DCM 1:1. The aqueous phase was extracted 
with DCM (3 x 10 ml) and the organic layer was dried over MgSO4. Then the solvent was removed 
by vacuum and the crude was purified by column chromatography on silica gel (DCM/EtOAC = 
75:25, 74% yields). 
1HNMR (CDCl3): 8.58 (dq, JD = 4.9 Hz, JD = 1.0 Hz, 1H), 8.19 (dt, JD = 7.9 Hz, JT = 1.2, 1H), 8.13 
(s, 1H), 7.78 (td JT = 7.9 1H, JD = 1.7 Hz, 1H), 7.23 (m, 1H), 6.09 (sett, J = 0.9 Hz, 1H), 5.54 
(quint, J = 1.6 Hz, 1H), 4.42 (t, J = 7.2 Hz, 2H), 4.13 (t, J = 6.69 Hz, 2H), 2.00-1.91 (m, 5H), 1.66 
(q, J = 6.73 Hz, 2H), 1.39-1.23 (m, 14H). 13CNMR (CDCl3): 167.5, 150.4, 149.3, 148.3, 136.9, 
136.5, 125.1, 122.8, 121.8, 120.2, 64.8, 50.5, 30.2, 29.4, 29.3, 29.2, 29.1, 29.0, 28.6, 26.4, 25.9, 
18.3. 
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The monomer bis-(2-fenilpiridina)-9-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)undecyl methacrylate-
iridium (III) [MW = 920.54 g / mol] was synthesized by the reaction between the iridium dimer 
{[(ppy)2Ir(µ-Cl)]2}, the synthesis of which is reported in the literature,[7, 8] and the ancillary ligand 
9-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)undecyl methacrylate (ptuma). 
In a 25 ml round-bottom flask equipped with a stirring bar, the ligand ptuma (0.039 g, 0.102 mmol) 
was dissolved in a 3:1 mixture of CH2Cl2/EtOH (10 mL) and the Iridium dimer  (0.058 g, 0.054 
mmol) was added. The mixture was left to stir at r.t. 48 h. The solution was evaporated and the 
resulting residue was dissolved in acetone (0.5 mL) and precipitate with Et2O. The solid was 
filtered to give pure Ir-monomer (94% yields). 
1HNMR (CDCl3, 400 MHz) δ 10.98 (s, 1H), 9.28 (d, J = 8.1 Hz, 1H), 8.01 (t, JT = 7.88 Hz, JD = 1.5 
Hz, 1H), 7.91 (d, JD = 8.0 Hz, 2H), 7.80-7.60 (m, 6H), 7.45 (t, 3H), 7.45 (d, J = 5.9 Hz, 1H), 7.20 (t, 
J = 6.8 Hz,1H), 7.05-6.85 (m, 6H), 6.32 (t, JT = 6.8 Hz,2H), 6.11-6.09 (m, 1H), 5.55 (q, J = 1.6 Hz, 
1H), 4.42 (t, J = 7.6 Hz, 2H), 4.13 (t, JD = 6.8 Hz, 2H), 2.00-1.90 (m, 5H), 1.66 (q, J = 7.3 Hz, 2H), 
1.40-1.15 (m, 14H). 
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Copolymers synthesis  
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Scheme 2: Copolymers synthesis. Poli[Ir(ppy)2(ptuma)-co-MMA] 
n=1, m=130, 150, 450, 820, 850, 1100, 2000, 12100 
 
The polymers were synthesized by radical reaction using AIBN (2% by mass in relation to the 
monomers) as a thermal initiator and anhydrous THF as solvent (1 g of monomer in 15 mL of 
solvent). All the copolymerization reactions were carried out in a sealed vial for 72 hours under 
vacuum at 60° C, after performing a series of vacuum-nitrogen cycles in order to deaerate the 
solutions. The copolymers thus obtained were purified by precipitation in large excess of a solution 
of methanol / hexane 3:1 and, after being dried at a temperature of 70 ° C under vacuum for several 
days until a constant weight, were characterized by 1HNMR spectroscopy . 
As an example is reported the 1HNMR spectrum of the copolymer poly [Ir (ppy)2(ptuma)-co-MMA] 
1:1100. 
1HNMR (CDCl3): 3.79-3.49 (3H, -OCH3), 2.10-1.70 (2H, -CH2- main chain), 1.50-1.20 (-CH2- side 
chain), 1.11-0.80 (3H, -CH3 main chain) ppm. 
 
Samples preparation for photoemission measurements 
In order to carry out the analysis of the photophysical properties, the monomer Ir(ppy)2(ptuma)Cl 
was dissolved in dichloromethane: 1 mg of compound dissolved in 10 mL of solvent, and 
subsequently diluted 1:10. In order to carry out the analysis of the photophysical properties, the 
monomer [Ir(ppy)2(ptuma)Cl] was dissolved in dichloromethane: 1 mg of compound dissolved in 
10 mL of solvent, and subsequently diluted 1:10. With regard to the copolymers, were obtained thin 
films by deposition of a solution in anhydrous THF on a solid support by means of spin-coating. 
The solutions of the copolymers in THF were placed in an ultrasonic bath for 30 minutes, and 
filtered using Teflon filters with porosity 0.2 m, so as to eliminate any residual polymer is not 
dissolved and dust. As a support, for the preparation of films, were used circular discs of quartz, 
washed with distilled water and soap. To increase their wettability were kept in an aqueous solution 
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of NaOH at 30% by weight for 30 minutes in an ultrasonic bath, washed with distilled water and 
then ethanol and finally dried with hot air flow. 5-6 drops of the solutions prepared were deposited 
on the supports (at room temperature) for spin-coating, varying speed, acceleration and timing of 
spinning in order to obtain homogeneous films and without defects. The films thus obtained were 
kept under high vacuum in a thermostat at 40° C overnight, so as to remove residual solvent. 
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6.2 - Biotinylated cyclometallated Ir(III) complexes as luminescent probes for avidin targeting 
 
Biomedical imaging 
Biomedical imaging is a generic process that allows acquiring, in a non-invasively way, an image of 
a target, inside a living organism. This type of images can be obtained for clinical purposes, to 
detect, to diagnose or to study a disease, or for scientific purposes allowing studying the anatomy 
and physiology of the organisms. Biomedical imaging includes several analysis techniques such as 
radiology, nuclear medicine, endoscopy, thermography and microscopy. 
In recent years, thanks to the discovery of new highly selective contrast agents, it was possible to 
improve the sensitivity and efficiency of non-invasive techniques (Figure1).1 Such techniques, can 
be divided according to the type of energy that take advantage of (X-rays, positrons, photons, radio 
waves) or according to the type of information that can give (anatomical, physiological, cellular and 
molecular). The macroscopic imaging systems that provide anatomical and physiological 
information are already widely used in clinical practice, such as computed tomography (CT), 
magnetic resonance (MR) and ultrasounds. On the other hand, systems furnishing molecular 
informations are still developing and are rarely used in clinical practice. They include the positron 
emission tomography (PET), the fluorescence reflectance, and the bioluminescent imaging.  
 
Figure 1: Evolution of biomedical imaging. 
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The in vivo and in vitro imaging on biological samples, has been carried out for several years, using 
optical microscopy. Among the available optical imaging techniques, fluorescence microscopy was 
one of the most powerful, because it allows to observe the luminescence of the sample with a good 
resolution.2,3 
The optical imaging techniques rarely take advantage of the intrinsic fluorescence of the biological 
sample, but usually, employ luminescent organic compounds or luminescent organo-metallic 
complexes. In these techniques a contrast agent injected near the area of tissue to be monitored 
absorbs UV or Vis light from an external source, and then releases the energy emitting at a 
wavelength that is selectively detected. 
 
Luminescent markers for bio-conjugation 
The importance of luminescent dyes for the qualitative and quantitative determination of analytes is 
greatly increased and the process of conjugation between a molecular probe and a specific 
biological receptor consists in the interaction of a suitable functional group present on the 
fluorophore, with a receptor group present on the target to highlight. Due to the complexity of the 
systems, to ensure the selectivity is very difficult. Usually this problem is dealt with in three ways: 
functionalization of the fluorophores: the fluorophore is functionalized with a group able to react 
only with the receptor 
exploiting the metabolism way, widely used in imaging of cells: the probe is equipped with a 
molecule that entering in the cell cycles will bring the fluorophore to accumulate in certain 
organelles rather than in other 
key-lock approach: it exploits the particular biological similarities, of some protein with certain 
organic molecules: the fluorophore bound to the "key" molecule  will be related only to a specific 
"lock" protein. 
It is also essential that the fluorophore able to bind the target will maintain some photophysical 
properties, after coordination. To minimize possible quenching interactions between the 
biomolecule and the marker, it is often necessary to outdistance the groups responsible for the 
emission and thcoordination, through the use of suitable spacers.  
The probes labeled with fluorophores are detected by spectroscopic measurements using the 
absorption and emission wavelengths typical of the fluorophore. The sensitivity obtained with a 
fluorescent marker is directly related to its molar extinction coefficient (and its fluorescence 
quantum yield ().The organic fluorophores may have (values in the range of 105 L mol-1cm-1 
and () percentages close to 100%. In order to achieve high efficiency, the luminescent probes, 
should display absorption and emission maxima where the interference with the biological matrix 
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(auto-fluorescence) is negligible. Furthermore, it is necessary to reduce scattering phenomena due 
to the presence of macromolecules such as proteins. Scattering and auto-fluorescence, particularly 
detectable in the visible region, strongly reduce the sensitivity of the method. Therefore a good 
fluorophore should display the following properties: 
- high photochemical stability 
- high quantum yield 
- tunable emission in the visible region 
- high solubility in order to avoid phenomena of self-aggregation 
 
Organic fluorophores 
The term fluorophore refers to a fluorescent chemical compound that is able to emit light after 
absorbing photons at a certain wavelength. The most important examples are the derivatives of 
xanthene (rhodamine and fluorescein). Figure 2 
 
 
Figure 2: Rhodamine (R), Fluorescein (F). 
 
Despite organic fluorophores are commonly used in biological imaging because of their structural 
versatility, these molecules have also some limitations: firstly they have very short lifetimes (order 
of nanoseconds), and secondly they cannot be used for long periods of observation because of their 
fast photodegradation, caused by their reactivity towards molecular oxygen at the excited states. 
Each fluorophore can be excited only to a specific wavelength, then the organic fluorophores cannot 
be used for multi-color imaging. Finally, the fluorescence of organic dyes may overlap the auto-
fluorescence of the tissues. 
 
Organometallic fluorophores  
With respect to transition metals complexes, the most representative examples of organometallic 
fluorophore are given by coordinatively saturated compounds in which the metal center is 
coordinated to chelating aromatic ligands. In particular, one of the first reported compound is 
represented by a polypyridinic Ru(II) complex [Ru(bpy)3]2+ (Figure 3) and its derivatives. Studies 
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performed on this class of compounds allowed the development of similar derivatives containing 
other transition metals, such as ciclometallated complex of Ir (III) and tricarbonilic derivatives of 
Re(I) (Figure 3). In particular, in recent years, the ciclometallated complexes of Ir(III) aroused a 
growing interest, as they show excellent high quantum yields and lifetimes. 
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Figure 3: complexes 
 
One of the first considered compounds is represented by the complex [Ir(ppy)2(CH3CN)2]+. It shows 
a weak emission in aqueous solution, but when it is in the presence of histidine, it increases its 
emission of 180 times.4 This was the first example of a new class of organometallic compounds 
which change its photophysical properties in the presence of a target. From this first example, it was 
possible to design and synthesize new probes containing luminescent metal complexes.  
The employed strategy is to synthesize polyfunctionalized organic molecules, having not only units 
able to form complexes with suitable metals, but also functional group such as biotin, estradiol and 
glucose, able to coordinate specific sites to particular proteins, hormones or vitamins. In this way 
we obtain luminescent organometallic complexes capable of interacting directly with target 
compounds by changing their fotoemissive properties depending by the presence or the absence of 
the bio-conjugation. 
Among the possible structures that form specific interactions with appropriate receptors, the biotin 
is very important. This molecule is a vitamin and it is used in many energy cell cycles as a co-factor 
of ATP-dependent decarboxylase, but its most interesting feature is its ability to form non-covalent 
interaction with avidin, a specific glycoprotein.5 
Avidin is a tetrameric or dimeric6 protein produced in the oviducts of birds, reptiles and amphibians 
deposited in the whites of their eggs. In chicken egg white, avidin makes up approximately 0.05% 
of total protein (approximately 1.8 mg per egg). The tetrameric protein contains four identical 
subunits (homotetramer), each of which can bind to biotin (Vitamin B7, vitamin H) with a high 
degree of affinity and specificity. The dissociation constant of avidin is measured to be KD ≈ 10−15 
M, making it one of the strongest known non-covalent bonds.7 
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Owing to the extraordinarily high affinity of biotin to avidin strong binding interactions can be 
formed and such system has been widely exploited as a powerful tool in a variety of bioanalytical 
applications. Recently various examples of Iridium (III) polypyridine biotin complexes have been 
utilized as luminescent probes since, in contrast to biotin-fluorophore conjugates, they show 
increased emission intensity and lifetimes when bound to avidin. In the reported papers a bipyridine 
was employed as ancillary ligand in the Ir(III) complexes. All the reported examples have in 
common a bipyridinic linker to which an amidic pendant of biotin was attached (Figure 4). The 
presence of avidin show in these complexes an increase in the emission response from 1.5 to 3.3 
times compared to the intensity measured in the absence of the target protein, as well as an 
increased lifetime.8 
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Figure 4: Biotinylated ciclometallated Ir(III) complexes. 
 
However, other nitrogen containing derivatives have been recently employed to obtain highly 
emissive complexes, such as pyridin-1,2,3-triazoles, easily obtained via a click reaction. In recent 
years, in fact, the CuI-catalyzed azide–alkyne cycloaddition (CuAAC),9 proved to be a very 
effective method to afford 1,4-substituted-1,2,3-triazoles (from azides and terminal alkynes) with 
essentially perfect regioselectivity under mild conditions, becoming an extremely used reaction in 
several chemical fields.10 
Taking inspiration from these results I was involved to the design and the synthesis of a new class 
of bifunctionalized ligands 1-3, (Figure 5), containing both a pyridine-1,2,3-triazole able to 
coordinate the desired metal and a biotin moiety able to interact with avidin. In addition, the 
importance of both the linker and the spacer arm between the two parts was investigated by 
comparing the luminescent properties of the corresponding Ir(III) complexes 4-6, (Figure 5), alone 
and in the presence of avidin. In particular, an amide and an ester linker were considered, together 
with the alkylic and aromatic nature of the spacer arms considering that it has been reported that 
long spacer-arms can increase the stability of the metal-avidin adducts. 
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Figure 5: Biotinylated ligands and their Iridium complexes. 
 
6.2.1 - Results and Discussion 
6.2.1.1 - Ligand Design and Synthesis 
In detail, ligands 1a-b were obtained following the synthetic strategy reported in Scheme 1. The 
azide derived from reaction of 11-Br-undecanol 7 with NaN3 underwent to a “click reaction” to 
form the 1,4-disubstituted 1,2,3-triazole 8 (85% yields from 7) when treated with 2-alkynylpyridine 
under CuAAC conditions. The hydroxyl pyridine-triazole 8 was transformed into the amine 9 by 
reaction of its corresponding tosylate with NaN3 and subsequent reduction trough a Staudinger 
reaction. Ligand 1a was finally obtained  by reaction of 9 with biotin-succinimino derivative 11 (92 
% yields). On the other hand, the key-intermediate 8 was further employed to give ligand 1b in 60 
% yields by reaction with the biotin acyl chloride 12. 
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Scheme 1 
The synthesis of ligands containing aromatic linkers are reported in Schemes 2 and 3. In particular, 
ligands 2a and 2b were obtained as follows. The aromatic azides from 13 were reacted with 2-
ethynylpyridine to give the 2-pyridintriazoles 14a-b that were then transformed in the 
corresponding amide 2a (63% yields) and ester 2b (55% yields) by reaction with biotin 10 
following a previously reported procedure for aromatic substrates (Scheme 2).11,12 
 
1) NaN3, CuI, DMSO
2) 2-ethynylpyridine,
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X
X
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14a X=NH2 85% yields
14b X=OH 85% yields
Scheme 2 
A similar synthetic approach led to ligands 3a-b (Scheme 3). The pyridintriazole 16, obtained by 
condensation of the appropriate azide from 15 with 2-ethynylpyridine, was submitted to a Suzuki 
coupling with the desired phenylboronic derivative 17a-b to give the biphenyl derivatives 18a (20% 
yields) and 18b (35% yields), that were therefore successfully converted into the biotin ligands 3a 
(65% yields) and 3b (55% yields). 
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S
cheme 3 
Therefore the Ir(III)-complexes 4-6 were synthesized through a known procedure by reacting the 
dimer 19 with the proper ligand,13 (Scheme 4). 
 
Scheme 4 
The absorption and photophysical properties of complexes 4-6 have been studied in DCM and in 
phosphate buffer solution in order to evaluate the effect of the polarity of the solvent. The collected 
data are summarized in Table 1. 
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Complex 
(solvent) 
abs (nm):  
104(M-1 cm-1) 
em (nm) em (nm) 
77 °K 
 (ns), air  (ns), 
deair 
 (ns) 
77 °K 

Air 

Deair 
4a 
(DCM) 
255 (4.50), 
381 (0.66) 
476, 508 474, 506, 
545 sh 
144 (90%) 
55 (10%) 
419 4160 0.048 0.148 
5a 
(DCM) 
269 (4.62), 
380 (0.16) 
478, 506, 
542 (sh) 
472, 506, 
538 
134 508 4749 (90%) 
1685 (10%) 
0.12 0.55 
6a 
(DCM) 
270 (6.05), 
294 (5.32), 
382 (0.69) 
476, 508 470, 506, 
536, 576 
(sh) 
227 1185 
(88%) 356 
(12%) 
5982 (84%) 
1714 (16%) 
0.078 0.34 
4b 
(DCM) 
255 (4.51), 
381 (0.55) 
476, 508 470, 505, 
532 sh 
148 1100 2130 (20%) 
4900 (80%) 
0.064 0.60 
5b 
(DCM) 
268 (4.67), 
383 (0.37) 
476, 508, 
544 (sh) 
470, 506, 
534 (sh) 
134 500 3928 0.098 0.25 
6b 
(DCM) 
272 (5.46) 288 
(5.10), 382 
(0.39) 
476, 506, 
544 (sh) 
472, 506, 
542 (sh) 
130 816 4930 (67%) 
2854 (33%) 
0.12 0.41 
         
4a 
(buffer) 
284 (4.05), 
374 (3.84) 
478, 504 / 569 / / 0.128 / 
5a 
(buffer) 
270 (4.05), 
285 (3.84), 
385 (0.63) 
478, 506 / 41 (30%)  
305 (70%) 
/ / 0.098 / 
6a 
(buffer) 
266 (4.05), 
303 (3.84), 
406 (0.63) 
478, 506 / 473 / / 0.016 / 
4b 
(buffer) 
268 (4.05), 
376 (3.84) 
478, 508 / 622 (60%) 
90 (40%) 
/ / 0.07 / 
5b 
(buffer) 
255 (2.91), 
263 (2.93), 
378 (0.27) 
478, 506 / 417 / / 0.22 / 
6b 
(buffer) 
272 (3.26) 286 
(3.15), 387 
(0.49) 
478, 504 / 393 / / 0.057 / 
Table 1. Photophysical properties of the obtained complexes. 
The absorption spectra of complexes 4-6 in DCM (ca. 10-4 M) show ligand centered (LC) 
transitions in the UV region (<300 nm), while at lower energy values (>300 nm) the charge 
transfer transitions (CT) can be found that, in the case of a d6 configuration, are attributed to metal-
to-ligand charge transfer (MLCT) processes, (Figure 6). The spectra recorded in a phosphate buffer 
solution (pH=7.4) show absorption profiles similar to those obtained in the organic solvent. Only 
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small batho-ipso chromic shifts can be observed. For example in the complex 6a there is an 
emission maxima shift to lower energy from =270, 294, 382 nm to =266, 303, 406 nm. 
 
Figure 6: Complex 6a absorption spectra. 
In DCM dilute solution (<10-5 M), all the complexes exhibit high luminescence. Using an excitation 
wavelength of about 380 nm, the complexes show an intense emission at about 475 nm, in the green 
region. The emission spectra appear structured, showing two intensity maxima (476, 508 nm), due 
to an emissive excited state with two transitions (LC and MLCT). If the solution is frozen at 77K, it 
is possible to observe that the contribution to the emission from MLCT transitions is affected by a 
blue shift, while the contribution to the emission from LC transitions remains unchanged (470, 506, 
536, 576 nm), (Figure 7). 
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Figure 7: Complex 6a emission spectra. 
The emission quantum yields of the six complexes range from 5% to 15% in oxygenated solutions, 
while they resulted increased in deaerated solutions (15% to 65%), confirming the phosphorescent 
nature of the emissions. Also the lifetimes confirm the phosphorescence emission, being in the 
order of microseconds. In the aqueous environment the profile of the emission does not change, 
compared to the sample in organic solvent (Figure 8) and this is very important in order to use our 
complexes as biotinylated probes for avidin detection.  
 
Figura 8: Emission spectra of complex 6a 
 
 
60 
 
6.2.1.2 - Avidin-complexes interactions: Emission Titrations14 
The avidin-binding properties of the biotin complexes 4-6 have been investigated by emission 
titrations of avidin using the complexes as the titrants. Avidin (3.8 M) was dissolved in a 
phosphate buffer solution (pH=7.4) and titrations were carried out by adding aliquots of 5 L of 
complex solution. 
The titration results have been compared with two control experiments in which avidin was absent, 
and avidin was pre-saturated with excess of unmodified biotin. The titration curves of complexes 
4a-b, 5a-b and 6a-b are shown in Figure 9. 
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Figure 9: Titration curves 
The graphs shows on the X axis the complex/avidin ratio, while on the Y axis the increase of the 
emission maximum intensity. As shown in Figure 9 in the titration of free avidin, the emission 
intensity of the complexes increases compared to emission intensity of the complexes in the control 
experiments. This behaviour is due to the coordination of the biotin with the protein. Bio-
conjugation, in fact, may limit the molecular motions of the whole complex, favouring the radiative 
decays. In the free avidin titration curve after the addition of a certain amount of titrant a point of 
inflection can be noted. After that point the trend of emission intensity changes and the line slope 
becomes similar to that found in control experiments. The change of curve slope represents the 
moment in which the biotinylated complex has saturated all available coordination sites of avidin: 
in correspondence of this "equivalent point", the concentration of the complex is about four times 
the concentration of avidin. The further added complex will be not involved in the coordination and 
therefore the trend of the line looks like the one of the control experiments. 
 
6.2.1.3 - HABA assay 
The HABA assay is the best way to quantitatively determine the stoichiometry of the interaction 
avidin-biotinylated complex. HABA (2-(4-Hydroxyphenylazo)benzoic acid) is a colorant that when 
it is coordinated to the avidin shows an absorption maximum at 500 nm. The affinity HABA-avidin 
(KD= 6*10-6M) is less strong than the affinity avidin-biotin (KD= 10-15M), therefore when 
increasing amounts of 4-6 complexes solutions are added to a HABA-saturated avidin solution, the 
biotinylated complexes remove HABA in the coordinating sites of avidin. A consequent decrease in 
absorbance at 500 nm, due to the decrease of the amount of the HABA coordinating to avidin is 
then observed.  
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Two different assays were performed: in the first one unmodified biotin was added to the HABA 
saturated-avidin solution, in the second one the complex 4a was used as titrant. 
As shown in the Figure 10, when the concentration biotin/avidin is approximately in a 4:1 ratio 
(after about 10 additions), the maximum absorption decreases stops. Regarding the complex, more 
additions are required. This is due to its poor solubility of the complex in the titration medium, so 
that its concentration is not exactly determinable. Further experiments will be necessary to clarify 
these inconsistencies. 
 
 
 
Figure 10: complex Ir (III)-biotin aliquots (5µl), are added to a mixture avidin (7.6µM) and HABA 
(0.3mM) in a buffer solution of Na2SO4, pH 7.4 (1 ml) per minute. The absorption spectra of the 
solution are recorded and subsequently is reported in a graph the value –ΔAbs500nm (y) and the 
number of additions (x).15 
 
6.2.2 -Conclusions 
In this work a synthetic method to bifunctional biotinylated ligands containing a pyridine triazole 
moiety able to form new iridium luminescent complexes was developed. These iridium complexes 
may be used as luminescent probes thanks to the presence of a Biotin unit on the ligand able to 
selectively combine avidin, a protein characteristic of egg. the absorption and emission 
photophysical properties in organic solvent and in aqueous solution buffered to pH 7 .4 have been 
studied. Subsequently, we studied the interactions biotinylated complex-biological target, by 
performing the titration of samples containing avidin dissolved in phosphate buffer at pH 7.4, and 
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using as a titrant, the biotinylated complexes of Ir (III). Finally, we studied the stoichiometry of the 
interaction avidin - biotinylated complexes via HABA assays. Based on the obtained results, it can 
be concluded that the complexes possess good photoemissive property that vary in the presence of 
avidin. This is due to the fact that it establishes a strong interaction between the avidin and the 
Biotin moiety of Ir (III) complex. 
6.2.3 - Experimental Section 
The solvents and chemicals were used as received from sellers, unless otherwise mentioned. NMR 
spectra were recorded by using a Varian Mercury 400 MHz or a Varian Inova 600 MHz 
spectrometer with tetramethylsilane as the internal standard. Elemental analyses were performed on 
a ThermoQuest Flash 1112 series EA instrument. ESI-MS analysis were performed by direct 
injection of acetonitrile solutions of the compounds using a WATERS ZQ 4000 mass spectrometer. 
The IR spectra were recorded with a FT-IR spectrometer Perkin Elmer Spectrum 2000. UV/Vis 
absorption spectra were measured on a Varian Cary 4 double-beam UV-Vis spectrometer and 
baseline corrected. Steady-state emission spectra were recorded on an Edinburgh FLS920P 
spectrofluorimeter equipped with a 450 W Xenon arc lamp, double excitation and single emission 
monochromators and a peltier cooled Hamamatsu R928P photomultiplier tube (185–850 nm). 
Emission and excitation spectra were corrected for source intensity (lamp and grating) and emission 
spectral response (detector and grating) by calibration curve supplied with the instrument. Emission 
lifetimes were determined on the same Edinburgh instrument with the Time Correlated Single 
Photon Counting (TCSPC) technique  using pulsed picosecond LEDs (EPLED 295 or EPLED 360, 
FHWM <800 ps, repetition rates between 10 kHz and 1 MHz) as the excitation source and the 
above-mentioned R928P PMT as detector. The goodness of fit was assessed by minimizing the 
reduced χ2 function andvisual inspection of the weighted residuals. The emission quantum yields 
were determined according to the optically dilute solutions method in ACN solutions with reference 
to Ru(bpy)3Cl2 as the standard (r) according to Equation (1),[31] where I refers to the area of the 
emission peaks of the complex and the reference, A to their absorptions and n is the refractive index 
of the corresponding solvents. 
 
 
 
Φ= Φr 
wavelength (nm) 
Ir    A   nr
2 
 
Φ= Φ
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Synthesis of Ligands  
Ligand 1a 
Synthesis of azide: In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, 11-
bromo-1-undecanol 7 (0.75 g, 3.0 mmol) and NaN3 (0.39 g, 6.0 mmol) was dissolved in 10 mL of 
DMSO. The reaction mixture was stirred under at room temperature for 24 h. Then water (15 mL) 
was added and the aqueous phase was extracted with ethyl acetate (3X 10 ml). The organic layer 
was dried over MgSO4 and the solvent evaporated to give a brown oil (98% yields). The product 
was used in the next step without further purification. 
1H NMR (CDCl3, 300 MHz) δ: 3.58 (dt, 2H, JHH= 6.5, JHH= 1.4), 3.22 (t, 2H, JHH=7.0), 1.62 - 1.47 
(m, 4H), 1.39 - 1.21 (m, 14H). 
Synthesis of ligand 8: In a 100 ml-two-necked round-bottom flask equipped with a stirring bar, the 
crude azide (3 mmol) was dissolved in a mixture of tBuOH/H2O=1:1 (20 ml), and 2-ethynyl 
pyridine (0.45 g, 4.4 mmol), sodium ascorbate (86 mg, 0.4 mmol) and CuSO4 (0.30 g, 1.2 mmol) 
were added. The reaction was left to stir overnight at room temperature. Then the solvent was 
removed by vacuum and 35 ml of CH2Cl2 and 35 ml of aqueous NH3 were added. The mixture was 
left to stir overnight. The aqueous layer was washed twice with 30 ml of CH2Cl2, and the organic 
phase was dried over MgSO4. The solvent was removed and the crude was purified by column 
chromatography on silica gel (EtOAc/CH2Cl2 = 6/4, CH2Cl2/MeOH = 9:1, 85% yields). 
1H NMR (CDCl3, 300 MHz) δ: 8.57 (ddd, 1H, JHH= 4.9, JHH= 1.0, JHH= 1.7), 8.19 (dt, 1H, JHH= 8.0, 
JHH= 1.0), 8.13 (s, 1H), 7.78 (dt, 1H, JHH= 7.7, JHH= 1.7), 7.23 (ddd, 1H, JHH= 7.4, JHH=4.9, 
JHH=1.3), 4.42 (t, 2H, JHH= 7.1), 3.63 (t, 2H, JHH= 6.6), 2.1 (bs, 1H), 1.90-2.00 (m, 2H), 1.50-1.60 
(m, 2H), 1.20-1.40 (m, 14H). 13C NMR (CDCl3, 101 MHz) δ: 150.6 (C), 149.5 (CH), 148.4 (C), 
137.2 (CH), 123.0 (CH), 122.1 (CH), 120.5 (CH), 63.1 (CH2), 50.7 (CH2), 33.0 (CH2), 30.4 (CH2), 
29.6 (CH2), 29.50 (CH2), 29.48 (CH2), 29.4 (CH2), 29.1 (CH2), 26.6 (CH2), 25.9 (CH2). 
Synthesis of tosylate ligand: To a solution of ligand 8 (0.40 g, 1.27 mmol) in dry DCM (15 mL) 
pyridine (150L, 1.90 mmol) was added at 0°C under nitrogen atmosphere. TsCl (0.72 g, 3.8 
mmol) was added to the solution over 5 min at the same temperature. After 1 h the ice bath was 
removed and the mixture was stirred at room temperature for 48 h. Then the reaction was quenched 
with H2O and extracted three times with Et2O. The combined organic layers were dried over 
anhydrous MgSO4 and evaporated. The residual product was purified by column chromatography 
on silica gel (DCM/EtOAc 1:1) to give tosylate ligand in 84% yields. 
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1H NMR (CDCl3, 300 MHz) δ:8.57 (ddd, 1H, JHH=4.9, JHH=1.8, JHH=1.0), 8.19 (dt, 1H, JHH=8.0, 
JHH= 1.0), 8.13 (s, 1H), 7.82 - 7.75 (m, 3H), 7.36-7.30 (m, 2H), 7.23 (ddd, 1H, JHH=7.5, JHH=4.9, 
JHH=1.2 Hz), 4.42 (t, 2H, JHH=7.2), 4.00 (t, 2H, JHH=6.5), 2.43 (s, 3H), 2.00-1.90 (m, 2H), 1.67-1.56 
(m, 2H), 1.40-1.15 (m, 14H). 
Synthesis of azido ligand: In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, 
ligand tosylate ligand (0.50 g, 1.07 mmol) and NaN3 (0.21 g, 3.19 mmol) was dissolved in 15 mL 
of DMF. The reaction mixture was stirred at room temperature for 24 h. The solvent was removed 
by vacuum. Then water (20 mL) and EtOAc (20 mL) were added and the aqueous phase was 
extracted with ethyl acetate (3X 10 ml). The organic layer was dried over MgSO4 and the solvent 
evaporated to give azido ligand (98% yields). The product was used in the next step without further 
purification. 
1H NMR (CDCl3, 300 MHz) δ: 8.58 (ddd, 1H, JHH=4.8, JHH=1.7, JHH=1.0), 8.19 (td, 1H, JHH=7.9, 
JHH=1.1), 8.13 (s, 1H), 7.78 (dt, 1H, JHH=7.9, JHH=1.8), 7.23 (ddd, 1H, JHH=7.5, JHH=4.9, JHH=1.2), 
4.42 (t, 2H, JHH=7.2), 3.25 (t, 2H, JHH=7.0), 2.00−1.90 (m, 2H), 1.65–1.50 (m, 2H), 1.40–1.20 (m, 
14H). 13C NMR (CDCl3, 101 MHz) δ: 150.6 (C), 149.6 (CH), 148.5 (CH), 137.1 (CH), 123.0 (CH), 
122.0 (CH), 120.4 (CH), 51.6 (CH2), 50.7 (CH2), 30.4 (CH2), 29.6 (CH2), 29.52 (CH2), 29.47 
(CH2), 29.3 (CH2), 29.1 (CH2), 29.0 (CH2), 26.9 (CH2), 26.6 (CH2). 
Synthesis of ligand 9: In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, 
azido ligand (0.36 g, 1.05 mmol) and triphenylphosphine (0.3 g, 1.26 mmol) was dissolved in 10 
mL of THF. Then H2O (50 µL, 2.7 mmol) was added to the solution. The reaction mixture was 
stirred at room temperature for 48 h. Then the solvent was removed by vacuum and the crude was 
purified by column chromatography on silica gel (DCM/EtOAc 4:6, DCM/MeOH 8:2) to give 9 in 
75% yields. 
1H NMR (CDCl3, 300 MHz) δ:8.58 (ddd, 1H, JHH=4.8, JHH=1.7, JHH=1.0), 8.16 (td, 1H, JHH=7.9, 
JHH=1.0), 8.13 (s, 1H), 7.78 (dt, 1H, JHH=7.7, JHH=1.9), 7.23 (ddd, 1H, JHH=7.5, JHH=4.9, JHH=1.1), 
4.42 (t, 2H, JHH=7.2), 2.66 (bt, 2H, JHH=7.0), 2.00–1.86 (m, 4H), 1.50–1.20 (m, 16H). 13CNMR 
(CDCl3, 101 MHz) δ: 150.6 (C), 149.6 (CH), 148.5 (C), 137.1 (CH), 123.0 (CH), 122.0 (CH), 120.4 
(CH), 50.7 (CH2), 42.3 (CH2), 33.6 (CH2), 30.4 (CH2), 29.7 (CH2), 29.6 (2CH2), 29.2 (CH2), 27.0 
(CH2), 26.6 (CH2). 
Synthesis of 11: Biotin 10 (0.20 g, 0.82 mmol), NHS (0.19 g, 1.64 mmol) and (DCC) (0.33 g, 1.64 
mmol) were dissolved in 10 mL of anhydrous DMF. The reaction mixture was stirred at room 
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temperature for 8 h. Then the solvent was removed by vacuum and the crude was washed with 
MeOH to give pure 11 in 87% yields. 
1H NMR (DMSO d6, 400 MHz) δ: 6.4 (bs, 1H), 6.3 (bs, 1H), 4.35–4.25 (m, 1H), 4.16 - 4.10 (m, 
1H), 3.15 –3.05 (m, 1H), 2.85–2.75 (m, 5H), 2.65 (t, 2H, JHH=7.5), 2.56 (d, 1H, JHH=12.4), 1.70–
1.55 (m, 3H), 1.55–1.30 (m, 3H). 13CNMR (DMSO d6, 101 MHz) δ:170.9 (C), 169.6 (C), 163.3 
(C), 61.7 (CH), 59.8 (CH), 55.9 (CH), 40.4 (CH2), 30.7 (CH2), 28.5 (CH2), 28.2 (CH2), 26.1 
(2CH2), 25.0 (CH2). ESI - MS: 364 [M+ + Na]. 
Synthesis of ligand 1a: Ligand 9 (0.21 g, 0.61 mmol) and 11 (0.25 g, 0.79 mmol) were dissolved in 
10 mL of anhydrous DMF. Et3N (250 µL, 1.83 mmol) was added to the solution and the reaction 
mixture was stirred at room temperature for 24 h. Then the solvent was removed by vacuum and the 
crude was washed with Et2O (3 x 15 ml). The solid was dissolved in CH2Cl2 (0.5 mL) and then 
precipitated with Et2O to give 1a in 92% yields. 
1H NMR (DMSO d6, 300 MHz) δ 8.60 (s, 1H), 8.58 (dq, JD = 4.8 Hz, JQ = 0.9 Hz, 1H), 8.01 (dt, JD 
= 7.9 Hz, JT = 1.1 Hz, 1H), 7.87 (td, JT = 7.6 Hz, JD = 1.8 Hz, 1H), 7.69 (bt, J = 5.5 Hz, 1H), 7.32 
(ddd, J = 7.6 Hz, J = 4.8 Hz, J = 1.2 Hz, 1H), 6,39 (bs, 1H), 6.33 (bs, 1H), 4.40 (t, J = 6.9 Hz, 2H), 
4.28 (dd, J = 7.7 Hz, J = 5.3 Hz, 1H), 4.14 - 4.07 (m, 1H), 3.11 - 3.03 (m, 1H), 3.02 - 2.92 (m, 2H), 
2.80 (dd, J =12.2 Hz, J = 5.1 Hz, 1H), 2.56 (d, J = 12.1 Hz, 1H), 2.02 (t, J = 7.3 Hz, 2H), 1.91 - 1.79 
(m, 2H), 1.66 - 1.12 (m, 23H). 13C NMR (CDCl3, 101 MHz) δ 173.1 (C), 163.4 (C), 150.6 (C), 
149.6 (CH), 148.5 (C), 137.9 (CH), 124.0 (CH), 123.7 (CH), 120.3 (CH), 61.9 (CH), 60.3 (CH), 
56.6 (CH), 50.3 (CH2), 41.3 (CH2), 39.7 (CH2), 36.7 (CH2), 30.5 (CH2), 29.9 (CH2), 29.8 (CH2), 
29.6 (CH2), 29.5 (CH2), 29.47 (CH2), 29.4 (CH2), 29.1 (CH2), 28.3 (CH2), 27.1 (CH2), 26.6 (CH2), 
24.7 (CH2) . ESI - MS: 542 [M+], 564 [M+ + Na]. 
Ligand 1b 
Synthesis of ligand 1b: Biotin 10 (0.19 g, 0.76 mmol) was dissolved in SOCl2 (6 ml). The reaction 
mixture was stirred at room temperature for 2 h under nitrogen atmosphere. Then the solvent was 
removed by vacuum and the crude was dissolved in anhydrous ACN (10 mL). To the solution 8 
(0.12 g, 0.38 mmol) was added dissolved in other anhydrous ACN (5 mL). This new reaction 
mixture was stirred at room temperature for 24 h under nitrogen atmosphere. Then the solvent was 
removed by vacuum and the crude was dissolved with an aqueous solution NaHCO3(sat) and EtOAc 
1:1. The aqueous phase was extracted with ethyl acetate (3 x 10 ml) and DCM (2 x 10 ml). The 
organic layer was dried over MgSO4 and the solvent evaporated. The solid was dissolved in CHCl3 
(0.5 mL) and precipitate with Esane to give 1b in 60% yields. 
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1H NMR (CDCl3, 400 MHz) δ 8.58 (d, J = 4.2 Hz, 1H), 8.22 - 8.13 (m, 2H), 7.78 (t, J = 7.6 Hz, 
1H), 7.26 - 7.20 (m, 1H), 5.25 (bs, 1H), 5.09 (bs, 1H), 4.54 - 4.48 (m, 1H), 4.41 (t, J = 7.1 Hz, 2H), 
4.34 - 4.29 (m, 1H), 4.05 (t, J = 6.7 Hz, 2H), 3.19 - 3.12 (m, 1H), 2.91 (dd, J = 12.9 Hz, J = 5.0 Hz, 
1H), 2.73 (d, J = 12.9 Hz, 1H), 2.31 (t, J = 7.4 Hz, 2H), 2.00 -1.90 (m, 2H), 1.77 - 1.14 (m, 24H). 
13C NMR (CDCl3, 101 MHz) δ 173.6 (C), 163.1 (C), 150.4 (C), 149.3 (C), 148.2 (CH), 137.0 (CH), 
122.8 (CH), 121.9 (CH), 120.3 (CH), 64.5 (CH2), 61.9 (CH), 60.1 (CH), 55.3 (CH), 50.5 (CH2), 
40.5 (CH2), 33.9 (CH2), 30.2 (CH2), 29.4 (CH2), 29.35 (CH2), 29.3 (CH2), 29.2 (CH2), 29.0 (CH2), 
28.6 (CH2), 28.31 (CH2), 28.26 (CH2), 26.4 (CH2), 25.9 (CH2), 24.8 (CH2). ESI - MS: 543 [M+],565 
[M+ + Na]. 
Ligand 2a 
Synthesis of azide  (following the procedure described in : J. Andersen, U. Madsen, F. Björkling, 
X. Liang Synlett, 2005, 2209): In a 100 ml-two-necked round-bottom flask equipped with a stirring 
bar, 4-iodoaniline 13a (3.51 g, 15 mmol) was dissolved in 30 mL of a DMSO–H2O (5:1) mixture, 
and NaN3 (1.95 g, 30 mmol) and sodium ascorbate (0.16 g, 0.75 mmol) were added. After bubbling 
N2 in the solution for 15 min, CuI (0.29 g, 1.5 mmol) and N,N’-dimethylethylendiamine (250 l, 
2.25 mmol) were added and the reaction mixture was stirred under N2 at room temperature. After 4 
hours the iodide was completely consumed (TLC check), then water (10ml) was added and the 
aqueous phase was extracted with ethyl acetate (3X 10 ml). The organic layer was dried over 
MgSO4 and the solvent evaporated. The 1H NMR analysis of the crude product was consistent with 
literature data (Wei Zhu and Dawei Ma Chem. Commun., 2004, 888 – 889) and the product was 
used in the next step without further purification. 
Synthesis of ligand 14a (following the procedure described in : Organometallics, 2008, 27, 5430): 
In a 25 ml-two-necked round-bottom flask equipped with a stirring bar, the crude azide (15 mmol) 
was dissolved in a mixture of tBuOH:H2O=1:1 (38 ml), and 2-ethynyl pyridine (1.9 equiv.), sodium 
ascorbate (0.3 equiv) and CuSO4 (0.05equiv.) were added. The reaction was left to stir overnight at 
room temperature. Then the solvent was removed by vacuum and 150 ml of CH2Cl2 and 150 ml of 
aqueous NH3 were added. The mixture was left to stir overnight. The aqueous layer was washed 
twice with 100 ml of CH2Cl2, and the organic phase was dried over MgSO4. The solvent was 
removed and the crude was purified by column chromatography on silica gel (CH2Cl2/MeOH=97/3, 
45% yields). 
1H NMR (CDCl3, 300 MHz) δ 8.60 (d, JHH=4.10 Hz, 1H), 8.46 (s, 1H), 8.23 (d, JHH =7.95 Hz), 1H),  
7.78 (triplo doppietto, JHH =7.74 Hz, 1H),  7.51 (d, JHH =8.63, 2H), 7.27-7.20 (m, 1H), 6.76 (d, JHH 
=8.73 Hz, 2H), 4.04 (bs, 2H). 13C NMR (CDCl3, 75 MHz) δ 150.22 (C), 149.47 (CH), 148.53 (C), 
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147.44 (C), 136.95 (CH), 128.39 (C), 122.94 (CH), 122.11 (CH), 120.34 (CH), 120.08 (CH), 
115.27 (CH). 
Synthesis of ligand 2a (following the procedure described in : Angewandte, 46 (34), (2007) 6469-
64-72): In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Biotin 10 (0.90 
mmol), EDCI*HCl (1.1 mmol),  HOBt (1.1 mmol) and Et3N (1.44 mmol) were dissolved in 
anhydrous DMF (6 mL) under a nitrogen atmosphere. After 10 min 14a (0.5 mmol) was added and 
the reaction was left to stir 72 h at room temperature. Then the solvent was removed by vacuum and 
the crude was purified by column chromatography on alumina gel (DCM/MeOH = 94:6, 65% 
yields). 
1H NMR (DMSO-d6, 300 MHz) δ 8.60 (d, 1H, JHH=4.31 Hz),  8.46 (s, 1H),  8.23 (d, 1H, JHH=7.80 
Hz),  7.78 (t, 1H, JHH=7.80 Hz),  7.51 (d, 2H, JHH=8.77 Hz),  7.24 (t, 1H, JHH=5.84 Hz), 6.75 (d, 2H, 
JHH=8.50),  4.08 (s, 2H). 13C NMR (DMSO-d6, 101 MHz) δ 172.01 (C), 163.19 (C), 150.10 (CH), 
150.03 (C),  148.51 (C), 140.24 (C), 137.76 (CH), 131.92 (C), 123.73 (CH), 121.43 (CH), 121.79 
(CH), 120.21 (CH), 120.74 (CH), 61.51 (CH), 59.67 (CH), 55.84 (CH), 40.31 (CH2), 36.70 (CH2), 
28.68 (CH2), 28.55 (CH2), 25.50 (CH2). 
 
Ligand 3a 
Synthesis of azide (following the procedure described in : J. Andersen, U. Madsen, F. Björkling, X. 
Liang Synlett, 2005, 2209): In a 100 ml-two-necked round-bottom flask equipped with a stirring 
bar, 1-bromo-4-iodobenzene 15 (3.51 g, 15 mmol) was dissolved in 30 mL of a DMSO–H2O (5:1) 
mixture, and NaN3 (1.95 g, 30 mmol) and sodium ascorbate (0.16 g, 0.75 mmol) were added. After 
bubbling N2 in the solution for 15 min, CuI (0.29 g, 1.5 mmol) and N,N’-dimethylethylendiamine 
(250 l, 2.25 mmol) were added and the reaction mixture was stirred under N2 at room temperature. 
After 4 hours the iodide was completely consumed (TLC check), then water (10ml) was added and 
the aqueous phase was extracted with ethyl acetate (3X 10 ml). The organic layer was dried over 
MgSO4 and the solvent evaporated. The 1H NMR analysis of the crude product was consistent with 
literature data (Wei Zhu and Dawei Ma Chem. Commun., 2004, 888 – 889) and the product was 
used in the next step without further purification. 
Synthesis of ligand 16 (following the procedure described in : N. K. Barral, A. D. Moorhouse, J. E. 
Moses, Org. Lett., (2007), 9, 1809-1811): In a 25 ml-two-necked round-bottom flask equipped with 
a stirring bar, the crude azide (2.0 mmol) was dissolved in ACN (8 mL), and 2-ethynyl pyridine (1.9 
equiv.), sodium ascorbate (0.3 equiv) and CuSO4 (0.05equiv. in 2 mL of H2O) were added. The 
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reaction was left to stir overnight at room temperature. Then the solvent was removed by vacuum 
and 150 ml of EtOAc and 150 ml of aqueous NH3 were added. The mixture was left to stir 
overnight. The aqueous layer was washed twice with 100 ml of EtOAc, and the organic phase was 
dried over MgSO4. The solvent was removed and the crude was purified by column 
chromatography on silica gel (CH2Cl2/ EtOAc =80/20, 45% yields). 
1H NMR (CDCl3, 300 MHz) δ 8.62 (dq, 1H, JHH=4.8, JHH=1.0), δ 8.52 (bs, 1H), 8.25 (dt, 1H, 
JHH=1.1, JHH=7.9), 7.82 (td, 1H, JHH=7.9, JHH=1.9), 7.75-7.65 (m, 4H), 7.28 (ddd, 1H, JHH=1.3, 
JHH=4.9, JHH=7.6). 13C NMR (CDCl3, 101 MHz) δ 149.9 (C), 149.8 (CH), 149.4 (C), 137.2 (CH), 
136.1 (C), 133.2 (CH), 122.7 (C), 122.0 (CH), 120.7 (CH), 119. 9 (CH). 
Synthesis of ligand 18 (following the procedure described in: Chem. Commun., 2004, 1774): In a 
25 ml-two-necked round-bottom flask equipped with a stirring bar, ligand 16 (0.602 g, 2.0 mmol) 
and 4-aminophenylboronic acid pinacol ester 17a (0.55 g, 2.5 mmol) were dissolved in THF (6 
mL). Then was edded EtOH (250 l) and an aqueous solution of K2CO3 2M (2 mL). After bubbling 
N2 in the solution for 15 min, Pd(PPh3)4 (2.0 mmol) was added and the reaction mixture was stirred 
under N2 at room temperature. After 48 hours saturated aqueous solution of NH4Cl and Na2CO3 
were added subsequently to the reaction mixture that was then extracted with DCM. The combined 
organic layers were dried over MgSO4. After filtration and removal of the solvent, the residue was 
purified by column chromatography on silica gel (DCM/EtOAc 80:20, 20% yields). 
1H NMR (CDCl3, 300 MHz) δ: 8.64 (s, 1H), 8.61 (s, 1H), 8.29 (d, 1H, JHH=7.9 Hz), 7.84 (m 3H), 
7.70 (d, 2H, JHH =7.5 Hz), 7.46 (d, 2H, JHH =7.5 Hz), 7.30 (s, 1H), δ 6.80 (d, 2H, JHH =7.5 Hz). 
Synthesis of ligand 3a (following the procedure described in : Angewandte, 46 (34), (2007) 6469-
64-72): In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Biotin 10 (0.90 
mmol), EDCI*HCl (1.1 mmol),  HOBt (1.1 mmol) and Et3N (1.44 mmol) were dissolved in 
anhydrous DMF (6 mL) under a nitrogen atmosphere. After 10 min 18 (0.5 mmol) was added and 
the reaction was left to stir 24 h at room temperature. Then MeOH was edded to the solution and the 
precipitate was filtered to give pure 3a (65% yields). 
1H NMR (DMSO, 300 MHz) δ 10.05 (s, 1H), 9.38 (s, 1H), 8.68 (d, 1H, JHH =4.2 Hz), 8.13 (m, 3H), 
7.96 (td, 1H, JHH =1.8 Hz), 7.89 (d, 2H, JHH =8.8 Hz), 7.65 (s, 4H),  7.42 (ddd, 1H, JHH=0.7 Hz, 
JHH=4.9 Hz, JHH=7.6 Hz),  6.45 (s, 1H),  6.38 (s, 1H), 4.32 (m, 1H),  4.15 (m, 1H), 2.35 (t, 2H, JHH 
=7.34 Hz), 1.57-1.40 (m, 9H). 
 
70 
 
Ligand 2b 
Synthesis of azide (following the procedure described in : J. Andersen, U. Madsen, F. Björkling, X. 
Liang Synlett, 2005, 2209): In a 10 ml-two-necked round-bottom flask equipped with a stirring bar, 
4-iodophenol 13b (0.660 g, 3 mmol) was dissolved in 6 mL of a DMSO–H2O (5:1) mixture, and 
NaN3 (0.390g, 6 mmol) and sodium ascorbate (0.030 g, 0.15 mmol) were added. After bubbling N2 
in the solution for 15 min, CuI (0.057 g, 0.3 mmol) and N,N’-dimethylethylendiamine (48 l, 0.45 
mmol) were added and the reaction mixture was stirred under N2 at room temperature. After 4 hours 
the iodide was completely consumed (TLC check), then water (10ml) was added and the aqueous 
phase was extracted with ethyl acetate (3X 10 ml). The organic layer was dried over MgSO4 an the 
solvent evaporated. The 1H NMR analysis of the crude product was consistent with literature data 
(Wei Zhu and Dawei Ma Chem. Commun., 2004, 888 – 889) and the product was used in the next 
step without further purification. 
Synthesis of ligand 14b: In a 25 ml-two-necked round-bottom flask equipped with a stirring bar, 
the crude azide  (3 mmol) was dissolved in a mixture of tBuOH:H2O=1:1 (15 ml) , and 2-ethynyl 
pyridine (1.1 equiv.), sodium ascorbate (0.3 equiv) and CuSO4 (0.05equiv.) were added. The 
reaction was left to stir overnight at room temperature. Then the solvent was removed by vacuum 
and 20 ml of CH2Cl2 and 20 ml of aqueous NH3 were added. The mixture was left to stir overnight. 
The aqueous layer was washed twice with 10 ml of CH2Cl2, and the organic phase was dried over 
MgSO4. The solvent was removed and the crude was purified by column chromatography on silica 
gel (CH2Cl2/MeOH=95/5, 80% yields).  
1H NMR (300 MHz, CDCl3):  6.95-7.05 (m, 2H), 7.30 (m, 1H), 7.65-7.75 (m, 2H), 7.85 (dt, 1H, 
J=7.8, J=1.7), 8.27 (bd, 1H, J=8.7), 8.51 (s, 1H), 8.62 (bd, 1H, J=5.3). 13C NMR (150 MHz, 
CD3OD):  117.2 (CH), 121.7 (CH), 122.2 (CH), 123.5 (CH), 124.7 (CH), 130.5 (C), 138.9 (CH), 
149.5 (C), 150.5 (CH), 150.9 (C), 159.8 (C). HRMS (m/z) +, (C13H10N4O)+H calcd 239.0933, found 
239.0927. 
Synthesis of ligand 2b (following the procedure described in: Org. Biomolec. Chem. 6, (2008), 
1625-1634): In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Biotin 10 (0.15 
mmol), ligand 14b and HOBt (0.30 mmol) were added under N2. After 10 min anhydrous DMF (3 
mL) was added. After bubbling N2 in the solution for 15 min, Et3N (0.60 mmol) and EDCI*HCl 
(0.38 mmol) were added and the reaction mixture was stirred under N2 at room temperature for 24 
h. Then further EDCI*HCl (1.5 equiv) was added and the reaction mixture was stirred under N2 at 
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room temperature overnight. Then the solvent was removed by vacuum and the crude was washed 
with MeOH to give 2b in 55% yields. 
1H NMR (DMSO, 400 MHz) δ 9.33 (s, 1H), 8.67 (d, JHH =4.28 Hz, 1H),  8.16 (d, JHH =8.15 Hz, 
1H),  8.08 (d, JHH =8.88 Hz, 2H), 7.96 (td, JHH =1.74 Hz, 1H),  7.44-7.37 (m, 3H), δ 6.47 (s, 1H),  
6.38 (s, 1H),  4.36-4.30 (m, 1H),  4.20-1.40 (m, 1H), 3.20-3.12 (m, 1H), 2.85 (dd, JHH =5.24 Hz), 
1H),  2.67-2.61 (m, 2H),  2.59 (s, 1H),  1.76-1.40 (m, 6H). 13C NMR (DMSO d6, 101 MHz) δ 
172.13 (C), 163.17 (C), 150.86 (C), 150.14 (CH), 149.93 (C), 148.68 (C), 137.80 (CH), 134.55 (C), 
123.82 (CH), 123.76 (CH), 121.98 (CH), 121.92 (CH), 120.26 (CH), 61.48 (CH), 59.67 (CH), 55.76 
(CH), 40.33 (CH2), 33.74 (CH2), 28.46 (CH2), 28.37 (CH2), 24.78 (CH2). 
 
Ligand 3b 
Synthesis of ligand 18b (following the procedure described in: Chem. Commun., 2004, 1774): In a 
25 ml-two-necked round-bottom flask equipped with a stirring bar, ligand 16 (0.15 g, 0.498 mmol) 
and 4-Hydroxyphenylboronic acid 17b (0.137 g, 0.996 mmol) were dissolved in THF (5 mL). Then 
was added EtOH (250 l) and an aqueous solution of K2CO3 2M (0.6 mL). After bubbling N2 in the 
solution for 15 min, Pd(PPh3)4 (2.0 mmol) was added and the reaction mixture was stirred under N2 
at 75°C. After 24 hours saturated aqueous solution of NH4Cl and Na2CO3 were added subsequently 
to the reaction mixture that was then extracted with DCM. The combined organic layers were dried 
over MgSO4. After filtration and removal of the solvent, the residue was purified by column 
chromatography on silica gel (DCM/EtOAc 85:15, 35% yields). 
1H NMR (CDCl3, 300 MHz) δ 8.64 (m, 2H), 8.28 (d, 1H, JHH = 8.23 Hz),  7.85 (m, 3H),  7.71 (d, 
2H, JHH=8.62 Hz), 7.53 (d,2H, JHH=8.62 Hz),  7.96 (d, 2H, JHH =8.70 Hz),  5.82 (bs, 1H). 
13C NMR (CD3OD-ACN-d3, 101 MHz) δ: 142.7 (C), 138.5 (C), 133.35 (C), 133.3 (CH), 132.8 (C), 
132.7 (CH), 132.6 (CH), 131.9 (C), 130.6 (C), 129.7 (CH), 129.6 (CH), 128.9 (CH), 128.3 (CH), 
121.7 (CH), 116.5 
Synthesis of ligand 3b (following the procedure described in: Org. Biomolec. Chem. 2008, 6, 
1625-1634): In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Biotin (0.154 
mmol), EDCI*HCl (0.385 mmol), HOBt (0.308 mmol) and Et3N ( 0.616 mmol) were dissolved in 
anhydrous DMF (6 mL) under a nitrogen atmosphere. After 10 min 18b (0.103 mmol) was added 
and the reaction was left to stir 24 h at room temperature. Then further EDCI*HCl (1.5 equiv) was 
added and the reaction mixture was stirred under N2 at room temperature overnight. Then the 
solvent was removed by vacuum and the crude was washed with MeOH to give L4 in 55% yields. 
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1H NMR (DMSO, 400 MHz) δ 9.40 (s, 1H),  8.68 (d, JHH =3.98 Hz, 1H), 8.14 (d, 3H, JHH =8.41 
Hz),  7.99-7.91 (m, 3H),  7.82 (d, JHH =8.70 Hz, 2H),  7.42 (t, JHH = 6.30 Hz, 1H),  7.26 (d, J JHH 
=8.62 Hz, 2H),  6.48 (s, 1H), δ 6.38 (s, 1H),  4.35-4.30 (m,1H),  4.20-4.14 (m, 1H), 3.20-3.12 (m, 
1H),  2.85 (dd, JHH =5.07 Hz, 1H),  2.65-2.57 (m, 3H),  1.85-1.40 (m, 6H). 13C NMR (DMSO d6, 
101 MHz) δ 172.2 (C), 163.2 (C), 150.9 (C), 150.1 (CH), 150.0 (C), 148.7 (C), 140.1 (C), 137.8 
(CH), 136.78 (C), 136.25 (C), 128.46 (CH), 128.35 (CH), 128.83 (CH), 122.90 (CH), 121.68 (CH), 
121.06 (CH),  120.29 (CH), 40.34 (CH2), 33.80 (CH2), 28.47 (CH2), 28.40 (CH2), 24.85 (CH2). 
Synthesis of Dimer 
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a)M. Nonoyama,Bull. Chem. Soc. Jpn. 1974, 47, 767.; b) S. Lamansky, P. Djurovich, D. Murphy, F. 
Abdel-Razzaq, R. Kwong, I. Tsyba, M. Bortz, B. Mui, R. Bau, M. E. Thompson, Inorg. 
Chem. 2001, 40, 1704-1711. 
Synthesis of Complexes 
Synthesis of complex 4a. In a 50 ml round-bottom flask equipped with a stirring bar, the ligand 1a 
(0.050 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (15 mL) and the Iridium dimer 
19 (0.054 g, 0.05 mmol) was added. The mixture was left to stir at r.t. 24 h. The solvent was 
removed and the crude was dissolved in DCM (1 mL) and precipitate with Et2O to give 4a in 60% 
yields. 
1H NMR (CDCl3, 400 MHz) δ 10.68 (s, 1H), 9.11 (d, J = 8.0 Hz, 1H), 8.04 (td, JT = 7.7 Hz, JD = 1.5 
Hz, 1H), 7.90 (d, J = 8.4 Hz, 2H), 7.80 -7.70 (m, 3H), 7.69 -7.62 (m, 3H), 7.47 (d, J = 5.7 Hz, 1H), 
7.23 - 7.18 (m, 1H), 7.06 - 6.83 (m, 6H), 6.49 (bt, J = 5.3 Hz, 1H), 6.31 (t, J = 7.6 Hz, 2H), 5.78 (bs, 
1H), 5.17 (bs, 1H), 4.53 - 4.39 (m, 3H), 4.36 - 4.30 (m, 1H), 3.28 - 3.11 (m, 3H), 2.90 (dd, J = 12.8 
Hz, J = 4.9 Hz, 1H), 2.75 (d, J = 12.6 Hz, 1H), 2.31 -2.21 (m, 2H) 2.00 - 1.06 (m, 24H). ESI -MS: 
1042 [M+]. 
Synthesis of complex 4b. In a 10 ml round-bottom flask equipped with a stirring bar, the ligand 1b 
(0.018 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (4 mL) and the Iridium dimer 19 
(0.018 g, 0.017 mmol) was added. The mixture was left to stir at r.t. 24 h. The solvent was removed 
and the crude was dissolved in DCM (0.5 mL) and precipitate with Et2O to give 4b in 80% yields. 
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1H NMR (CDCl3, 400 MHz) δ 10.65 (s, 1H), 9.14 (d, J = 7.6 Hz, 1H), 8.02 (t, JT = 7.0 Hz, 1H), 
7.89 (d, JD = 8.0 Hz, 2H), 7.79 -7.60 (m, 6H), 7.46 (d, JD = 5.5 Hz, 1H), 7.19 (t, JT = 6.4 Hz, 1H), 
7.06 - 6.72 (m, 6H), 6.30 (t, J = 7.5 Hz, 2H), 5.53 (bs, 1H), 5.34 (bs, 1H), 4.54 - 4.36 (m, 3H), 4.33 
- 4.26 (m, 1H), 4.05 (t, JT = 6.7 Hz, 2H), 3.18 - 3.09 (m, 1H), 2.88 (dd, JD = 12.6 Hz, JD = 4.7 Hz, 
1H), 2.77 (d, J = 12.7 Hz, 1H), 2.31 (t, J = 7.1 Hz, 2H), 1.97 - 1.86 (m, 2H), 1.78 - 1.53 (m, 3H), 
1.50 - 1.37 (m, 3H), 1.36 - 1.06 (m, 16H). 
Synthesis of complex 5a. In a 10 ml round-bottom flask equipped with a stirring bar, the ligand 2a 
(0.014 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (5 mL) and the Iridium dimer 19 
(0.015 g, 0.014 mmol) was added. The mixture was left to stir at r.t. 48 h. The solvent was removed 
and the crude was purified by column chromatography on silica gel (CH2Cl2/ MeOH = 90/10, 70% 
yields). 
1H NMR (DMSO-d6, 400 MHz) δ 10.40 (s, 1H),  10.01 (s, 1H),  8.46 (d, 1H, JHH =7.78 Hz),  8.28-
8.20 (m, 3H),  7.96-7.86 (m, 4H),  7.86-7.80 (m, 3H),  7.72 (d, 3H, JHH =6.97 Hz),  7.66 (d, 1H, JHH 
=5.30),  7.56 (t, 1H, JHH=6.33 Hz),  6.17 (d, 2H, JHH =4.33 Hz),  7.00 (t, 1H, JHH =7.50 Hz),  6.90 
(q, 2H, JHH 7.50 Hz),  6.79 (t, 1H, JHH =7.50 Hz),  6.41 (s, 1H),  6.35 (s, 1H),  6.20-6.12 (m, 2H), 
4.31-4.23 (m, 1H),4.12-4.08 (m, 1H),  3.10 (m, 1H),  2.80 (dd, 1H, JHH =4.70 Hz),  2.56 (d, 1H, JHH 
=12.40 Hz), δ 2.34 (d, 2H, JHH =6.47 Hz),  1.60-1.05 (m, 6H). 13C NMR (DMSO-d6, 150 MHz) δ 
172.21 (C), 167.68 (C), 166.94 (C), 163.18 (C), 152.80 (C), 150.40 (CH), 150.03 (CH), 149.93 (C), 
149.45 (CH), 149.38 (C), 149.14 (C), 146.81 (C), 144.49 (C), 144.52 (C), 141.37 (C), 140.62 (CH), 
139.28 (CH), 139.18 (CH), 131.90 (CH), 131.28 (CH), 131.02 (CH), 130.65 (CH), 129.90 (CH), 
127.59 (CH), 125.66 (CH), 125.44 (CH), 124.98 (CH),124.43 (CH), 124.20 (CH), 123.37 (CH), 
122.91 (CH2), 122.92 (CH), 122.08 (CH), 120.32 (CH), 120.15 (CH), 61.50 (CH), 59.66 (CH), 
55.81 (CH), 36.63 (CH2), 36.33 (CH2), 28.66 (CH2), 28.53 (CH2), 25.38 (CH2). 
ESI - MS: 964 (M+, 100) 
Synthesis of complex 5b. In a 50 ml round-bottom flask equipped with a stirring bar, the ligand 2b 
(0.05 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (10 mL) and the Iridium dimer 19 
(0.04 g, 0.037 mmol) was added. The mixture was left to stir at r.t. 48 h. The solvent was removed 
and MeOH was added. Then the solid was filtered off and washed with MeOH (2 mL). The solution 
was evaporated and the resulting residue was dissolved in MeOH (0.5 mL) and precipitate with 
Et2O. The solid was filtered to give pure complex 5b (50% yields). 
1H NMR (CD3OD, 400 MHz) δ 9.62 (s, 1H), 8.28 (d, 1H, JHH =8.2 Hz),  8.05 (m, 3H), 7.80-7.95 
(m, 9H), 7.68 (d, 1H, JHH =7.6 Hz), 7.55 (m, 5H), 7.35-7.40 (m, 1H),7.05-6.92 (m, 3H),  6.88 (dt, 
2H, JHH =1 Hz, JHH =7.6 Hz), 6.73 (t, 1H, JHH =7.59 Hz),6.15 (dd, 2H, JHH =3.00 Hz), 4.45-4.55 (m, 
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2H), 3.40-3.50 (m, 1H), 2.90-3.10 (m, 2H), 2.35 (t, 2H, JHH =7.34 Hz), 1.90-1.40 (m, 6H). 13C NMR 
(DMSO d6, 150 MHz) δ 171.83 (C), 167.69 (C), 166.96 (C), 161.67 (C), 150.38 (CH), 149.97 (C), 
149.49 (CH), 149.32 (C), 149.26 (C), 146.74 (C), 144.51 (C), 144.46 (C), 141.70 (C), 140.66 (CH), 
140.07 (C), 139.30 (CH), 139.20 (CH), 135.01 (CH?), 133.07 (CH?), 131.90 (CH), 131.31 (CH), 
130.66 (CH), 129.92 (CH), 127.96 (CH), 127.68 (CH), 127.51 (CH), 125.70 (CH), 125.46 (CH), 
124.99 (CH), 124.44 (CH), 124.22 (CH), 123.38 (CH), 122.92 (CH), 122.33 (CH), 121.71 (CH), 
120.33 (CH), 119.91 (CH), 70.36 (CH), 59.02 (CH2), 56.27 (CH), 53.22 (CH), 36.57 (CH2), 27.09 
(CH2), 25.56 (CH2), 25.41 (CH2). 
ESI - MS: 1040 (M+). 
Synthesis of complex 6a. In a 10 ml round-bottom flask equipped with a stirring bar, the ligand 3a 
(0.014 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (4 mL) and the Iridium dimer 19 
(0.016 g, 0.015 mmol) was added. The mixture was left to stir at r.t. 48 h. The solvent was removed 
and the resulting residue was dissolved in MeOH (0.5 mL) and precipitate with Et2O. The solid was 
filtered to give pure complex 6a (60% yields). 
1H NMR (CDCl3, 400 MHz) δ 11.6 (s, 1H),  9.33 (d, 1H, JHH =7.68 Hz),8.10 (d, 2H, JHH =8.56 Hz), 
7.99 (t, 1H, JHH =7.70 Hz),  7.84 (d, 2H, JHH =8.23 Hz),  7.70 (d, 4H, JHH=5.76 Hz), 7.60 (m, 2H), 
7.43 (d, 1H, JHH =5.69 Hz),  7.25 (m, 3H), 7.00-6.75 (m, 6H), 6.33 (dt, 2H, JHH =7.4 Hz, JHH=5.7 
Hz), 4.45 (m, 1H), 4.25 (m, 1H),  3.10 (m, 1H), 2.82 (dd, 1H, JHH =3.97 Hz),  2.67 (d, 1H, JHH 
=13.03 Hz),  2.45 (t, 2H, JHH =7.41 Hz), 1.70 (m, 4H),  1.43 (t, 2H, JHH =7.66 Hz). 13C NMR 
(CDCl3, 101 MHz) δ 170.70 (C), 167.39 (C), 166.51 (C), 162.57 (C), 150.37 (C), 148.91 (C), 
148.86 (C), 148.53 (C) , 148.51 (CH), 148.47 (CH), 148.45 (CH), 147.35 (CH), 145.23 (C), 142.71 
(C), 142.64 (C), 138.97 (CH), 137.02 (CH), 136.98 (CH), 132.44 (C), 130.93 (CH), 130.70 (CH), 
129.68 (CH), 129.01 (CH), 128.72 (CH), 125.83 (CH), 125.15 (CH), 124.29 (CH), 123.67 (CH), 
123.31 (CH), 122.33 (CH), 122.23 8CH), 121.84 (CH), 121.67 (CH), 121.21 (CH), 120.61 (CH), 
118.55 (CH), 118.43 (CH), 60.93 (CH), 59.15 (CH), 54.42 (CH), 39.57 (CH2), 32.80 (CH2), 27.30 
(CH2), 23.63 (CH2). ESI - MS: 965 (M+). 
Synthesis of complex 6b. In a 10 ml round-bottom flask equipped with a stirring bar, the ligand 3b 
(0.016 g, 2 equiv) was dissolved in a 3:1 mixture of CH2Cl2/EtOH (4 mL) and the Iridium dimer 19 
(0.016 g, 0.015 mmol) was added. The mixture was left to stir at r.t. 48 h. The solvent was removed 
and the crude was purified by column chromatography on silica gel (CH2Cl2/ MeOH = 90/10, 30% 
yields). 
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1H NMR (CDCl3, 400 MHz) δ 11.79 (s, 1H), 9.38 (d, 1H),  8.16 (d, JHH =8.51 Hz, 2H),  8.06 (t, JHH 
=7.53 Hz, 1H),  7.92 (dd, JHH =3.66 Hz, 2H), 7.81-7.73 (m, 4H),  7.70-7.64 (m, 4H),  7.57-7.51 (m, 
3H),  7.27 (s, 1H),  7.15 (d, JHH =8.59 Hz, 2H), 7.07-6.95 (m, 4H),  6.95-6.85 (m, 2H),  6.34 (dd, 
JHH =2.20 Hz, 2H),  5.75 (s, 1H), 5.18 (s, 1H),4.55-4.45 (m, 1H),  4.35-4.30 (m, 1H),  3.22-3.16 (m, 
1H), 2.92 (dd, JHH =4.95 Hz, 1H),  2.75 (d, JHH =12.67 Hz, 1.90-1.40 (m, 6H).  
13C NMR (CDCl3, 101 MHz) δ 171.06 (C), 167.45 (C), 166.57 (C), 162.26 (C), 149.62 (C), 149.04 
(C),148.94 (C), 148.50 (C), 148.47 (CH), 148.42 (CH), 147.38 (CH), 145.32 (C), 142.71 (C), 
142.64 (C), 140.59 (C), 147.38 (CH), 145.32 (C), 142.71 (C), 142.64 (C), 140.59 (C), 138.96 (CH), 
136.97 (CH), 136.92 (CH), 136.12 (C), 134.28 (C), 130.95 (CH), 130.70 (CH), 129.70 (CH), 
129.03 (CH), 127.37 (CH), 127.13 (CH), 125.90 (CH), 125.05 (CH), 125.41 (CH), 123.67 (CH), 
123.30 (CH), 122,29 (CH), 121.81 (CH), 121.67 (CH), 121.20 (CH), 121.14 (CH), 119.74 (CH), 
118.52 (CH), 118.41 (CH), 60.92 (CH), 59.12 (CH), 54.33 (CH), 39.55 (CH2), 32.97 (CH2), 29.68 
(CH2), 27.34 (CH2), 23.72 (CH2). 
ESI - MS: 1041 (M+) 
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6.3 - Biotinylated cyclometallated Re(I) complexes as luminescent probes for avidin targeting 
As previously mentioned, during recent years, the development of new luminescent probes 
containing transition metals complexes for biological imaging has received high attention. These 
probes are constituted by a emissive unit which consists precisely in a luminescent metal complex, 
and an other fragment able to identify a specific biological target. In this work some of the 
previously described binders containing a chelating unit separated from biotin by an amide bridge 
were used to synthesize tricarbonilic derivatives of Rhenium (I). The obtained luminescent 
complexes, thanks to their good emission properties, allowed us to work with a metal certainly 
cheaper than Iridium and certainly suitable for biological investigations.1 
The design and the synthesis of a new class of bifunctionalized ligands L1-L3, (Figure 1), 
containing both a pyridine-1,2,3-triazole and a biotin unit have been reported in the previous 
chapter.  
In this project we choose the ligands containing an amide bond to investigate luminescent properties 
of the corresponding Re(I) complexes ReL1(Br), ReL2(Br), ReL3(Br), ReL1(pir) and ReL2(pir). 
(Figure 1), and their variation in the presence of the avidin target. In particular, the importance of 
the nature of the amide linker was evaluated, considering that it has been reported that long spacer-
arms can increase the stability of the metal-avidin adducts. 
 
 
 
Figure 1 
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6.3.1 - Results and Discussion 
6.3.1.1 - Complexes synthesis 
After the preparation of the ligands, the next step the synthesis of the corresponding Re (I) neutral 
complexes. The ligands L1, L2 and L3 were reacted with Re(CO)5Br using respectively toluene, 
ethanol and a mixture of toluene/ethanol = 1/1, as solvents owing to the different solubility of the 
starting materials, at reflux under N2 (Scheme 1), to give the complexes ReL1(Br), ReL2(Br) and 
ReL3(Br). 
 
Scheme 1 
 
In addition, with the aim of improving the solubility of the complexes in an aqueous environment 
where interaction with biotin takes place, two cationic complexes were obtained by substituting the 
bromide on Rhenium with a neutral ligand such as p-benzylpyridine in complexes ReL1(Br) and 
ReL2(Br). 
The synthesis was performed in two steps. Firstly, the complex ReL1(Br) was reacted, in a mixture 
of DCM and methanol at room temperature, with silver triflate to extract the bromide. The 
precipitated silver bromide was subsequently removed by filtration and the solvent was removed by 
evaporation. In the second step, the crude product was dissolved in THF and reacted at reflux with 
p-benzilpiridine which linked to the metal center, leading to the complex ReL1(pir) (Scheme 2). An 
analogous procedure made it possible to synthesize the complexes ReL2(pir) (Scheme 2). 
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Scheme 2: Complexes ReL1(pir) and ReL2(pir) synthesis. 
The obtained complexes were fully characterized by NMR analysis. Interestingly, the IR analysis 
allowed to achieve two important informations on the ionic character of the new complexes. As 
example, the IR spectra of ReL2(Br) and ReL2(pir) are reported in Figure 2. Switching from the 
neutral specie (the brominated derivative) to the cationic one (the pyridine complex) the three 
carbonyl groups coordinated to the metal centre maintain a facial geometry, as indicated by the 
typical IR band shape; moreover, the character of the cationic complex is evidenced by the shift of 
carbonyl (M-CO) stretchings towards higher wave numbers. 
 
Figure 2: IR spectrum of the neutral complex ReL2(Br) (blue); IR spectrum of the cationic complex 
ReL2(pir) (black). 
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6.3.1.2 - Photophysical properties 
Once the synthesis procedure of the complexes was optimized and completed, we moved to the 
study of the photophysical properties of these new systems in order to evaluate their potential use as 
biological probes. The characterization of the absorption and emission properties of the compounds 
was initially carried out in dichloromethane (CH2Cl2).  
As regards to the absorption spectra, the profiles are consistent with the structure of an octahedral 
complex, in which the π-π* transitions centered on binders are observed at wavelengths below 300 
nm and MLCT transitions in the area between 330 and 450 nm. 
The UV-vis absorption spectra of species ReL1(Br) and ReL1(pir) (Figure 3) and ReL2(Br) and 
ReL2(pir) (Figure 4), in dichloromethane, are reported below. The absorption spectrum of the 
complex ReL1(Br) presents two bands, well evident, with maxima at 240 and 352 nm and a 
shoulder at 274 nm, as shown in Figure 3. 
It is interesting to note that from a neutral to a cationic complex the absorption maximum shifts to 
lower energies. Such shifts may be attributed to the charge increase of the complex, and are 
observed in all the complexes. 
 
 
Figure 3 
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Figure 4 
 
In Figure 5 the excitation and emission spectra of the complex ReL2(Br), at room temperature in the 
presence of oxygen are reported. In these species a certain difference between the profile of the 
excitation and absorption, is frequently observed especially when the emission comes from excited 
states of MLCT nature. 
 
Figure 5 
As can be seen from the profiles of the spectra, there is a considerable distance in energy between 
the excitation (or absorption) spectrum, and the emission spectrum. This is dueto the so called 
“Stokes shift”. 
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To easily compare the emission properties of the four complexes, their emission spectra are 
reported together in Figure 6. 
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Figure 6: Emission spectra; C2=ReL1(Br), C4=ReL2(Br), C5=ReL2(pir), C1=ReL1(pir) 
As underlined from the recorded spectra, all the complexes are luminescent and exhibit their 
maximum emission in a range of wavelengths from 494 nm to 540 nm. From the Figure 6 it can be 
noted how, in the cationic complexes, the emission maximum moves to lower wavelengths, respect 
to the neutral complexes. 
Emission spectra were recorded also in the absence of oxygen and at 77 K. the registered maxima 
are reported in Table 1.  
 
COMPLEX λ with O2 (ns) λ  Deaerated sol. (nm) λ 77K (nm) 
ReL1(Br) 540 [288] 539 [390] 486 [340] 
ReL2(pir) 494 [293] 496 [293] 458 [322] 
ReL2(Br) 534 [301] 542 [301] 490 [306] 
ReL1(pir) 494 [392] 496 [380] 470 [360] 
Table 1: Emission maxima, [wavelength of excitation] 
As Ir(III) complexes, even the Re(I) complexes are phosphorescent and the emissions derive from a 
of an excited triplet state. In fact, even if the value of the maximum emission does not vary, from a 
solution in the presence of oxygen to a degassed, its intensity changes considerably as shown in 
Figure 7. 
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Figure 7: ReL1(pir) emission 
The characterization is performed by changing some parameters. These variations are important, as 
they allow to distinguish the nature of the different excited states from which luminescence derives. 
In particular, carrying out the analysis at 77 K, the energy dissipation due to phenomena with non-
radiative constant, such as vibrations and rotations, is minimized; this implies a luminescence 
increase, as well as a lengthening of the lifetime. For these Re (I) complexes, a shift of the emission 
maximum at higher energies has been observed from a spectrum registered at room temperature to a 
frozen one. Such behavior is typical of such complexes that present MLCT transitions. In these 
conditions, the emission maxima range from 458 nm to 490 nm (Table 1). In Figure 8 the 
comparison between the emission spectrum of ReL1(pir) recorded at 77 K and at room temperature 
is shown, highlighting the shift of the max.  
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Figure 8: Comparison of emission spectra of the complex ReL1(pir) recorded at ambient 
temperature and 77 K. 
 
Finally, the quantum yields and the lifetimes of the obtained complexes were determined in various 
conditions. The simplest way to determine the quantum yield of a fluorophore is based on a 
comparison with a standard of known quantum yield.2 The quantum yield of emission of these 
reference compounds are almost independent on the wavelength of excitation, so it is possible to 
use them in all their absorbance range. 
The unknown quantum yield is calculated using the following formula:3 
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where Φ is the quantum yield of the emission of the sample, I is the area subtended by the spectrum 
all over the λ emission range, A is the absorbance at λ excitation and n is the refractive index of the 
solvent. 
In Table 2 the values of quantum yield measured in the presence of oxygen and in degassed solution 
are reported. 
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COMPLEX Φ with O2 Φ Deaerated sol. 
ReL1(Br) 0,0454 0,0318 
ReL2(pir) 0,0834 0,146 
ReL2(Br) 0,0308 0,184 
ReL1(pir) 0,192 0,206 
Table 2: Complexes quantum yields 
 
Regarding the detection of the lifetimes of luminescence the technique of "time correlated single 
photon counting" (TCSPC), commonly called "single photon", was used. The lifetimes of the 
complex, in dichloromethane, measured in three different conditions, in the presence of oxygen, in 
degassed solution and 77 K are summarized in Table 3. 
 
COMPLEX τ with O2 (ns) τ  Deaerated sol. (ns) τ 77 K (ns) 
ReL1(Br),  123,5 163,9 8470,0 
ReL2(pir) 241,6 496,3 1000,0 (3,3 %)) 
6469,2 (96,7 %) 
ReL2(Br) 131,6 609,4 8806,4 
ReL1(pir) 2,3 (11,9 %)) 
305,9 (88,1 %) 
2,4 (6,5 %) 
584,2 (93,5 %) 
7,4 (58,2 %) 
22,8 (41,8 %) 
Table 3: Complexes lifetime 
 
Analyzing the tabulated data, an increase of the lifetimes is observed from a room temperature 
solution in the presence of oxygen to a degassed solution, demonstrating the nature of the triplet 
excited state from which the emission originates. 
 
6.3.1.3 - Interaction between the biotinylated complexes of Re (I) and avidin 
The study of the photophysical properties of these new complexes of Re (I) showed that they 
present a number of features good for their use as luminescent probes.  
The next step is to determine if the photophysical properties of the biotinylated Re(I)-complexes 
undergo some variations upon interaction with avidin, in order to be considered a good probe for 
avidin. To perform such type of study is necessary, above all, to characterize the complexes in an 
aqueous solvent. Typical experiments of biotin-avidin bio-conjugation are generally conducted in 
aqueous solutions maintained at pH 7.4 by means of sodium or potassium phosphate buffers. The 
biotin-avidin interaction was verified by monitoring the variation of the complex 
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photoluminescence properties, in the presence of avidin. It was therefore necessary, even before 
placing in contact our complexes with the avidin, to evaluate their fotoemissive properties in 
aqueous solution, buffered to pH = 7.4. The obtained data are reported in Table 4 and show how the 
two complexes (ReL1(pir) and ReL2(pir)) are luminescent even in aqueous solution, with the 
maximum emission at 508 nm, shifted towards red if compared with the data obtained in 
dichloromethane, (max= 494 nm for both complexes). 
 
Complex max  (nm)  (ns)  
ReL1(pir)  508 [293] 101,19 0,00428 
ReL2(pir) 508 [298] 176,42 0,0473 
Table 4: Emission maxima in aqueous solution, [wavelength of excitation] 
 
Subsequently, in order to verify the interaction of the complexes ReL1(pir) and ReL2(pir) with the 
avidin some titration experiments were performed. Specifically, according to a protocol reported in 
the literature,4 avidin solutions were titrated using complexes of Re(I) in buffer solution of known 
concentration, and the increase in the emission intensity was measured after each addition. 
Figure 9 shows the "multiscan" graph of the titration of avidin with the complex ReL1(pir). Each 
curve represents the emission spectrum of the solution, after each addition of titrant. 
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Figure 9: Multiscan titration. 
In order to verify that such behavior is actually due to the interaction of the complex with the 
avidin, it is necessary to carry out two control titrations: one by adding increasing amount of the 
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complex solution to a buffer solution in the absence of avidin, and a second one in which a buffer 
solution containing avidin pre-saturated with an excess of free biotin is titrated with the complex 
solution. The trends of the titration are expressed in a graph in which the increase of the intensity of 
the emission maximum (Y-axis) is reported as a function of the amount of added complex (X-axis).  
The analogous literature examples reported that in such titration graphs the avidin-complex curve 
and those of control experiments presented different angular coefficients. Furthermore, a change of 
slope in the titration curves, ie a point of inflection, can be observed in the avidin-complex curve. 
This point corresponds to the saturation of avidin by the biotin, whether it comes from the 
biotinylated complex or from free biotin. After this equivalence point, the slope of the avidin-
complex curve is generally similar to that of control experiments.  
In the titration of our Re(I) complexes, we observed analogous trends. In Figures 10 and 11 the 
graphs related to the experiments conducted using as the titrant complex ReL1(pir) and complex 
ReL2(pir) are reported. 
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Figure 10: Titration curves of avidin 3.8 uM (blue), a solution of avidin and biotin 3.8 uM 4.75*10-5 
M (green) and a solution of 50 mM phosphate buffer (pink) with a solution in phosphate buffer + 
10% DMSO of complex ReL1(pir). Each addition corresponds to 10 mL of titrant. 
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Figure 11: Titration curves of avidin 3.8 uM (blue), a solution of avidin and biotin 3.8 uM 4.75*10-5 
M (green) and a solution of 50 mM phosphate buffer (pink) with a solution in phosphate buffer + 
10% DMSO complex of ReL2(pir). Each addition corresponds to 10 mL of titrant. 
 
For both experiments, the avidin-complex curves display a first linear part up to the flexion point 
(for both tests detectable about the twentieth addition), after which the curve shows a trend 
comparable to that of the control titrations. Specifically, the two tests show two different cases of 
change in emission intensity of the complexes in the presence of avidin, compared to control 
titrations. In the experiment in Figure 10, in the first section of the curves, there is an increase of 
angular coefficients compared to those of the control experiments, while, in the section after the 
inflection, there a slight decrease is registered. An opposite situation occurs in the test in the Figure 
11, in which, in the first section, it is possible to observe a decrease in the angular coefficients and, 
after the inflection, a significant increase of the latter.  
Even if the presence of a bioconjugation between the complexes and avidin can be deducted from 
the reported titrations, with regard to the quantitative analysis of the amount of complex necessary 
to completely saturate avidin, we run into some problems concerning the low solubility of the 
complex in an aqueous environment, which has not allowed to obtain solutions of known 
concentration of titrant.  
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6.3.2 - Conclusions 
The study of the photophysical properties of the obtained Re(I) complexes, in dichloromethane, 
except for the L3 species, showed photoemissive processes of phosphorescent nature and therefore 
distinguishable from autofluorescence of samples, hypothesis corroborated by time-resolved 
measurements. The cationic complexes ReL1(pir) and ReL2(pir), were further characterized in a 
phosphate buffer at pH = 7.4 +10% DMSO. 
From this characterization it was observed as the complexes maintain their phosphorescent 
photoemittive properties also in this aqueous solvent. This made it possible to analyze the 
interaction of these two species with a water soluble glycoprotein specific for biotin: avidin. 
In the titration of a avidin solution with the complex ReL1(pir), it is observed how the emission 
intensity of the latter increases compared to that measured in control experiments. In the second 
titration, performed with the species ReL2(pir), an opposite situation is encountered, namely a 
decrease of emission intensity compared to control titrations. The change in emission intensity is 
due to the coordination of the complex-biotin to the protein. In the graphs an inflection point is 
observable after the addition of a certain quantity of complex; after that point the trend of the 
intensity of emission changes slope and becomes analogous to the behavior found in the control 
experiments. It can be assumed that the change of slope represents the moment in which the 
equivalence point is reached, but there was no possibility to perform a quantitative analysis because 
of the poor solubility of the complexes in aqueous medium, in spite of the use of cationic complexes 
instead of neutral ones. Future studies, may relate precisely the issue of solubility, in order to be 
able to prepare solutions of known concentration of titrant. 
 
6.3.3 - Experimental section 
 
Synthesis of Complex ReL1(Br) 
Re(CO)5Br (0.117 g, 0.228 mmol) and ligand L1 (0.120 g, 0.221 mmol) were dissolved in 
anhydrous toluene (15 ml) and the solution was left to stir at 130°C under N2 for 24 h. The cooled 
mixture is filtered and the obtained solid was washed with MeOH (3 x 15 ml), dissolved in the 
minimum amount of acetone and precipitated with Et2O. The obtained product ReL1(Br) was 
isolated by centrifugation (80% yields, mp= 169 -171°C). 1H NMR (CD3OD, 600 MHz) δ 8.97 (d, J 
= 5.4 Hz, 1H), 8.95 (s, 1H), 8.18 - 8.11 (m, 2H), 7.54 (td, JT = 8.7 Hz, JD = 2.6 Hz, 1H), 4.59 (t, J = 
7.5 Hz, 2H), 4.48 (dd, J = 7.7 Hz, J = 5.0 Hz, 1H), 4.29 (dd, J = 7.9 Hz, J = 4.5 Hz, 1H), 3.22 - 3.16 
(m, 1H), 3.13 (JT = 7.0 Hz, JD = 1.7 Hz, 2H), 2.91 (dd, J = 12.8 Hz, J = 5.0 Hz, 1H), 2.69 (d, J = 
12.7 Hz, 1H), 2.18 (t, J = 7.6 Hz, 2H), 2.06 - 1.98 (m, 2H), 1.76 - 1.25 (m, 25H). 13C NMR 
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(CD3OD, 150 MHz) δ 197.2 (C), 195.7 (C), 188.6 (C), 174.8 (C), 164.9 (C), 153.2 (CH), 149.8 (C), 
149.0 (C), 140.1 (CH), 126.0 (CH), 125.0 (CH), 122.5 (CH), 62.3 (CH), 60.5 (CH), 55.9 (CH), 52.2 
(CH), 40.0 (CH2), 39.3 (CH2), 35.8 (CH2), 29.8 (CH2), 29.5 (CH2), 29.3 (CH2), 29.2 (CH2), 28.8 
(CH2), 28.6 (CH2), 28.4 (CH2), 26.9 (CH2), 26.2 (CH2), 25.9 (CH2). ESI - MS: 892 [M+], 914 [M+ + 
Na]. 
 
Synthesis of Complex ReL2(Br) 
In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Re(CO)5Br, (0.23 mmol) 
and the ligand L2 (0.19 mmol) was dissolved in a mixture of Tol/EtOH = 1:1 (16 mL) and refluxed 
for 24 h. The solution was cooled to room temperature and the solvent was removed by vacuum. 
The crude was washed with Acetone to give product C4 in 95% yield. 
1H-NMR (DMSO): δ = 1.30-1.70 (m, 6H), 2.30-2.40 (m, 2H), 2.60 (d, 1H, J=12.3), 2.84 (dd, 1H, 
J=12.3, J=4.9), 3.10-3.20 (m, 1H), 4.10-4.20 (m, 1H). 4.30-4.40 (m, 1H), 6.36 (bs, 1H), 6.45 (bs, 
1H), 7.65-7.75 (m, 1H), 7.90-8.00 (m, 4H), 8.25-8.40 (m, 2H), 9.03 (d, 1H, J=5.3), 9.90 (bs, 1H), 
10.30 (s, 1H).  
13C-NMR (DMSO): δ = 25.4 (CH2), 28.6 (CH2), 28.7 (CH2), 36.7 (CH2), 40.3 (CH2), 55.8 (CH), 
59.7 (CH), 61.5 (CH), 120.3 (CH), 122.1 (CH), 123.1 (CH), 124.4 (CH), 127.1 (CH), 130.6 (C), 
141.2 (CH), 141.6 (C), 149.0 (C), 149.4 (C), 153.8 (CH), 163.2 (C), 172.2 (C), 189.3 (C), 193.8 
(C), 196.6 (C). 
 
Synthesis of Complex ReL3(Br) 
In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, Re(CO)5Br, (0.11 mmol) 
and the ligand L3 (0.085 mmol) were dissolved in EtOH (10 mL) and refluxed for 24 h. The 
solution was cooled to room temperature and the solid was filtered to give pure product C3 in 15% 
yield. 
1H-NMR (DMSO): δ = 1.10-1.80 (m, 6H), 2.30-2.40 (m, 2H), 2.59 (d, 1H, J=12.8), 2.84 (dd, 1H, 
J=4.9, J=12.8), 3.10-3.20 (m, 1H), 4.10-4.20 (m, 1H), 4.30-4.40 (m, 1H), 6.35 (bs, 1H), 6.45 (bs, 
1H), 7.65-7.75 (m, 1H), 7.77 (bs, 4H), 8.01 (d, 2H, J=8.8), 8.09 (d, 2H, J=8.8), 8.30-8.40 (m, 2H), 
9.05 (d, 1H, J=5.6), 10.03 (s, 1H), 10.05 (bs. 1H). 
13C-NMR (DMSO): δ = 25.5 (CH2), 28.6 (CH2), 28.7 (CH2), 36.7 (CH2), 40.3 (CH2), 55.9 (CH), 
59.7 (CH), 61.5 (CH), 119.9 (CH), 121.7 (CH), 123.1 (CH), 124.5 (CH), 127.2 (CH), 127.7 (CH), 
128.2 (CH), 133.0 (C), 134.6 (C), 140.1 (C), 141.3 (CH), 142.0 (C), 148.9 (C), 149.5 (C), 153.8 
(CH), 163.2 (C), 171.8 (C), 183.6 (C), 189.3 (C), 196.6 (C). 
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Synthesis of Complex ReL1(pir) 
In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, the complex ReL1(Br) 
(0.08 mmol) was dissolved in a mixture of DCM/MeOH = 3:1 (12 mL) , and AgSO3CF3 (1.5 
equiv.) was added. The reaction flask was wrapped in aluminium foil and the reaction was left to 
stir overnight at room temperature. Then the solid was filtered off and washed with DCM (2 mL). 
The solution was evaporated and the resulting residue was dissolved in anhydrous THF (5 mL), 
under a nitrogen atmosphere. p-Benzyl-pyridine (1 equiv.) was added, and the reaction mixture was 
stirred at 70° C under a nitrogen atmosphere for 24 h. Then the solvent was removed by vacuum 
and the crude was purified by column chromatography on alumina gel (DCM/MeOH = 96:4, 35% 
yields). 
1H-NMR (CDCl3): δ = 1.10-1.80 (m, 22H), 1.90-2.05 (m, 2H), 2.14 (t, 2H, J=7.3), 2.65 (d, 1H, 
J=13.6), 2.83 (dd, 1H, J=5.0, J=13.6), 3.05-3.15 (m, 3H), 3.86 (s, 2H), 4.20-4.30 (m, 1H), 4.40-4.45 
(m, 1H), 4.53 (t, 2H, J=7.2), 5.30 (bs, 1H), 5.90 (bs, 1H), 6.20 (bs, 1H), 6.95-7.05 (m, 4H), 7.20-
7.30 (m, 3H), 7.48-7.53 (m, 1H), 7.97-8.00 (m, 2H), 8.01-8.15 (m, 1H), 8.38 (d, 1H, J=10.2), 8.95 
(d, 1H, J=5.0), 9.33 (d, 1H, J=3.8). 
13C-NMR (CDCl3): δ = 24.6 (CH2), 24.7 (CH2), 25.1 (CH2), 25.6 (CH2), 25.7 (CH2), 26.9 (CH2), 
27.0 (CH2), 27.4 (CH2), 27.5 (CH2), 28.0 (CH2), 28.3 (CH2), 28.6 (CH2), 34.9 (CH2), 38,4 (CH2), 
39.6 (CH2), 40.0 (CH2), 51.9 (CH2), 54.5 (CH), 59.1 (CH), 60.8 (CH), 123.6 (CH), 125.9 (CH), 
126.4 (CH), 126.5 (CH), 128.1 (CH), 128.2 (CH), 135.4 (C), 140.7 (CH), 140.8 (CH), 148.1 (C), 
148.9 (C), 150.3 (CH), 151.2 (CH), 154.2 (C), 162.6 (C), 172.2 (C), 189.5 (C), 192.8 (C), 195.0 
(C). 
 
Synthesis of Complex ReL2(pir) 
In a 50 ml-two-necked round-bottom flask equipped with a stirring bar, the complex ReL1(Br) 
(0.17 mmol) was dissolved in a mixture of DCM/Acetone/MeOH = 16:16:1 (16.5 mL), and 
AgSO3CF3 (1.5 equiv.) was added. The reaction flask was wrapped in aluminium foil and the 
reaction was left to stir overnight at room temperature. Then the solid was filtered off and washed 
with DCM (2 mL). The solution was evaporated and the resulting residue was dissolved in 
anhydrous THF (15 mL), under a nitrogen atmosphere. p-Benzyl-pyridine (5 equiv.) was added, and 
the reaction mixture was stirred at 70° C under a nitrogen atmosphere for 24 h. Then the solvent 
was removed by vacuum and the crude was purified by column chromatography on alumina gel 
(DCM/MeOH = 98:2, DCM/MeOH = 93:7, 35% yields). 
1H-NMR (CD3OD): δ = 1.45-1.85 (m, 6H), 2.45 (t, 2H, J=7.3), 2.7 (d, 1H, J=12.6), 2.92 (dd, 1H, 
J=12.6, J=5.0), 3.19-3.25 (m, 1H), 3.92 (s, 2H), 4.32 (dd, 1H, J=4.6, J=8.2), 4.50 (dd, 1H, J=5.0, 
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J=8.2), 7.10-7.15 (m, 2H), 7.15-7.25 (m, 6H), 7.75-7.80 (m, 1H), 7.90-8.00 (m, 4H), 8.20-8.25 (m, 
1H), 8.26-8.30 (m, 1H), 8.30-8.35 (m, 2H), 9.29 (d, 1H, J=5.9), 9.52 (s, 1H). 
13C-NMR (CD3OD): δ = 25.2 (CH2), 28.1 (CH2), 28.4 (CH2), 36.3 (CH2), 39.7 (CH2), 40.2 (CH2), 
55.6 (CH), 60.2 (CH), 61.9 (CH), 120.4 (CH), 121.5 (CH), 123.1 (CH), 126.6 (CH), 127.4 (CH), 
128.5 (CH), 128.8 (CH), 131.0 (C), 137.6 (C), 141.2 (C), 141.4 (CH), 149.1 (C), 149.7 (C),  151.7 
(CH), 153.7 (CH), 155.6 (C), 164.7 (C), 173.3 (C), 190.8 (C), 193.8 (C), 195.3 (C). 
 
6.3.4 - Bibliography 
1. a) K. K.-W. Lo, W.-K. Hui, D. C.-M. Ng J. Am. Chem. Soc. 2002, 124, 9344-9345. b) M.-
W.Louie, H.-W. Liu, M. H.-C. Lam, Y.-W. Lam, K. K.-W. Lo Chem. Eur. J. 2011, 17, 8304 – 8308 
2. J. N. Demas, G. A. Crosby, J. Phys. Chem. (1971), 75, 991–1024. 
3. D. F. Eaton, Pure Appl. Chem. (1988), 60, 1107. 
4. K. K.-W. Lo, K. Y. Zhang, S. P.-Y. Li, Eur. J. Inorg. Chem., (2011), 3551-3568. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
93 
 
7) Tripodal triazole-based ligands  
The recent advance of “click chemistry” has boosted the number of molecules available for several 
leading-edge fields, including medicinal chemistry, biology and material sciences.[1] Among “click” 
reactions, the Cu(I)-catalyzed azide alkyne cycloaddition (CuAAC)[2] has received extraordinary 
attention since it is the most effective method to afford 1,4-substituted-1,2,3-triazoles from a wide 
range of usable substrates, with essentially perfect regioselectivity under mild conditions.[3] In 
addition, the development of the CuAAC reaction resulted in an renewed interest toward the 
employment of 1,4-functionalized-1,2,3-triazoles in coordination chemistry because of their 
potential to act as N-donor ligands.[4] In fact, in recent years, various bi-, tri-, and polydentate 1,2,3- 
triazole-containing structures have been synthesized and studied as metal ligands.[4a] In particular, 
polydentate ligands can be exploited to coordinate high coordination number ions such as 
lanthanides, which possess fascinating and versatile photophysical properties.[5] In fact, in recent 
years the considerable progresses in lanthanide chemistry have led the applications of lathanides-
based compounds in the fields of optical materials,[6] sensors,[7] bioassays[8] and diagnostics.[9] 
Among lanthanides, Cerium is the most abundant of the rare earth elements, one of the least 
expensive, it displays low to moderate toxicity and it played an important role in organic 
synthesis.[10] Furthermore, Ce3+ ion exhibits a 5d–4f emission with a large absorption in the UV 
region and a short luminescence lifetime due to allowed electric dipole transitions.[11] Generally, the 
emission of Ce3+ ion occurs in the UV spectral region but it can be red-shifted depending on the 
environment.[5,12] Taking advantage from these characteristics, some interesting applications in 
emitting devices have been carried out, especially by adding Ce3+ ions to inorganic crystals.[11, 13] 
On the other hand, investigations on the luminescence properties of Ce3+ ion in organic 
coordination environments remain rather rare,[14] although studies on the photophysical proprieties 
of Ce3+ in halides, organometallics, and polymer films has been reported.[15]  
In this project,[16] we exploited a triple click reaction to synthesize of a new series of symmetrical 
tertiary amines carrying in each side arm an aryl substituted aromatic triazole moiety and its use as 
coordinating agent of Ce3+ to obtain luminescent complexes. 
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7.1 - Results and Discussion 
We employed a recently reported protocol[17] to perform a new triple one-pot “click reaction” to 
obtain ligands L1 and L2. The procedure involves the in situ formation of aryl azides from the 
reaction of the corresponding amines 1 with t-BuONO and TMSN3, and the subsequent addition of 
tripropargylamine 2, CuSO4 and a reducing agent to give the tris triazole amines L1 and L2 without 
any intermediate work-up procedure, (Scheme 1). L1 and L2 were obtained in good yields (61% 
and 67% respectively), probably owing also to the autocatalytic activity previous reported for this 
kind of products.[18]  
NH2
N
3
N
N N
N
N
NN
N
N
N
1a X=H
1b X=F
X
X
X
2
L1 X=H, 61% yields
L2 X=F, 67% yields
1) t-BuONO, TMSN3
ACN, 0°C rt, overnight
Na-ascorbate, aq. CuSO4,
rt, 2 days
2)
X  
Scheme 1. Synthesis of ligands L1 and L2. 
The X-ray structure of L2 as ammonium salt, with nitrate as counteranion, was obtained. The 
structure is reported in Figure 1 and the corresponding crystallographic parameters in Table 1. 
 
Figure 1. Crystal structure of [L2H]+NO3- 
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Table1. Crystallographic parameters for L2 and 3b 
 L2 3b 
Empirical formula C27H22F3N11O3 C43H17CeF3N21O9 
Formula weight 605.56 1168.05 
Temperature (K) 298(2) 298(2) 
 (Å) 0.71073 0.71073 
Crystal system Triclinic Hexagonal 
Space Group P-1 P65 
a (Å) 6.177(2) 22.287(5) 
b (Å) 14.820(5) 22.287(5) 
c (Å) 16.615(6) 14.581(3) 
 (°)  65.935(4) 90 
 (°) 82.870(4) 90 
 (°) 78.528(4) 120 
V (Å3) 1359.6(8) 6272(2) 
Z 2 6 
Dcalcd 1.479 1.969 
 (mm-1) 0.116 1.166 
F(000) 624 3678 
Crystal size (mm) 0.350.100.10 0.300.150.15 
Crystal shape Sticks Brick 
Crystal color Colorless Pale yellow 
  range (°) 1.53 – 26.00 1.75 – 24.83 
Limiting indices -7  h  7; -18  k  18; -20  l  20 -26  h  26; -26  k  26; -17  l  17 
Reflections 12043  43891  
Reflections (independent) 5298 (R = 0.0207) 7184 (R = 0.0448) 
Completeness to max (%) 99.1 99.0 
Max. and min. transmission 0.9604 - 0.9884 0.6925 – 0.8263 
Refinemend methods full-matrix least-squares on Fo2 
Data/restraints/parameters 5298 / 0 / 400 7184/ 5 / 431 
Goodness-of-fit on F2 1.028 1.003 
Final R indices [I > 2(I)] R1 = 0.0408; wR2 = 0.1021 R1 = 0.0397; wR2 = 0.0999 
R indices (all data) R1 = 0.0622; wR2 = 0.1150 R1 = 0.0537; wR2 = 0.1065 
Largest diff peak/hole (e/ Å3) -0.151 and 0.131 -0.342 and 0.542 
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The coordination ability of ligands L1 and L2 towards Ce3+ ion was tested by reaction with various 
cerium(III) salts having anions with different coordinating characteristics.[19] 
The complexes of L1 and L2 with Ce(NO3)3, Ce(ClO4)3 and Ce(OTf)3 were prepared in acetonitrile 
(ACN), using cerium salts that were carefully washed with DCM to remove any residual acidity. 
Slow diffusion of diethyl ether in the reaction mixture induced the precipitation of 3a-b, 4a-b and 
5a-b complexes (Figure 2). 
As expected, owing to the ability of nitrate ion to strongly coordinate metals because of its bidentate 
character, the reaction with Ce(NO3)3 gave heteroleptic complexes 3a and 3b in which only one 
ligand coordinated to the metal (Figure 2). On the contrary, to obtain homoleptic Ce3+complexes 
containing two coordinating organic fragments, ligands L1 and L2 were reacted with cerium salts 
carrying generally not coordinating counteranions such as Ce(ClO4)3 and Ce(OTf)3, yielding the 
desidered complexes 4a-b and 5a-b (Figure 2). 
N
N
N
N
N
N N
Ce3+
N N
N
X
X
X
N
NN
N N
NN
N
N
N
X
X
X
N
N
N
N
N
N N
Ce
N N
N
X
X
X
O
O O OON
N
O
O
O
NO
3a X=H
3b X=F
4a X=H, A= ClO4 4b X=F, A= ClO4
5a X=H, A= CF3SO3 5b X=F, A= CF3SO3
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Figure 2: Complexes 3a-b, 4a-b and 5a-b 
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Compound 3b crystallizes in the hexagonal space group P65, with six molecules per unit cell (Table 
1). Cerium is bound to six oxygen atoms from the three nitrates, as well as to the four nitrogens of 
the tripodal ligand, thus yielding a ten-coordinated centre. As from Figure 3, the heteroleptic 
complex has C3 symmetry, and the asymmetric unit correspond to a whole molecule. 
 
Figure 3.Crystal data for complex 3b 
 
Unfortunately, any attempt to obtain good crystals of compounds 3a, 4a-b and 5a-b failed, thus an 
experimental structure of these complexes is not available. However, a computational approach 
could afford to a reasonable structure of the complexes, provided that a reliable theoretical model is 
found. Given the scarce literature data on computations of organic compounds containing 
cerium,[20] a preliminary investigation was conducted on the complex 3b where the theoretical 
results could be compared with the experimental structure observed in the solid state.  
The calculations were performed using the B3LYP functional and the SDD basis set,[21, 22] which 
has proven to be effective for inorganic compounds such as cerium oxide.[23] Although DFT 
calculations were performed as single molecule in gas phase, whereas X-rays structure is affected 
by solid state constraints, the optimized structure of 3b is very close to the experimental one (Figure 
4), showing Ce-N bond distances similar to that experimentally measured (Table 2) 
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Figure 4. X-rays (top) and calculated (bottom) structures of 3b. 
It should be noted that the largest mismatch (about 8% of the experimental value) was observed for 
the bond between the cerium and the sp3 nitrogen of the ligand, that is quite sensitive to any 
conformational change. The good match between the calculated and the experimental geometry of 
the complex indicate that this computational approach should be reliable also for the optimization of 
the homoleptic complexes 4-5. The geometry optimization of complex 4b was performed on the 
isolated cation (3+) in the doublet state, by the preliminary optimization of the core containing the 
six triazole rings, and adding the phenyl rings in a subsequent optimization step. The final structure 
(Figure 5, bottom) shows that the cerium is octa-coordinated, with total symmetry D3d, and Ce-N 
bond distances very similar to those observed for complex 3b (Table 2). 
Table 2. Experimental and calculated Ce-N distances in complexes 4b, 5b and 6b. Calculations at 
the B3LYP/SDD level. 
 
Distances Exp. Dist. in 3b (Å) Calcd. for 3b (Å) Calcd. for 4b, 5b (as 3+ cation, Å) 
Ce-N(CH2)3 2.826 3.05 2.91 (average) 
Ce-N(triazole) 2.69 (average) 2.66 (average) 2.56 (average) 
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Figure 5. Calculated structures of 4b and 5b. Top: complete structure; bottom: coordination 
geometry of Ce3+ 
All the obtained complexes were studied using a variety of techniques. The FT-IR spectra of 
complexes as solid samples gave a confirmation of their structures. In fact, typical peaks of the 
nitrate groups[24] appear at ca 1500 cm-1, 1306 cm-1, 1026 cm-1 and 816 cm-1 and the difference 
between two strongest absorptions of the nitrate groups is about 200 cm-1, confirming that the NO3- 
groups coordinate to the lanthanide ion as bidentate ligands.[24e] Otherwise, 4a-b and 5a-b showed 
characteristic frequencies of free anion, i.e. about 1600, 1110, 1090 and 624 for perchlorates[25] and 
1275, 1030, 759, 638 and 517 for triflates.[26] 
NMR analysis of the complexes produced very interesting results, giving evidence that both 
homoleptic and heteroleptic complexes are stable in solution. The 1H-NMR spectra revealed the 
formation of metal-ligand interactions through a massive broadening of most of the signals with 
respect to the pure ligands, together with large variations in chemical shifts.[27] 
1H-NMR spectra recorded in acetonitrile-d3 at 25°C on 4b and on 5b showed a broad signal at about 
-3 ppm. On the contrary, the spectra of 3b complex did not show the signal at -3 ppm, but a very 
broad signal centered at about -0.5 ppm. Having assigned all the other signals, in the cases of 4b 
and 5b, the signals at -3.2 ppm must be assigned to the three CH2 bonded to the central nitrogen of 
the tripodal ligand. The huge upfield shift can be ascribed to the proximity to the paramagnetic 
Ce3+, that acts as an internal shift reagent.[28] On one side the observation of this paramagnetic shift 
is a proof of the presence of a cerium complex in solution, on the other side it is not a definitive 
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proof of the existence of the homoleptic complex in solution. For this reason, a NMR sample of 4b 
was prepared using about 1.5 eq of ligand with respect to Ce(ClO4)3. NMR spectra recorded in 
acetonitrile-d3 showed a signal at -3.0 ppm and a smaller signal at -0.5 ppm (about 50% by 
integration). On addition of small portions of L2, the signal at -0.5 ppm disappeared and the signal 
of the free ligand (4.1 ppm) eventually appeared when the ligand was in excess (Figure 6 ).[29]  
  
Figure 6. 1H NMR spectra of compound 4b. Spectrum a) corresponds to a sample prepared with 1.5 
eq. of ligand. Spectra b-d were recorded after consecutive addition of free ligand, showing the 
disappearance of the signal at -0.2 ppm and the raising of the signal of the free ligand (green arrow) 
when the ratio is bigger than 2:1. The signal of the homoleptic complex at -3.35 ppm (blue arrow) 
grows in integral without any change in chemical shift. 
This behavior unequivocally showed that the signal at -3.0 ppm corresponds to the (L2)2Ce(ClO4)3 
complex 4b, whereas the signal at -0.5 ppm is due to the (L2)Ce(ClO4)3 complex. The same 
behavior was observed in the case of the triflate 5b. 
On the contrary, the spectra acquired on the nitrate complex 3b prepared using 1.5 eq of L2 still 
showed a very broad signal at about -0.5ppm. To ascertain if a dynamic process took place, variable 
temperature spectra were recorded. On lowering the temperature, the upfield signal sharpens and 
moves upfield to -3.4 ppm at -20°C, and a second signal appears at 4.0 ppm, the latter being 
coincident with the chemical shift of the free ligand. This behaviour can be ascribed to the chemical 
exchange of the ligand between the complexed and the free status, the broad signal observed at 
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+25°C being the weighted average of the two chemical shift when the exchange is fast in the NMR 
timescale. The chemical shift of the upfield signal at -20°C is almost coincident with the signals of 
the perchlorate and triflate compounds (albeit a temperature shift is possible). To understand 
whether the signal at -3.4 ppm observed at -20°C corresponded to a temperature induced upfield 
shift of the heteroleptic complex or to the formation of the homoleptic complex, a set of spectra was 
recorded at 0°C for the three compounds 3b, 4b and 5b. (Figure 7). At this halfway temperature the 
upfield signal of the perchlorate and triflate compounds moved to about -4 ppm whereas the signal 
of the nitrate complex was found at -1.9 ppm. The different chemical shift observed for 3b confirms 
the exclusive formation of the heteroleptic compound in the case of nitrate anion, as experimentally 
observed by X-ray. 
 
Figure 7. 1H NMR spectra (600 MHz in CD3CN) recorded at 0°C for the three L2-complexes 3b, 
4b and 5b. 
The samples can be stored at room temperature at least for 48 hours without noticeable variation of 
the spectra, thus indicating that all the complexes are stable in acetonitrile solutions. Moreover, 
dilution NMR analysis was performed (concentration range 5x10-3-5x10-5 M) showing that neither 
the concentration nor the amount of water in the solvent affected the nature of the species in 
solution. 
The ESI-MS spectra of homoleptic complexes 4a-b and 5a-b recorded in acetonitrile showed peaks 
corresponding to the (L1)2Ce3+ motifs with 0-3 charge-balancing ions, whereas peaks 
corresponding to the (L1)Ce3+ species were not detected, confirming again that the homoleptic 
motif is favored in solution. A representative example is reported in Figure 8. On the contrary, the 
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spectra of heteroleptic complexes 3a-b showed both kind of peaks, probably since rearrangements 
can occur during the analysis[30] and the different instrumental response depending on the 
compound charge. 
 
Figure 8. Mass spectrum of complex 4a. 
The photophysical properties of the new complexes are summarised in Table 3. The absorption 
spectra of the L1-Ce3+-complexes in ACN solution, together with those of the starting Ce3+ salts 
and of the free ligand L1, all of which were measured from samples at the same concentration 
(5.0x10-5 M), are reported in Figure 9. 
 
Figure 9. Absorption spectra of 1x10-5M ACN solutions of L1, 3a, 4a and 5a (left), L2, 3b, 4b and 
5b (right), and 5x10-5M ACN solution of Ce3+ salts. 
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In particular, the spectrum of each L1-Ce3+ complex does not macroscopically differ from that of 
the free ligand L1, as all of the absorption profiles display ligand centered (LC) –* transitions 
centered at ca. 250 nm. However, the formation of the various homoleptic [Ce(L1)2]3+ species, 
namely 4a and 5a, is witnessed by fact that the intensity of this band almost doubles those relative 
to the heteroleptic complex 3a and the free ligand L1, respectively (Figure 5). As expected, totally 
different absorption profiles were displayed by all of the Ce(III) saline precursors (Figure 9). The 
spectra of these latter species, in fact, consist of very weak transitions in the wavelength range 
comprised between 250 and 270 nm. 
A substantially analogous behaviour was displayed by the ligand L2 and the whole series of the 
corresponding Ce3+-L2 complexes (Figure 9). 
Compound 
Absorption  
max(nm): 104 (M-1  
cm-1) 
Emission  (nm)  (ns)  
L1 247 (3.1) 454 4 <0.1% 
L2 250 (3.8) 386, 408, 430 4 <0.1% 
3a (L1Ce(NO3)3) 247 (2.7) 456 10 1.0% 
4a ((L1)2Ce(ClO4)3) 246 (6.0) 486 21 1.5% 
5a ((L1)2Ce(OTf)3) 250 (6.4) 476 22 1.0% 
3b (L2Ce(NO3)3) 252 (3.1) 416 10 0.5% 
4b ((L2)2Ce(ClO4)3) 248 (5.6) 418 22 1.0% 
5b ((L2)2Ce(OTf)3) 245 (5.8) 406 27 0.5% 
Table 3. Photophysical data of ligands and Ce(III)-complexes in ACN solutions (5.0x10-5M). 
All the compounds that are reported here, including the “free” ligands L1 and L2, are luminescent 
at room temperature in acetonitrile solutions (water content less than 1%). The spectra were 
recorded at various concentrations (from 10-3 to 10-5 M) and no appreciable differences were 
observed. At a glance, the emission spectra of the L1 containing Ce3+ complexes do not differ 
appreciably from that of the ligand L1 that was obtained in the same conditions. However, the 
different nature of the excited states from which emissions originates in the Ce3+-L1 complexes is 
suggested by the analysis of their excitation spectra. As depicted in Figure 10, the excitation spectra 
of the various Ce3+-L1 species display two different contributions at ca. 275 and 335 nm, 
respectively, while a single maximum centred at ca. 275 nm is observed in the excitation spectrum 
of the free ligand L1. 
The emission profile of the heteroleptic complex 3a resemble the one of L1, with a maximum 
around 456 nm, whereas a red shift to 486 and 476 nm was observed for the homoleptics 4a and 5a 
respectively. 
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Figure 10. Normalized excitation and emission spectra of ligands L1 and the corresponding cerium 
(III) complexes, 3a, 4a and 5a in ACN at r.t.. 
Relative to the triazole-based fluorinated L2 and to the corresponding Ce3+ complexes, the analysis 
of the fluorescence spectra enlighten some differences with respect to the previous cases (Figure 
11). Indeed, upon excitation at 300 nm, the free ligand L2 displays a vibronically structured 
emission spectrum with maxima centered at 386 and 430 nm, respectively. This emission profile 
turns to broad and structureless as the Ce3+-L2 complexes are formed, also giving rise, in most 
cases, to substantially different excitation spectra. It is also worth noting that, at opposite with what 
observed for the L1-Ce3+ type complexes, no particularly evident difference was detected from the 
comparison of the steady-state emission spectrum of the heteroleptic compound 3b with respect to 
those of the homoleptics 4b and 5b. 
 
Figure 11. Normalized excitation and emission spectra of ligands L2 and the corresponding cerium 
(III) complexes, 3b, 4b and 5b in ACN at r.t.. 
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The measured lifetime decays () of the new complexes, which are comprised between 10 and 27 
ns, are comparable with those previously reported for Cerium (III) derivatives7d, 9 and one order of 
magnitude higher than those displayed by the free ligands, suggesting the Ce3+ ion as responsible of 
the emissions. The emission quantum yields (Φ) values that were determined from diluted (5x10-5 
M) acetonitrile solutions of all the new Ce3+ complexes vary from 0.5% to 1.5% and are 
significantly lower than those relative to a series of similar (L)2Ce3+ species.[14] This discrepancy 
could be attributed to a partially fulfilling “Ce(III)-encapsulating attitude” displayed by the ligands 
employed in this work. 
7.2 - Conclusions 
Two new tripodal aromatic triazole-based ligands L1 and L2 have been synthesized and exploited 
to obtain blue-emitting Ce3+ complexes. Depending on the counteranion , different structures of 
heteroleptic and homoleptic compounds were obtained. These complexes were studied using a 
variety of techniques, which revealed the important role that the counteranion plays in the 
characteristics of such systems. Studies are in progress in our laboratories to evaluate the effect of 
different triazole substituents on the formation and on the nature of Cerium (III) and other 
Lanthanide (III) complexes. 
7.3 - Experimental Section 
The solvents and chemicals were used as received from sellers, unless otherwise mentioned. 
NMR spectra were recorded by using a Varian Mercury 400 MHz or a Varian Inova 600 MHz 
spectrometer with tetramethylsilane as the internal standard.  
Elemental analyses were performed on a ThermoQuest Flash 1112 series EA instrument. 
ESI-MS analysis were performed by direct injection of acetonitrile solutions of the compounds 
using a WATERS ZQ 4000 mass spectrometer.  
The IR spectra were recorded with a FT-IR spectrometer Perkin Elmer Spectrum 2000. 
UV/Vis absorption spectra were measured on a Varian Cary 4 double-beam UV-Vis spectrometer 
and baseline corrected. Steady-state emission spectra were recorded on an Edinburgh FLS920P 
spectrofluorimeter equipped with a 450 W Xenon arc lamp, double excitation and single emission 
monochromators and a peltier cooled Hamamatsu R928P photomultiplier tube (185–850 nm). 
Emission and excitation spectra were corrected for source intensity (lamp and grating) and emission 
spectral response (detector and grating) by calibration curve supplied with the instrument. Emission 
lifetimes were determined on the same Edinburgh instrument with the Time Correlated Single 
Photon Counting (TCSPC) technique  using pulsed picosecond LEDs (EPLED 295 or EPLED 360, 
FHWM <800 ps, repetition rates between 10 kHz and 1 MHz) as the excitation source and the 
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above-mentioned R928P PMT as detector. The goodness of fit was assessed by minimizing the 
reduced χ2 function andvisual inspection of the weighted residuals. The emission quantum yields 
were determined according to the optically dilute solutions method in ACN solutions with reference 
to Ru(bpy)3Cl2 as the standard (r) according to Equation (1),[31] where I refers to the area of the 
emission peaks of the complex and the reference, A to their absorptions and n is the refractive index 
of the corresponding solvents. 
 
Ligands synthesis: Ligands L1 and L2 were obtained following synthetic scheme according to a 
previous reported one-pot ‘click reaction’.[17] 
General procedure. In a 50 mL round-bottom flask, the desired aniline 1 (1.67 g, 15.0 mmol) was 
dissolved in CH3CN (30 mL) and cooled to 0 °C 
in an ice bath. To this stirred mixture, tBuONO (2.32 g, 2.68 mL, 22.5 mmol) was added dropwise, 
followed by TMSN3 (2.07 g, 2.37 mL, 18.0 mmol). The resulting solution was stirred and left to 
reach room temperature during the night. Then, tripropargylamine 2 (0.39 g, 420 µL, 3.0 mmol), 
CuSO4.5H2O (190 mg, 0.75 mmol) in 4.4 mL of H2O and sodium ascorbate (0.97 g, 4.5 mmol) were 
then added and the reaction was left to stir at room temperature for 2 days. Most of the solvent was 
evaporated and the crude was dissolved in 30 ml of a 1/1 mixture of CH2Cl2/aq NH3. After 3 h 
stirring, the layers were separated and the water was further extracted with ethyl acetate. The 
collected organic phases were dried over MgSO4, the solvent evaporated and the crude product was 
purified by flash chromatography over neutral Al2O3. 
Tris ((1-phenyl-1H-1, 2, 3-triazol-4-yl)methyl)amine (L1): Pale yellow solid, 0.89 g, 61 % 
yields; mp= 148.8-149.6 °C; 1H NMR (CDCl3)  3.99 (s, 6H), 7.40-7.48 (m, 3H), 7.50-7.67 (m, 
6H), 7.75-7.81 (m, 6H), 8.27 (s, 3H); 13C NMR (CDCl3)  47.0 (CH2), 120.5 (CH), 122.0 (CH), 
128.7 (CH), 129.7 (CH), 137.1 (C), 144.6 (C). IR (KBr, cm-1): 3131, 3057, 2842, 1600, 1504, 1335, 
1235, 1221, 1168, 1048, 989, 906, 825, 756, 687, 520. C27H24N10 (488.22): calcd. C 66.38, H 4.95, 
N 28.67; found C 66.75, H 5.16, N 28.89. ESI-MS: 489 [M+1]+ 
Tris ((1-(4-fluorophenyl)-1H-1, 2, 3-triazol-4-yl) methyl)amine (L2): Pale yellow solid, 1.09 g, 
67 % yields; mp= 179.5-180.3 °C;   1H NMR (CDCl3)  3.96 (s, 6H), 7.15-7.30 (m, 6H), 7.54-7.56 
(m, 6H), 8.22 (s, 3H); 19F NMR (CDCl3)  -112.5 (3F); 13C NMR (CDCl3)  47.3 (CH2), 116.7 
(CH, JCF=23.3), 122.2 (CH), 122.4 (CH, JCF=8.7), 133.3 (C, JCF=3.5), 144.7 (C), 162.2 (C, 
JCF=249.2). IR (KBr, cm-1): 3129, 3092, 2929, 2833, 1602, 1517, 1447, 1332, 1233, 1155, 1048, 
Φ= Φr I   Ar   n
2 
Ir    A   nr
2 
 
Φ= Φ
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835, 610, 521. C27H21F3N10 (542.19): calcd. C 59.77, H 3.90, N 25.82; found C 59.43, H 3.55, N 
26.03. ESI-MS: 543 [M+1]+  
Complexes synthesis: After optimization of ligand/Ce(III) salt ratio, all the complexes were 
prepared in a similar way, as follow. The Ce(III) salts were suspended in CH2Cl2, and the mixtures 
were left to stir for 2 h at r.t. The solvent was filtered off and the solids were dried in vacuum. Then, 
an acetonitrile solution of the appropriate Ce(III) salt (0.05 mmol in 2 ml) was added to a solution 
of the ligand (0.1 mmol) in 4 ml of acetonitrile. The resulting mixture was stirred for 1 h at room 
temperature, and then left in diethyl ether vapours. After several days, a precipitate or crystals were 
formed, that were collected, dried in air and submitted to analysis. 
(L1)Ce(NO3)3 3a: From Ce(NO3)3.6H2O. 33.0 mg, 81 % yields. IR (KBr, cm-1): 3136, 2915, 2848, 
1594, 1502, 1465 (NO3), 1384, 1306 (NO3), 1233, 1188, 1067, 1026 (NO3), 993, 816 (NO3), 761, 
687. 1H NMR (CDCl3)  -0.58 (bs, 6H), 7.4 (bs, 3H), 7.65 (bs, 3H), 7.72 (bs, 6H), 8.07 (bs, 6H); 
C27H24CeN13O9 (814.09): calcd. C 39.81, H 2.97, N 22.35; found C 40.01, H 3.10, N 22.90. ESI-
MS: 752 [(L1)Ce(NO3)2]+. 
(L1)2Ce(ClO4)3 4a: From Ce(ClO4)3.xH2O. 55.2 mg, 78 % yields. IR (KBr, cm-1): 3120, 3057, 
2842, 1637, 1598(ClO4), 1501, 1466, 1384, 1235, 1196, 1115 (ClO4), 1111(ClO4), 1089 (ClO4), 
986, 759, 689, 624 (ClO4), 521. 1H NMR (CDCl3)  -3.20 (bs, 6H), 7.57 (bs, 3H), 7.92 (bs, 3H), 
9.00 (bs, 6H); C54H48CeCl3N20O12 (1413.19): calcd. C 45.82, H 3.42, N 19.79; found C 45.98, H 
3.87,N 20.01. ESI-MS: 1316 [(L1)2Ce(ClO4)2]+, 608 [(L1)2Ce(ClO4)/2]+, 372 [(L1)2Ce/3]+.  
(L1)2Ce(SO3CF3)3 5a: From Ce(SO3CF3)3. 57.8 mg, 74 % yields.  IR (KBr, cm-1): 3146, 3016, 
2927, 2855, 1598, 1504, 1468, 1275 (SO3), 1245, 1168 (SO3), 1030 (SO3), 991, 911, 832, 759 
(SO3), 690, 638 (SO3), 517 (SO3). 1H NMR (CDCl3)  -3.27 (bs, 6H), 7.54 (bs, 3H), 7.91 (bs, 3H), 
7.99 (bs, 6H), 8.99 (bs, 6H); C57H48CeF9N20O9S3 (1563.20): C 43.76, H 3.09, N 17.91; found C 
43.92, H 3.19, N 18.03. ESI-MS: 633 [(L1)2Ce(SO3CF3)/2]+, 372 [(L1)2Ce/3]+. 
(L2)Ce(NO3)3 3b: From Ce(NO3)3.6H2O. 36.0 mg, 83 % yields. IR (KBr, cm-1): 3431, 3143, 2957, 
1627, 1513, 1465 (NO3), 1288, 1262, 1229, 1152, 1099, 1070, 1023 (NO3), 803 (NO3), 735, 617. 
1H NMR (CDCl3)  -0.50 (bs, 6H), 7.48 (bs, 9H), 8.11 (bs, 6H); C27H21CeF3N13O9 (868.06): calcd. 
C 37.33, H 2.44, N 20.96; found C 37.95, H 2.87, N 21.10. ESI-MS: 806 [(L2)Ce(NO3)2]+, 372 
[(L1)Ce(NO3)/2]+. 
(L2)2Ce(ClO4)3 4b: From Ce(ClO4)3.xH2O. 60.9 mg, 80 % yields.  IR (KBr, cm-1): 3084, 2950, 
1604 (ClO4), 1517, 1384, 1233, 1122, 1117 (ClO4), 1104 (ClO4), 1086 (ClO4),, 1045, 839, 625 
(ClO4), 525. 1H NMR (CDCl3)  -3.30 (bs, 6H), 7.69 (bs, 3H), 7.90 (bs, 6H), 9.19 (bs, 6H); 
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C54H42CeCl3F6N20O12 (1521.13): found C 42.57, H 2.78, N 18.39; found C 42.83, H 3.08, N 18.63. 
ESI-MS: 1422 [(L2)2Ce(ClO4)2]+, 662 [(L2)2Ce(ClO4)/2]+, 408 [(L2)2Ce/3]+. 
(L2)2Ce(SO3CF3)3 5b: From Ce(SO3CF3)3. 57.8 mg, 69 % yields. IR (KBr, cm-1): 3426, 3144, 
1653, 1609, 1517, 1450, 1270 (SO3), 1237, 1163 (SO3), 1100, 1067, 1030 (SO3), 840, 637 (SO3), 
517 (SO3). 1H NMR (CDCl3)  -3.14 (bs, 6H), 7.59 (bs, 3H), 7.81 (bs, 6H), 9.03 (s, 6H); 
C57H42CeF15N20O9S3 (1671.14): C 40.94, H, 2.53, N 16.75; found C 41.20, H 2.96, N 17.02. ESI-
MS: 1672 [(L2)2Ce(SO3CF3)3 +1]+, 1522 [(L2)2Ce(SO3CF3)2]+, 687 [(L2)2Ce(SO3CF3)/2]+. 
Calculations details: 
Calculations on 3b and on the 3+ cation of 4b and 5b were performed by the Gaussian 09 rev A.02 
series of programs using the unrestricted B3LYP functional and the SDD basis set applied to all the 
atoms. Due to the difficulties experienced with standard convergence criteria, all the calculations 
employed the quadratically convergent SCF procedure together with a loose convergence criteria 
(“scf=(QC,conver=6)” keyword). However, to check the optimized structures, harmonic vibrational 
frequencies were calculated at the same level of theory. As revealed by the frequency analysis, 
imaginary frequencies were absent and the visual inspection of the lowest energy normal mode 
showed a conformational motion of one ligand versus the second one. 
 
7.4 - Bibliography 
[1] a) C. W. Tornøe, M. Meldal, in Peptides: the wave of the future, M. Lebl, R. A. Houghten, 
ed.; Kluwer Academic Publishers, Dordrecht, 2001, pp. 263; b) H. C. Kolb, M. G. Finn, K. B. 
Sharpless, Angew. Chem., Int. Ed., 2001, 40, 2004-2021. 
[2] a) V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem., Int. Ed., 
2002, 41, 2596; b) R. Huisgen, in 1,3-Dipolar cycloaddition chemistry, ed. A. Padwa, Wiley, New 
York, 1984, vol. 1, p. 1. 
[3] a) S. Rana, J. W. Cho, Nanoscale, 2010, 2, 2550-2556. b) G. Franc, A. K. Kakkar, Chem. 
Soc. Rev. 2010, 39, 1536–1544; c) C. Wangler, R. Schirrmacher, P. Bartenstein, B. Wangler, Curr. 
Med. Chem., 2010, 17, 1092-1116; d) D. Astruc, L. Liang, A. Rapakousiou, J. Ruiz, Acc. Chem. 
Res., 2012, 45, 630–640; e) H. C. Kolb, K. B. Sharpless, Drug Discovery Today 2003, 8, 1128; f) P. 
Wu, V. V. Fokin, Aldrichimica Acta 2007, 40, 7; g) C. W. Tornøe, C. Christensen, M. Meldal, J. 
Org. Chem. 2002, 67, 3057; h) M. Meldal, C. W. Tornøe, Chem.Rev. 2008, 108, 2952. 
[4] a) B. Happ, D. Escudero, M. D. Hager, C. Friebe, A. Winter, H. Görls, E. Altuntaş, L. 
González, U. S. Schubert, J. Org. Chem. 2010, 75, 4025–4038; b) Z. E. A. Chamas, X. Guo, J.-L. 
Canet, A. Gautier, D. Boyer, R. Mahiou, Dalton Trans. 2010, 39, 7091–7097. 
109 
 
[5] a) P. Hänninen, H. Härmä, Lanthanide Luminescence: Photophysical, Analytical and 
Biological Aspects Ed. Springer Verlag Heidelberg Berlin 2011; b) S. V. Eliseeva, J.-C. G. Bünzli, 
Chem. Soc. Rev. 2010, 39, 189–227; c) M. A. Katkova, M. N. Bochkarev Dalton Trans. 2010, 39, 
6599–6612; d) A. Vogler, H. Kunkely, Inorg. Chim. Acta 2006, 359, 4130–4138. 
[6] a) G. Bergamini, E. Marchi, P. Ceroni, Coord. Chem. Rev. 2011, 255, 2458–2468; b) S. 
Dang, J.-H. Zhangb, Z.-M. Sun, J. Mater. Chem. 2012, 22, 8868-; c) J. Kido, Y. Okamoto, Chem. 
Rev. 2002, 102, 2357–2368; d) T. Oyamada, Y. Kawamura, T. Koyama, H. Sasabe, C. Adachi, Adv. 
Mater. 2004, 16, 1082–1086; e) M. K. Lam, K. L. Kwok, S. C. Tse, S. K. So, J. B. Yuan, L. M. 
Leung, M. L. Gong, Opt. Mater. 2006, 28, 709–713. 
[7] a) C. Lincheneau, F. Stomeo, S. Comby, T. Gunnlaugsson, Aus. J. Chem. 2011, 64, 1315-
1326; b) T. Terai, H. Ito, K. Kikuchi, T. Nagano Chem. Eur. J. 2012, 18, 7377–7381; c) M. 
Schäferling Angew. Chem. Int. Ed. 2012, 51, 3532–3554; d) C. D. S. Brites, P. P. Lima, N. J. O. 
Silva, Angel Millán, V. S. Amaral, F. Palacio, L. D. Carlos, New J. Chem. 2011, 35, 1177–1183; e) 
I. Hemmila, S. V. Laitala, J. Fluoresc. 2005, 15, 529–542. 
[8] a) E. G. Moore, A. P. S. Samuel, K. N. Raymond, Acc. Chem. Res. 2009, 42, 542–552; b) S. 
Shinoda, H. Tsukube Analyst 2011, 136, 431-435; c) L. Tian, Z. C. Dai, L. Zhang, R. Y. Zhang, Z. 
Q. Ye, J. Wu, D. Y. Jin, J. L. Yuan, Nanoscale 2012, 4, 3551-3557; d) Y. Liu, X. Wu, C. He, Y. 
Jiao, C. Duan, Chem. Commun. 2009, 7554–7556. 
[9] a) J. Zhang, Y. Li, X. Hao, Q. Zhang, K. Yang, L. Li, L. Ma, S. Wang, X. Li, Mini-Rev. 
Med. Chem. 2011, 11, 678-694; b) M. Bottrill, L. Kwok, N. J. Long, Chem. Soc. Rev. 2006, 35, 
557–571; c) S. Aime, D. Delli Castelli, S. Geninatti Crich, E. Gianolio, E. Terreno, Acc. Chem. Res. 
2009, 42, 822–831; d) P. Escribano, B. J. López, J. Planelles-Aragó, E. Cordoncillo, B. Viana, C. 
Sanchez, J. Mater. Chem. 2008, 18, 23–40. 
[10] a) G. Bartoli, E. Marcantoni, M. Marcolini, L. Sambri, Chem. Rev., 2010, 110, 6104–6143; 
b) V. Sridharan, J. C. Menéndez, Chem. Rev., 2010, 110, 3805–3849; c) V. Nair, L. Balagopal, R. 
Rajan, J. Mathew, Acc. Chem. Res., 2004, 37, 21-30; d) G. A. Molander, Chem. Rev. 1992, 92, 29-
68, e) G. Bartoli, E. Marcantoni, L.Sambri, Synlett 2003, 2101-2116. 
[11] C. Tang, Y. Bando, D. Golberg, R. Ma, Angew. Chem. Int. Ed. 2005, 44, 576–579. 
[12] a) J.-C. G. Bünzli, Acc. Chem, Res. 2006, 39, 53; b) M. E. Azenha, H. D. Burrows, S. M. 
Fonseca, M. L. Ramos, J. Rovisco, J. Seixas de Melo, A. J. F. N. Sobral, K. Kogej, New J. Chem. 
2008, 32, 1531-1535; c) T. Yu, W. Su, W. Li, R. Hua, B. Chu, B. Li, Solid-State Electron. 2007, 51, 
894; d) G.-C. Han, Y.-N. Liu, Luminescence 2010, 25, 389–393. 
[13] a) C. Canevali, M. Mattoni, F. Morazzoni, R. Scotti, M. Casu, A. Musinu, R. Krsmanovic, 
S. Polizzi, A. Speghini, M. Bettinelli, J. Am. Chem. Soc. 2005, 127, 14681–14691; b) H. Deng, S. 
110 
 
Yang, S. Xiao, H.-M. Gong, Q.-Q. Wang J. Am. Chem. Soc. 2008, 130, 2032-2040; c) R. Le 
Toquin, A. K. Cheetham, Chem. Phys.s Lett. 2006, 423, 352–356; d) K. Klier, A. C. Miller, L. L. 
Zhang, M. K. Hatalis, Chem. Mater. 2008, 20, 1359–1366; e) T.i Li, F. Li, J. Lü, Z. Guo, S. Gao, R. 
Cao, Inorg. Chem. 2008, 47, 5612-5615. 
[14] a) X.-L. Zheng, Y. Liu, M. Pan, X.-Q. Lü, J.-Y. Zhang, C.-Y. Zhao, Y.-X. Tong, C.-Y. Su 
Angew. Chem. Int. Ed. 2007, 46, 7399, and cited references. 
[15] a) D. F. Aull, H. P. Jenssen, Phys. Rev. B 1986, 34, 6640–6646; b) S. T. Frey, W. D. 
Horrocks, Jr., Inorg. Chem. 1991, 30, 1073–1079; c) P. N. Hazin, C. Lakshminarayan, L. S. Brineq, 
J. L. Knee, J. W. Bruno, W. E. Streib, K. Foltingt, Inorg. Chem. 1988, 27, 1393–1400; d) W. Li, T. 
Mishima, H. Adachi, J. Shiokawa, Inorg. Chim. Acta 1987, 131, 287–291;e) M- J. Tapia, H. D. 
Burrows Langmuir 2002, 18, 1872-1876; f) K. V. Vasudevan, N. A. Smith, B. L. Scott, B. L. 
Bennett, R. E. Muenchausen, J. C. Gordon Dalton Trans. 2012, 41, 1924–1927; g) H. Kunkely, A. 
Vogler, J. Photochem. Photobiol. A-Chem. 2002, 151, 45–47; i) S. Giuffrida, G. G. Condorelli, L. 
L. Costanzo, G. Ventimiglia, A. Di Mauro, I. L. Fragalà J. Photochem. Photobiol. A-Chem. 2008, 
195, 215–222. 
[16] A. Baschieri, A. Mazzanti, S. Stagni, L. Sambri, Eur. J. Inorg. Chem. 2013, in press, 
DOI: 10.1002/ejic.201201361. 
[17] K. Barral, A. D. Moorhouse, J. E. Moses, Org. Lett., 2007, 9, 1809-1811. 
[18] a) T. R. Chan, R. Hilgraf, K. B. Sharpless, V. V. Fokin Org. Lett., 2004, 6, 2853-2855. b) V. 
O. Rodionov, V. V. Fokin, M. G. Finn, Angew. Chem., Int. Ed. 2005, 44, 2210; c) P. S. Donnelly, S. 
D. Zanatta, S. C. Zammit, J. M. White, S. J. Williams, Chem. Commun., 2008, 2459–2461. 
[19] a) P. Di Bernardo, A. Melchior, M. Tolazzi, P. L. Zanonato Coord. Chem. Rev. 2012, 256, 
328–351; b) J.-C. G. Bünzli, C. Mabillard, Inorg. Chem., 1986, 25, 2750; c) J.-C. G. Bünzli, A. 
Milicic-Tang, in Handbook on the Physics and Chemistry of Rare Earths, eds. K. A. Gschneidner 
and L. Eyring, Elsevier, Amsterdam, 1995, vol. 21, ch. 145, pp. 306–366. 
[20] a) A. Ikeda-Ohno, S. Tsushima, C. Hennig, T. Yaita, G. Bernhard, Dalton Trans. 2012, 41, 
7190-7192; b) I. Kostovaa, N. Trendafilovab, I. Georgieva, Spectrosc. Lett. 2007, 40, 65-81. 
[21] X. Y. Cao, M. Dolg, J. Mol. Struct. (Theochem), 2002, 581, 139-47. 
[22] SDD basis set as implemented in Gaussian 09 Rev. A.02. M. J. Frisch, G. W. Trucks, H. B. 
Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. 
A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. 
Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. 
Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. 
111 
 
Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, 
J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, 
R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. 
Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. 
Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., 
Wallingford CT, 2009. 
[23] J. Kullgren, C.W.M. Castleton, C. Müller, D. Muñoz Ramo, K. Hermansson, J. Chem. Phys. 
2010, 132, 054110. 
[24] a) Z.-Z. Yan, G.-L. Dai, H.-D. Liang, Y.-Q. Lin, Luminescence 2011, 26, 218-222; b) K. 
Nakamato, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B, 
Applications in Coordination, Organometallic, and Bioinorganic Chemistry, 6th Ed., Wiley, New 
York, 2009; c) N. F. Curtis, Y. M. Curtis. Inorg Chem 1964, 4, 804-809; d) M. R. S. Foreman, M. J. 
Hudson, M. G. B. Drew, C. Hill, C. Madic Dalton Trans. 2006, 1645-1653; e) K. Lei, W. Liu, K. 
Yu Monat. Chemie, 2006, 137, 413-417. 
[25] M. Pan, M.-H. Lan, X.-T. Wang, C. Yan, Y. Liu,C.-Y. Su, Inorg. Chim. Acta 2010, 363, 
3757–3764. 
[26] D. H. Johnston, D. F. Shiver Inorg. Chem. 1993, 32, 1045-1047. 
[27] a) P. Dröse, S. Blaurock, C. G. Hrib, L. Hilfert, F. T. Edelmann, Z. Anorg. Allg. Chem. 
2011, 637, 186–189; b) I. Kostova, V.K. Rastogi, W. Kiefer, A. Kostovski, Appl. Organometal. 
Chem. 2006, 20, 483-493; c) J. W. Walton, R. Carr, N. H. Evans, A. M. Funk, A. M. Kenwright, D. 
Parker, D. S. Yufit, M. Botta, S. De Pinto, K.-L. Wong, Inorg. Chem. 2012, 51, 8042−8056. 
[28] a) I. Bertini, Y-M. Lee, C. Luchinat, M. Piccioli, L. Poggi, Chembiochem, 2001, 2, 550-558; 
b) I. Bertini, M.B.L. Janik, G. Liu, C. Luchinat, A. Rosato, J. Magn. Reson. 2001, 148, 23-30. 
[29] B. E. Aroussi, N. Dupont, G. Bernardinelli, J. Hamacek, Inorg. Chem. 2010, 49, 606-615. 
[30] An additional interpretation could be due to the sensitivity of the ESI spectrometer that is 
much higher in the case of charged species with respect to neutral ones. In this framework the 
presence of a tiny amount of homoleptic complex would be easily detected. 
[31] K. Binnemans Chem. Rev. 2009, 109, 4283–4374 
 
 
 
 
 
 
112 
 
8) Carbazole-Terpyridine ligands  
Carbazole (Cbz) and 2,2’:6’,2”-terpyridine (Tpy) are molecular units of outstanding importance in 
materials, coordination and supramolecular chemistry. Carbazole is a luminescent1 nitrogen-bridged 
diphenyl which can be easily functionalized2,3 with a large variety of substituents or undergo 
polymerization to afford new materials with tailored chemical and physical properties.4-6 
Polycarbazoles, for instance, are extensively utilized for their electric and optical properties as hole 
transporters, electron donors or blue emitters in optoelectronic devices.7,8 On the other hand, 
2,2’:6’,2”-terpyridine, along with a huge number of related derivatives,9 has been the object of 
intensive investigations particularly in the area of metallo-supramolecular complexes involving, 
among others, RuII, OsII, FeII, PtII and ZnII ions.10-17 Their optical, electrochemical, luminescent, 
magnetic, catalytic and therapeutic properties make them attractive for applications in the areas of 
solar energy conversion, optoelectronic devices, sensors and medicinal chemistry, as 
comprehensively reviewed in recent years.18-24 Despite the impressive number of papers related to 
carbazole- and terpyridine-based organic and inorganic photoactive systems, only a limited number 
of reports deal with molecules, metal complexes or materials in which these two widely exploited 
subunits are combined.25-32 In this context, we decided to take advantage of the complementary 
electron donor (D, Cbz) and acceptor (A, Tpy) character of these two subunits and prepare D-π-A 
conjugated systems33,34 in which carbazole and terpyridine are linked through a phenylene bridge 
directly attached to the Tpy unit. D-π-A molecules are utilized for different applications in materials 
science including nonlinear optics and fluorescent probes, just to mention the most frequent.35,36 
One of the key electronic properties of D-π-A is that, compared to the individual subunits, they may 
exhibit intramolecular charge-transfer (ICT) absorption and/or emission bands, typically solvent-
dependent and red-shifted relative to those arising from the local excited (LE) states centred on the 
separated moieties.37 Some examples of D-π-A systems involving carbazole as donor have been 
reported,37 but the use of the versatile terpyridine moiety as acceptor partner in this context remains 
rather unexplored.26 We thought that this combination might open a straightforward route to 
tuneable organic luminescent materials. Herein, we report38 on the synthesis, electrochemistry and 
photophysical properties of 1,26 2 and 3 (Figure 1), in which the bridging units between Cbz and 
Tpy are constituted by phenylene, methylene-phenylene and ethynylene-phenylene, respectively.  
The observed electronic transitions, which in some cases entail double luminescence, have been 
investigated by means of Density Functional Theory (DFT) and Time Dependent DFT (TD-DFT)39-
41 in an effort to get a deeper insight into the relationship between structure and properties. 
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Carbazole (Cbz) and 4’-p-tolyl-2,2’:6’,2”-terpyridine (Ttpy, Figure 1) have been also studied for 
comparison purposes. 
 
Figure 1: Chemical structure of the synthesized compounds 1-3 and of the reference samples Cbz 
and Ttpy. 
8.1 - Results and discussion 
8.1.1 - Synthesis and characterization 
The syntheses of Ttpy and 4’-(4-bromophenyl)-2,2’:6’,2”-terpyridine 4, used as starting material 
for the synthesis of 1, were carried out according to a previously published procedure.42 Terpyridine 
derivative 1 was prepared in 40% yield by an Ullmann-type condensation of 4 with carbazole Cbz 
using a modified literature method,26 as reported in Scheme 1. 
 
Scheme 1: Synthesis of 1. 
Compound 2 was obtained following the synthetic sequence reported in Scheme 2. The N-
alkylation product formed by reaction of Cbz with the benzylic bromide 5 led to the derivative 6 
(60% yield). The cyanide moiety was effectively reduced with DIBAL-H to give the corresponding 
aldehyde 7 (94% yield), which is the key intermediate to obtain the desired terpyridine. In fact, the 
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one-step condensation of 7 with 2-acetylpyridine, in the presence of KOH and aqueous ammonia as 
nitrogen source, led to carbazole-terpyridine 2 in 35% yield under mild reaction conditions. 
 
Scheme 2: Synthesis of 2. 
Finally, the synthetic strategy to obtain 3 is reported in Scheme 3. Syntheses of α-haloalkynes are 
usually based on the use of terminal alkynes as starting materials. However, these are often 
unstable, lowering the final yield. Therefore, the useful intermediate α-bromoalkyne 9 was directly 
obtained by reacting trimethylsilyl-substituted precursor 8 with NBS (95% yield, Scheme 3) 
obviating the need of deprotection and, as a consequence, saving one preparation step.43 The 
ethynyl-carbazole derivative 10 was obtained in 75% yield via CuI-catalyzed cross-coupling44 of 
alkynyl bromide 9 with Cbz using a catalytic amount of CuSO4 • 5H2O and 1,10-phenanthroline. 
The rigid π-conjugated carbazole-terpyridine 3 was prepared in only one step45 by condensation of 
the p-substituted benzaldehyde 10 and an excess of 2-acetylpyridine (60% yield). 
 
Scheme 3: Synthesis of 3. 
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8.1.2 - Electrochemical properties 
The electrochemical behaviour of 1-3 was investigated by cyclic voltammetry (CV) in deaerated 
DMF vs. SCE (Figure 2).  
 
Figure 2: Cyclic voltammograms of 1 (red), 2 (green) and 3 (blue) in DMF solution with 0.1 TBAF 
at 0.05 V s–1 (concentration 1÷10 mM). 
CVs were also recorded in the same conditions for the reference compounds Cbz and Ttpy. Cbz 
displayed only an irreversible monoelectronic wave in the anodic side, whereas for Ttpy only a 
reversible process in the cathodic side was observed. Compounds 1 and 2 exhibit a quasi-reversible 
monoelectronic process at about –1.9 V, which is attributable to the reduction of the terpyridine 
moiety according to both literature reports46 and a direct comparison with Ttpy. On the other hand, 
in the case of 3, two monoelectronic irreversible processes are observed at –1.82 V and –2.06 V, 
possibly due to electrochemical polymerization of the ethynyl moiety.47 
 Cbz Ttpy 1 2 3 
E°red (V) --- –1.96 –1.92 –1.91 
–1.82a 
–2.06a 
Epox (V) +1.14 --- +1.34 +1.31 +1.36 
Table 1: Redox potentials of Cbz, Ttpy and 1-3 in DMF. a The value is the peak potential since the 
process is irreversible. 
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In the anodic region the electrochemical processes are centred on the carbazole moiety and are 
always irreversible, due to coupling reactions between radical cations.48 The oxidation of pristine 
carbazole occurs at +1.14 V, a lower potential compared to the related processes of 1-3. This effect 
is brought about by the groups directly attached to the carbazole nitrogen, which are known to shift 
anodically the oxidation potential. From the electrochemical data (Table 1) it is possible to calculate 
the energy content of charge-separated states for 1-3, corresponding to the oxidation of carbazole 
and the reduction of the terpyridine moieties. The energy of these states can be estimated by the 
following equation: 
 
where E°ox and E°red are the standard potentials of the oxidation and reduction waves recorded by 
cyclic voltammetry.49,50 This equation can be suitably applied only to electrochemically reversible 
couples but, in case one process is irreversible, the peak potential can be used instead of E°. The 
resulting values are +3.16 (1), +3.12 (2) and +3.08 (3) eV. These ICT states are at relatively high 
energy but in principle can be populated upon excitation of the singlet energy levels of the Cbz or 
the Ttpy moiety, which are located at +3.66 and +3.80 eV (as derived from the 77 K fluorescence 
spectra of pristine Cbz and Ttpy). 
8.1.3 - DFT and TD-DFT calculations 
To gain insight into the mechanisms which rule the electronic distribution in the ground and excited 
states of 1-3, all the series was investigated by means of DFT and TD-DFT using the hybrid 
functional PBE0.51,52 The electron density plots of 1-3 (Figure 3) evidence that the HOMO is 
always centred on the Cbz moiety; in the case of the conjugated 1 and 3, HOMO is also extended 
over the adjacent aryl ring, whereas, in case 2, the methylene bridge virtually breaks the π-
conjugation. On the contrary, the LUMO is always extensively localized on the Ttpy moiety. 
Accordingly, electrochemical oxidation is centred on Cbz, while the reduction entails Ttpy.  
The examination of the natural charges obtained by the NBO population analysis53,54 evidences that 
-CH2- is an electron donor and breaks the π-conjugation between the two moieties. Compared to 1, 
the extra charge of the anion and cation in 2 are more strongly localized on the Ttpy and Cbz 
moiety, respectively. On the contrary, ethynylene acts as an effective wire and electrons are 
extensively delocalized all across 3. However, the anionic form of this molecule acquires a 
perpendicular arrangement of the two moieties. 
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Figure 3: Electron density plot of 1-3.55 
An estimation of the energy of charge separated states in 1-3 was performed, to be compared with 
values obtained by cyclic-voltammetry data and considering the average energy required for the 
formation of the cationic and anionic species through the calculated ionization potentials (IP) and 
electron affinities (EA). The calculated energies of 3.29 (1), 3.34 (2), and 3.10 (3) eV, are in good 
agreement with the values estimated by CV data (Table 2), supporting the suitability of the 
molecular modelling adopted to describe the electronic properties of these compounds in the ground 
state. To investigate the electronic properties of 1-3, transitions to singlet excited states were 
calculated by PCM-TD-PBE0 using the default linear response method (LR).56 Actually, this 
method is considered a good compromise between accuracy and computational cost to describe the 
transitions to excited states of medium/large molecules in solution. Moreover, it was already 
applied successfully to the analysis of the absorption spectra of several systems in solution, also 
displaying a partial CT character.57 The assignments of the absorption spectra of 1-3 above 250 nm 
are based on 24 vertical excitation energies (VEE) calculated both in toluene (TOL) and acetonitrile 
(ACN) solutions and are discussed in detail in the next section. The calculated transitions to the 
excited states are characterized by means of the two main contributions by single excitations 
referring to the electron density plots of 1-3 shown in Figure 3. The shapes of the frontier orbitals 
point to low energy ICT transitions characterized by Cbz→Ttpy excitations in all cases. Excitations 
localized on the two moieties of the ligands contribute to the description of transitions to higher 
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excited states. Notably, the calculated absorption spectra in toluene do not substantially differ from 
those obtained in polar solvent, in good agreement with what observed experimentally. For 
comparison, the electronic transitions of 1-3 were also investigated by means of the hybrid long 
range corrected functional CAM-B3LYP, which is also indicated to characterize CT excitations.58 
Though PCM-TD-CAM-B3LYP overestimates the excitation energies of 1-3 with respect to those 
calculated by the PBE0 hybrid functional and observed in the absorption spectra,59,60 it indicates 
that local excitations (LEs) on the two moieties of 1-3 play a relevant role even for lower-energy 
excited states. Actually, in the case of 2, it assigns low-lying states to Cbz→Cbz and Ttpy→Ttpy 
transitions, in order of increasing energy. 
 1 2 3 Solvent 
∆Eexp. 3.16/392 3.12/397 3.08/402 DMF 
∆Ecalc. 3.29/377 3.34/371 3.10/400 ┴ DMF 
∆ES0LR 
3.51/353 
(0.3581) 
3.77/329 
(0.0009) 
3.42/362 
(1.2216) ∥ TOL 
∆ES0LR 
3.52/353 
(0.9988) 
3.74/331 
(0.0052) 
3.41/363 
(1.1687) ∥ ACN 
∆ES1LR 
3.30/375 
(1.2045) 
3.17/391 
(0.0357) 
3.03/409 
(1.5705) ∥ TOL 
∆ES1LR 
3.15/393 
(1.4105) 
3.16/392 
(0.0622) 
2.87/432 
(1.7430) ∥ 
2.88/430  
(0.0000) ┴ 
ACN 
∆ES1SS 
2.18/568 
(0.0945) --- 
2.45/505 
(0.9831) ∥ ACN 
The Cbz-Ttpy coplanar (ǁ) and perpendicular (┴) conformers of 3 are indicated. The oscillator strengths are reported 
within brackets.  
Table 2: Separated state energies/wavelengths (eV/nm) estimated by cyclic voltammetry (∆Eexp. = –
∆H0CV) and calculated by PCM-PBE0/6-311+G(2d,p) (∆Ecalc. = IP – EA). S0 →S1 transition 
energies/wavelengths calculated by PCM-LR-PBE0/6-311+G(2d,p) at the S0 geometries (∆ES0LR), 
PCM-LR-PBE0/6-311+G(d) (∆ES1LR) and PCM-SS-PBE0/6-311+G(d) at the S1 geometries 
(∆ES1SS). 
To investigate the emission properties of 1-3 in apolar and polar solvents the structural relaxation of 
their first excited state was modelled by the PCM-LR-TD-PBE0 method,57 both in TOL and ACN 
solutions. The calculated deexcitation energies are reported in Table 2. The relaxation process in the 
first excited state is always driven by the fact that an extra charge is delocalized on Ttpy after 
HOMO→LUMO excitation, so that the whole Ttpy moiety planarizes, in agreement with what 
found experimentally by Siebert et al. for π-conjugated terpyridines.61 In the case of 3 both the 
planar and the perpendicular arrangements of Cbz and Ttpy were considered in acetonitrile. It 
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turned out that in the first excited state these two conformers are close in energy (∆E < 0.11eV) 
while in the ground state, where the π-conjugation between Cbz and the central aryl ring largely 
stabilizes the energy of the planar conformer, the perpendicular one is not foreseen by the adopted 
molecular modelling. As previously mentioned, the perpendicular conformation of 3 is favoured 
when an extra negative charge is localised on Ttpy. The emission from the first excited state of 1-3 
in acetonitrile solution was also modelled using the PCM-SS-TD-PBE0/6-311+G* method62 to 
investigate the effect of solvent equilibration on the emission in polar solvents. A large red shift is 
calculated for the S1→S0 transition when the relaxation of the solvent electronic polarization in the 
deexcitations process is considered. The calculated transition wavelengths of 568 nm for 1 and 505 
nm for 3 are in reasonable agreement with those of the emission data (see below), while they result 
largely overestimated with respect to the experimental findings in the case of 2 (> 1000 nm). This 
very odd result suggests that the CT transition calculated by TD-PBE0 does not adequately 
characterize the first excited state of 2.  It must be pointed out that the appropriate modelling of 
emission should include the PCM correction for the excited state and the GS at the excited state 
geometry,62 but it largely underestimates the deexcitations energies also of 1 and 3. However, the 
calculations suggest that the large red shift observed in the emission spectra of these compounds in 
polar solvents can be attributed to solvent equilibration effects. 
8.1.4 - Photophysical properties 
UV-Vis absorption, luminescence and excited state lifetime data have been obtained at room 
temperature (RT) in three solvents of different polarity (i.e., toluene (TOL), dichloromethane 
(DCM) and acetonitrile (ACN)). In order to allow a comprehensive comparison between 
spectroscopic and electrochemical data, a complete study was also performed in a solvent in which 
both types of measurements were carried out, i.e. DMF. These data are only partially reported in 
this paper, since the photophysical properties of all the compounds in DMF are virtually identical to 
those in ACN. Because of a rather complicated scenario at room temperature, further studies have 
been carried out at 77 K in butyronitrile glass in order to suppress solvent reorganization effects 
and/or thermal equilibration of different emitting states. 
UV-Vis absorption 
In Figure 4 are gathered the room-temperature electronic absorption spectra of Cbz, Ttpy and 1-3 
in ACN and TOL; in the latter solvent, spectra start from 300 nm due to solvent absorption.  
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Figure 4: Room-temperature absorption spectra of 1 (red), 2 (green) and 3 (blue) in acetonitrile 
(full) and toluene (dashed). Absorption spectra of reference molecules Cbz (black) and Ttpy (pink) 
are also reported. The spectral profiles obtained from the sum of the spectra of Cbz and Ttpy is also 
reported for comparison (light-dashed green). 
While Cbz, Ttpy and 2 do not display intense absorption at λ > 300 nm, the extensively conjugated 
systems 1 and 3 show strong features (ε > 15000 M–1 cm–1) originated by the large transition dipole 
moment  along the long molecular axis, which characterizes their S0→S1 transition (see Supporting 
Information). All of the compounds exhibit a minor bathchromic shift of the lowest energy 
absorption features by increasing the polarity of the solvent. This change is more pronounced for 
the conjugated systems 1 and 3 than for 2, while absorption spectra of Cbz and Ttpy are virtually 
unaffected by the solvent. Moreover, compared to the sum of the spectra of Cbz and Ttpy (light-
dashed green spectrum in Figure 4), bichromophoric systems exhibit a progressively less resolved 
and red-shifted vibronic structure of the lowest energy band in the following order: 2, 1, 3. These 
observations suggest the presence of low-energy transitions exhibiting some charge-transfer 
character in 1 and 3. This is confirmed by the analysis of the single excitations contributing to the 
S0→S1  transitions, which are always largely characterized by HOMO-LUMO transitions with 
Cbz→Ttpy character (see Fig. 3), when calculated by the PBE051,52 hybrid functional. Though it is 
known that in the case of CT transitions the kind of functional used can significantly underestimate 
the excitation energies and oscillator strengths,63,64  such an effect is not dramatic for 1-3 upon 
comparison with experimental UV-Vis spectra (Figure 4). In fact, the calculated vertical excitation 
energies (VEEs) of S0→S1 in ACN are 3.52 eV (353 nm) for 1, 3.74 eV (332 nm) for 2, and 3.41 
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eV (364 nm) for 3. These theoretical values are very close or virtually coincident with those 
calculated in TOL (see Table 2). However, as mentioned above, in the case of 2, TD-CAM-B3LYP 
gives a different description of the S0→S1  transition assigning it to Cbz→Cbz. Moreover, contrary 
to 2, 1 and 3 have transition dipole moments completely aligned along the long molecular axis with 
large oscillator strengths, in agreement with the trend shown by the intensities observed in the first 
band of the absorption spectra. Besides the transition to the first excited state, the lowest energy 
absorption band of 1-3 entails transitions up to S0→S6 in the TD-PBE0 scenario. Specifically, in 
order of increasing energy, two transitions mainly contribute to its intensity, i.e. one with 
predominant HOMO-(LUMO+2) excitation (Cbz→Cbz) that is found to be weak and of 
comparable intensities in all the three molecules and one calculated at about 305 nm due to 
(HOMO-2)-LUMO excitation (Tpy→Ttpy). The absorption bands at 240-300 nm are assigned to 
transitions largely characterized by excitations starting from the four highest occupied MOs and 
ending onto the four lowest unoccupied MOs, with contributions from other excitations. 
Particularly, transitions up to S0→S12 are characterized by the (HOMO-2)-(LUMO+1) excitation 
(Tpy→Tpy) calculated at 281-284 nm and by the (HOMO-1)-(LUMO+2) (Cbz→Cbz) transition at 
273-277 nm with significant oscillator strengths. The S0 → S15,16 transitions of 1 and 3, calculated at 
260-264 nm with large oscillator strengths, are mainly originated by the (HOMO-3)-LUMO and 
(HOMO-3)-(LUMO+1) (Ttpy→ Ttpy,Tpy) transitions, while in 2 these excitations characterize the 
S0→S11,12 transitions at 273-275 nm. It must be pointed out that the comparison among the 
absorption spectra and the TD-PBE0 calculated ones, which nicely reproduce the observed spectral 
features of 1-3, does not evidence any inadequacy of the theoretical method used for the proposed 
assignments. However, as it was mentioned before, the long range corrected TD-CAM-B3LYP 
method suggests that the transition energies of LEs should largely contribute to the description of 
the low excited states, particularly in the case of 2. Only the following analysis of the emission 
spectra will resolve the nature of the low excited states of 1-3. 
Luminescence at 298 K 
The emission properties of 1-3 and their reference compounds Cbz and Ttpy were investigated at 
RT in solvents of different polarity (i.e., toluene, dichloromethane, acetonitrile and 
dimethylformamide). All photophysical data are summarized in Table 3, while in Figure 5 only the 
emission spectra in TOL and ACN are reported.  
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Figure 5: Normalized emission spectra of 1 (red),  2 (green) and  3 (blue) in toluene (top, dashed) 
and acetonitrile (bottom, full) at room temperature. Emission spectra of reference molecules Cbz 
(black) and Ttpy (pink) are also reported for comparison; λexc = 310 nm for toluene solutions, λexc = 
275 nm for acetonitrile solutions. 
 TOL DCM ACN DMF 
 Φ (%) τ (ns) Φ (%) τ (ns) Φ (%) τ (ns) Φ (%) τ (ns) 
Cbz 33.3 7.6 24.4 6.7 25.8 7.4 37.8 10.3 
Ttpy 18.6 2.2 13.7 1.8 11.0 1.4 10.9 1.3 
1 62.8 2.1 65.4 4.4 47.8 5.8 55.0 6.1 
2 15.3 4.3 6.7 ** 5.6 10.9 11.7 ** 
3 2.8 ** 1.9 ** 1.4 ** 0.5 ** 
** Biexponential decay. 
Table 3: Room-temperature photophysical data of 1-3 in different solvents, together with reference 
molecules Cbz and Ttpy. 
In line with the trend of absorption spectra, Cbz and Ttpy show almost solvent-independent 
luminescence profiles, with minor red-shifts in the most polar medium (< 2 nm); fluorescence 
spectra clearly indicate that the lowest singlet states of Cbz and Ttpy are virtually isoenergetic at 
room temperature. By contrast, 1-3 exhibit substantial spectral variations of the emission bands as a 
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function of solvent, much more pronounced compared to the absorption spectra.31 At higher 
polarity, fluorescence bands loose the vibronic structure and are red-shifted, suggesting a charge-
transfer character. Such a result is not surprising on the basis of theoretical findings  which evidence 
the presence of charge transfer transitions (Cbz→Ttpy). Most notably, the emission colours of 1, 2, 
3 in ACN are, respectively, blue, yellow and white. Excited-state exciplex interactions are ruled out 
because emission profiles do not change up to a concentration of 10–3 M. The most straightforward 
case is 2, where the Cbz and Ttpy moieties are decoupled by the presence of a methylene bridge. In 
this case two well-defined behaviours can be detected: (1) in low polarity media (e.g., TOL), a very 
structured band at 347 nm is observed; (2) as the solvent polarity increases (e.g., ACN), a new 
broader and unstructured band arises at longer wavelengths (λmax ≈ 500 nm). Despite the fact that 
Cbz and Ttpy singlets are almost isoenergetic, on the basis of 77 K data, we ascribe the localized 
emission in TOL to the singlet of the carbazole moiety; on the other hand, the broad band observed 
in ACN is attributed to an ICT excited state, whose energy is stabilized in the polar solvent. 
Actually, also in acetonitrile, a weak but still discernible emission signal in the region below 400 
nm suggests the presence of some residual emission very similar in shape to what observed in 
apolar toluene (LE <–> ICT equilibrium).37,65 Passing to the highly conjugated system 1, a broad 
and unstructured band is observed in any solvents (Figure 5). Such band is strongly red shifted upon 
increasing solvent polarity (λmax = 387 vs. 464 nm in toluene and acetonitrile, respectively). The 
emission behavior observed in acetonitrile can be attributed to the fast reorganization of the polar 
solvent after excitation, as suggested by PCM-TD-SS-PBE062 calculations, further corroborating the 
CT character of the associated transition. The case of 3 is more complicated since multiple 
emissions are observable in any solvents: one structured around 370 nm and one or more at lower 
energies. The structured band does not shift with solvent polarity and is considerable in all solvents; 
it is assigned to a LE which occurs at the diphenylacetyl unit in the perpendicular conformer. On the 
other hand the broader feature, which becomes more pronounced and more red-shifted by 
increasing the polarity of the medium, is attributed to the vibronic structure of the emission from the 
CT state of the relaxed planar structure, since the oscillator strength of the other conformer is null 
for such transition. Excitation spectra of 1-3 match the absorption profiles at any emission 
wavelengths (see SI). This crucial observation suggests that molecules are excited at the same 
ground state geometry but, upon excitation, two or even more excited states can be made 
available.37 Among the various combinations molecule/solvent, the sharpest case of dual emission 
appears to be 2 in ACN where the weak higher energy emission is attributed to a local excited state 
(LE) of Cbz, whereas the predominant broader band is assigned to an ICT state accessible in the 
polar medium. For 3 the situation is much more complex, with emission bands attributable to LE 
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and CT states, which occur as a consequence of the peculiar nature of the alkyne bridge which 
allows more excited state conformations. 
Luminescence decays are monoexponential for 1 and 2 when detected at the emission maxima with 
lifetimes of the order of a few nanoseconds, suggesting singlet character of the related excited state. 
For 3, emission decays are multiexponential, with the longer component having increasing 
amplitude on the low-energy side of the spectrum, indicating an increasing weight of the lowest 
energy charge-transfer component attributed to the planar conformer. 
77 K fluorescence 
In order to corroborate the contribution of charge-transfer transitions to the fluorescence bands of 1-
3, emission spectra were recorded also at 77 K in a solvent that provides transparent glasses 
preventing detection of scattered light (i.e., butyronitrile, Fig. 6). 
 
Figure 6: Normalized fluorescence spectra of 1 (red),  2 (green) and  3 (blue) in butyronitrile glass 
at 77 K, together with the ones of reference molecules Cbz (black) and Ttpy (pink). 
Phosphorescence is purposely removed from the spectrum; λexc = 280 nm. 
Under these conditions, solvent reorganization effects are substantially decreased and thermal 
equilibration between closely-spaced states is virtually suppressed. As a consequence, ICT levels 
are expected to be drastically increased in energy, limiting spectral tuning as a function of solvent 
polarity. Indeed, all spectra display only one emission band, typically similar to the one detected in 
the most apolar medium at room temperature, i.e. toluene. While the 77 K fluorescence band of Cbz 
is literally superimposed to that at 298 K, in the case of Ttpy a blue shift of 6 nm is observed upon 
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cooling (λmax = 334 nm); therefore, at 77 K, Ttpy singlet becomes higher in energy if compared to 
Cbz. This different behaviour for the two molecules can be rationalized by considering that the 
HOMO–LUMO transition of Ttpy entails the promotion of one electron centred on the terpyridine 
moiety (HOMO) to a more delocalized orbital (LUMO), differently from carbazole where HOMO 
and LUMO are largely superimposed. On the other hand, 2 displays a strongly vibronically resolved 
fluorescence band and almost no shift (less than 2 nm) is observed if compared to the room 
temperature spectrum in TOL. This emission profile resembles that of standard N-alkyl-substituted 
carbazoles and, as typically found for this kind of molecules,1 the lowest singlet level is slightly 
lower in energy compared to pristine Cbz (in this case, λmax = 345 vs. 339 nm). This result shows 
that, at 77 K, the methylene bridge of 2 is able to isolate the carbazole and terpyridine moieties, 
preventing significant electronic interactions between them. This is not the case in 1, where the 
observed broad band (λmax = 380 nm) is attributable to an ICT transition, blue shifted of more than 
10 nm relative to 298 K due to the lack of solvation effects. This emission energy value (3.26 eV) is 
in good agreement with the theoretical one and the estimation of the ICT energy performed by 
cyclic voltammetry (Table 1). The behaviour of 3 turns out to be more straightforward compared to 
room temperature. At 77 K, in fact, this molecule exhibits only one wide band at λmax = 383 nm, 
with a vibronic shoulder at 379 nm. The profile of this band is similar to 1 and attributed to the ICT 
state. Since at 77 K the equilibrium between planar and orthogonal conformers of 3 is suppressed 
(ratio of 99:1), only the most stable conformer is present in the glass, the conjugated planar one. 
Such a scenario can explain why, in the case of 3, only the CT emission band is observed at 77 K, 
while at least two emissions were observed at room temperature: a LE band at 365 nm attributed to 
the orthogonal conformer, and a CT band, which is attributable to a planar conformer (415 nm in 
TOL). At 77 K only the latter can be detected since only the planar conformer occurs in the low 
temperature regime. 
77 K phosphorescence 
Triplet phosphorescence spectra of 1-3, together with those of the reference molecules Cbz and 
Ttpy were also recorded (Fig. 7). 
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Figure 7: Normalized phosphorescence spectra of 1 (red), 2 (green) and  3 (blue) in butyronitrile 
glass at 77K, together with the ones of reference molecules Cbz (black) and Ttpy (pink). In order to 
discard fluorescence, a delay of 100 µs is applied in all the cases; λexc = 310 nm. 
The triplet of Cbz (λ0-0 = 406 nm; τ = 7.2 s) is higher-lying than that of Ttpy (λ0-0 = 437 nm; τ = 1.7 
s) by about 0.21 eV. Because of this energy gap, the emitting triplet in 1-3 is always centered on the 
terpyridine moiety (see Figure 7 for comparison) and this is supported by the triplet lifetimes of 1-3 
(i.e., 1.4 s, 1.7 s and 1.2 s, respectively) which are quite similar to that of Ttpy. This behaviour is 
particularly evident in the case of 2, in which the vibronic progressions and the triplet lifetime are 
virtually identical to those of Ttpy. The vibronic features of Ttpy are clearly discernible also in the 
conjugated systems 1 and 3, but the bands are broader probably due to the establishment of excited 
state conformeric equilibria even at 77 K on the very long timescale of triplet levels. Broadening is 
particularly remarkable for 3, which is a white triplet emitter. The lifetime decay of this compound 
is not perfectly monoexponential as for all the other compounds. 
8.2 - Conclusions 
Due to their remarkable electronic properties carbazole and 2,2’:6’,2”-terpyridine are widely 
utilized building blocks in several fields of research (e.g., supramolecular chemistry) and 
technology (e.g., optoelectronics), but their combination remains still rather unexplored. We have 
synthesized three bischromophoric Cbz-Tpy systems 1,26 2 and 3 and systematically investigated 
their electronic and photophysical properties by means of theoretical, electrochemical and 
photophysical methods. 
127 
 
The complementary electron donor-acceptor character of Cbz and Ttpy affords bichromophoric 
systems with highly tuneable luminescence properties all across the Vis spectral region (Fig. 5b). In 
the case of 3 the presence of multiple emissions can afford white photoluminescence under specific 
conditions of solvent and temperature (Figs. 5b and 7). 
Comparison of the emission spectra at room temperature and 77 K and in solvents of different 
polarity, in combination with DFT and TD-DFT methods, provides deeper insight into the nature of 
the lowest electronic excited states of 1-3, particularly localized vs. charge transfer. For the highly 
conjugated systems 1 and 3, characterized by strong ICT transitions, the hybrid functional PBE0 
best characterizes electronic levels, whereas the long-range corrections considered by TD-CAM-
B3LYP are necessary for an accurate determination of the electronic transitions in the case of the 
decoupled system 2. The fact that all the emission bands in acetonitrile show large broadenings and 
unstructured shapes is attributed to solvent relaxation effects on the ICT state, as indicated by the 
PCM-TD-SS-PBE0 molecular modelling. 
The results presented in this work are a springboard for expanding the family of Cbz-Tpy 
chromophores and luminophores via chemical functionalization, bridge tuning and metal 
complexation. We are currently working to implement the use of these systems in optoelectronic 
devices and sensors.66 
8.3 - Experimental section 
Materials and methods 
1H, 13C, NMR spectra were recorded on a Varian AS 300 or on a Mercury 400 spectrometer. 
Chemical shifts (δ) are reported in ppm relative to residual solvent signals for 1H and 13C NMR (1H 
NMR: 7.26 ppm for CDCl3; 13C NMR: 77.0 ppm for CDCl3). 13C NMR spectra were acquired with 
1H broadband decoupled mode. Mass spectra were recorded on a micromass LCT spectrometer 
using electrospray (ES) ionisation techniques. Analytical grade solvents and commercially available 
reagents were used as received, unless otherwise stated. Chromatographic purifications were 
performed using 70-230 mesh silica. 
Synthesis of derivatives 
4’-[p-(Carbazole-9-yl)phenyl]-2,2’:6’,2”-terpyridine (1)26 
The mixture of carbazole (168 mg, 1.0 mmol), 4’-(p-bromophenyl)-2,2’:6’,2’’-terpyridine 4 (388 
mg, 1.0 mmol), potassium carbonate (207 mg, 1.5 mmol), CuI (10 mg, 0.05 mmol) and 18-crown-6 
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(7 mg, 0.025 mmol) was heated at 185°C under stirring for 48 h. After the reaction mixture was 
cooled to ambient temperature, chloroform and water were added. The aqueous phase was 
discarded, and the organic phase was washed with distilled water (3 x 10 mL), dried over anhydrous 
MgSO4 and then evaporated. Precipitation of a concentrated solution of the crude product in 1 mL 
DCM with methanol (25 mL) afforded 1 as a white solid in 40%yield (190 mg). 1H NMR (CD3Cl, 
300 MHz) δ 8.86 (s, 2H), 8.76 (qd, , J= 4.7 Hz, J= 0.8 Hz, 2H), 8.72 (td, J= 8.0 Hz, J= 0.9 Hz, 2H), 
8.20-8.12 (m, 4H), 7.91 (dt, J= 7.6 Hz, J= 1.8 Hz, 2H), 7.77-7.71 (m, 2H), 7.53-7.29 (m, 8H); 13C 
NMR (CD3Cl, 75 MHz) δ 156.4, 149.6, 149.4, 140.9, 138.7, 137.8, 137.2, 129.1, 127.6, 126.3, 
124.2, 123.8, 121.6, 120.6, 120.4, 119.1, 110.1; ESI-MS: 475 [M+ + 1], 497 [M+ + Na]. 
4-[(9H-Carbazol-9-yl)methyl] benzonitrile (6) 
Carbazole (418 mg, 2.5 mmol), 4-(bromomethyl)benzonitrile 5 (490 mg, 2.5 mmol) and NaH 95% 
(90 mg, 3.75 mmol) were dissolved in anhydrous THF (10 mL), and the reaction mixture was 
stirred at 70° C under a nitrogen atmosphere for 24 h. After the reaction was terminated the solvent 
was evaporated, distilled water was added, and the resultant solution was extracted with DCM (3 x 
15 mL). The collected organic layer was dried over anhydrous MgSO4 and then evaporated. The 
residue was purified by silica gel column chromatography using a mixture of CH2Cl2/petroleum 
(4:6) to give product 6 as a white solid in 60% yield (420 mg). 1H NMR (CD3Cl, 300 MHz) δ 8.19 
(d, J = 7.8 Hz, 2H), 7.55 (d, J = 8.3 Hz, 2H), 7.48 (m, 2H), 7.36-7.28 (m, 4H), 7.21 (d, J = 8.0 Hz, 
2H), 5.55 (s, 2H); 13C NMR (CD3Cl, 75 MHz) δ 142.9, 140.6, 132.9, 127.3, 126.4, 123.4, 120.9, 
120.0, 118.8, 111.7, 108.8, 46.4; ESI-MS: 305 [M+ + Na]. 
4-[(9H-Carbazol-9-yl)methyl] benzaldehyde (7) 
To a solution of 4-((9H-carbazol-9-yl)methyl) benzonitrile 6 (419 mg, 1.48 mmol) in anhydrous 
toluene (10 mL) DIBAL-H (1.5 M in toluene, 1.5 mL, 2.23 mmol) was added at 0° C. After 5 h the 
ice-bath was removed and the solution was stirred overnight at room temperature. HCl 1M (25 mL) 
was added slowly and after 5 h the mixture was extracted with DCM (3 x 15 mL). The combined 
organic phase was dried on anhydrous MgSO4 and then evaporated to give pure product 7, as a 
white solid in 94% yield (398 mg). 1H NMR (CD3Cl, 400 MHz) δ 9.92 (s, 1H), 8.17 (d, J = 7.7 Hz, 
2H), 7.76 (d, J = 8.2 Hz, 2H), 7.48-7.43 (m, 2H), 7.43-7.24 (m, 6H), 5.54 (s, 2H); 13C NMR 
(CD3Cl, 100 MHz) δ 191.9, 144.4, 140.7, 136.0, 130.5, 127.2, 126.3, 123.4, 120.8, 119.9, 108.9, 
46.6; ESI-MS: 308 [M+ + Na]. 
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4’-[4-(9H-Carbazol-9-ylmethyl)phenyl]-2,2’:6’,2”-terpyridine (2) 
2-Acetylpyridine (130 µL, 1.15 mmol) was added to a solution of 4-((9H-carbazol-9-yl)methyl) 
benzaldehyde 7 (143 mg, 0.5 mmol) in MeOH (3 mL). Finely ground KOH (65 mg, 1.15 mmol) 
and aqueous NH3 (2 mL, 30%, 1.23 mmol) were then added to the solution that was left to stir at 
room temperature for 7 days. The precipitated solid was collected by filtration and washed with 
MeOH (3 x 20 mL) to give pure product 2 as a white solid in 30% yield (73 mg). 1H NMR (CD3Cl, 
300 MHz) δ 8.70 (d, J = 4.6 Hz, 2H), 8.67 (s, 2H), 8.64 (d, J= 8.1 Hz, 2H), 8.16 (d, J= 7.7 Hz, 2H), 
7.86 (dt, J= 7.6 Hz, J= 1.9 Hz, 2H), 7.80 (d, J= 8.3 Hz, 2H), 7.50-7.24 (m, 10H), 5.60 (s, 2H); 13C 
NMR (CD3Cl, 75 MHz) δ 156.4, 156.2, 150.0, 149.4, 140.9, 138.3, 138.1, 137.1, 128.0, 127.3, 
126.2, 124.1, 123.3, 121.6, 120.7, 119.6, 119.1, 109.1, 46.7; ESI-MS: 489 [M+ + 1], 511 [M+ + Na]. 
4-(Bromoethynyl) benzaldehyde (9) 
4-[(Trimethylsilyl)ethynyl] benzaldehyde 8 (1.5 g, 7.4 mmol) and AgF (940 mg, 7.4 mmol) were 
dissolved in CH3CN (75 mL). The reaction flask was wrapped in aluminium foil and NBS (1.32 g, 
7.4 mmol) was added. The mixture was stirred overnight at room temperature. Then the solid was 
filtered off and washed with CH3CN (25 mL). The solution was evaporated and the resulting 
residue was dissolved in Et2O and washed with water (3 x 25 mL). The organic part was dried over 
anhydrous MgSO4 and then evaporated to give product 9 as a white solid in 95% yield (1.47 g). 1H 
NMR (CD3Cl, 300 MHz) δ 10.01 (s, 1H), 7.83 (d, J= 8.5 Hz, 2H), 7.60 (d, J= 8.3 Hz, 2H); 13C 
NMR (CD3Cl, 75 MHz) δ 191.5, 136.0, 132.8, 129.7, 129.1, 79.5, 54.9; ESI-MS: 231 [M+ + Na]. 
4-[(9H-Carbazol-9-yl)ethynyl] benzaldehyde (10) 
To a solution of 4-(bromoethynyl)benzaldehyde 9 (90 mg, 0.44 mmol)in 5 mL of anhydrous toluene 
carbazole (67 mg, 0.4 mmol), K3PO4 (170 mg, 0.8 mmol), CuSO4-5H2O (20 mg, 0.08mmol) and 
1,10-phenanthroline (30 mg, 0.16 mmol) were added. The reaction mixture was purged with 
nitrogen and heated at 80° C for 5 days. The progress of the reaction was monitored by TLC. Upon 
completion, the reaction mixture was dried in vacuo and the residue was dissolved in water and 
extracted with DCM (3 x 15 mL). The combined organic phases were dried with anhydrous MgSO4 
and then evaporated. The crude residue was purified by silica gel flash chromatography using a 
mixture of CH2Cl2/petroleum (4:6) to give product 10 as a pale white solid in 75% yield (89 mg).1H 
NMR (CD3Cl, 400 MHz) δ 10.02 (s, 1H), 8.04 (d, J= 7.6 Hz, 2H), 7.89 (d, J= 8.4 Hz, 2H), 7.74-
7.70 (m, 4H), 7.55 (dt, J= 7.4 Hz, J= 1.2 Hz, 2H), 7.38 (dt, J= 7.5 Hz, J= 1.1 Hz, 2H); 13C NMR 
(CD3Cl, 100 MHz) δ 191.5 140.4, 135.1, 131.2, 130.0, 129.8, 127.2, 124.1, 122.8, 120.8, 111.6, 
83.6, 75.3; ESI-MS: 296 [M+ + 1], 318 [M+ + Na]. 
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4’-[4-(9H-Carbazol-9-ylethynyl)phenyl]-2,2’:6’,2”-terpyridine (3) 
2-Acetylpyridine (135 µL, 1.2 mmol) was added to a stirred suspension of crushed NaOH (48 mg, 
1.2 mmol) in PEG 200 (1mL) at 0° C. After 10 min 4-[(9H-carbazol-9-yl)ethynyl] benzaldehyde 10 
(148 mg, 0.5 mmol) was added and stirring was continued at 0° C for 2 h. Then concentrated 
aqueous NH3 solution (1.5 mL) was added and the suspension stirred at 100° C for 24 h. The 
precipitate was isolated by vacuum filtration and washed with water ( 50 mL) and ethanol (10 mL) 
to give product 3 as a brown solid in 60% yield (150 mg).1H NMR (CD3Cl, 400 MHz) δ 8.78 (s, 
2H), 8.75 (d, J= 5.5 Hz, 2H), 8.69 (d, J= 8.0 Hz, 2H),8.05 (d, J= 8.1 Hz, 2H), 7.97 (d, J= 8.5 Hz, 
2H), 7.90 (dt, J= 7.8 Hz, J= 1.7 Hz, 2H), 7.76 (t, J= 9.2 Hz, 4H), 7.56 (t, J = 7.7 Hz, 2H) 7.40-7.35 
(m, 4H); 13C NMR (CD3Cl, 100 MHz) δ 156.4, 156.3, 149.6, 149.4, 140.6, 137.9, 137.1, 131.9, 
127.6, 127.0, 124.1, 124.0, 123.9, 122.4, 121.6, 120.6, 118.8, 111.6, 80.6, 74.8; ESI-MS: 499 [M+ + 
1], 521 [M+ + Na]. 
Electrochemistry 
Cyclic voltammetry was performed in a three electrode cell equipped with a SCE reference 
electrode and a platinum plate counter electrode in DMF solution with 0.1 M tetrabutyl-ammonium 
hexafluorophosphate (TBAF, electroanalysis grade) as supporting electrolyte, and containing the 
investigated compounds in the 1-10 mM concentration range. Glassy carbon (GC) (d = 3 mm) and 
platinum rod (d = 2 mm) working electrodes were used, respectively, in cathodic and anodic 
investigation in order to minimize passivation processes. All experiments were performed in 
nitrogen atmosphere at room temperature. The iR compensation (positive feedback) was used in all 
measurements. Electrochemical experiments were carried out with CH Instruments Mod. 660 C 
potentiostat, controlled by a personal computer via CH Instruments software. The values of the 
cathodic and anodic peak potentials were recorded for both the electrochemical processes. When the 
electrochemical behaviour is quasi-reversible the values of formal potentials (see Table 1) were also 
calculated from the half-sum of the cathodic and anodic peak potential. 
Theoretical calculations 
The electronic properties of 1-3 were investigated by means of Density Functional Theory (DFT) 
and Time-Dependent DFT (TD-DFT)39-41 implemented in Gaussian 09.67  Bulk solvent effects were 
always taken into account in the calculations using the polarizable continuum model (PCM).68  The 
parameter free DFT hybrid model PBE051,52 was employed to optimize the molecular geometries of 
the neutral and ionic species in DMF using the 6-311+G* basis set.69,70 The electron distribution of 
the examined systems was investigated using the 6-311G(2d,p) basis set by means of the natural 
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bond population analysis (NBO version 3.1).53,54 The ionization potentials (IPs) and electron 
affinities (EAs) were calculated by the so-called ∆SCF method using the 6-311+G(2d, p) basis set. 
The transitions to the singlet excited states of 1-3 in TOL and ACN were calculated by TD-PBE0/6-
311+G(2d,p) at the GS geometry using the default linear response method (LR).56,71 S1→S0 
emission energies were calculated by the LR-TD-PBE0/6-311+G* method57 after optimization of 
the S1 state geometry, which started from the planar conformation in the case of 1 and  3. For the 
latter, also the perpendicular arrangement of the Cbz and Ttpy moieties was considered. The first 
excited state was also modelled via the state-specific (SS) method56,62,71 in acetonitrile. This method 
accounts also for solvent relaxation in the de-excitation process and calculates the energy by 
making the electrostatic potential generated by the excited state density self-consistent with the 
solvent reaction field. The non-equilibrium time regime, in which only the solvent electronic 
polarization is in equilibrium with the excited state electron density, was considered. Transitions to 
the singlet states of 1-3 were also calculated by the long range corrected hybrid functional CAM-
B3LYP58 at the PBE0 calculated geometries. 
Photophysics 
The luminescence measurements were conducted in fluorescence cuvettes of 1 cm path length. 
Absorption spectra were recorded with a Perkin-Elmer 950 spectrophotometer. The uncorrected 
emission spectra were recorded with an Edinburgh Instruments FLS920 spectrometer with a Peltier-
cooled Hamamatsu R928 photomultiplier tube (185–850 nm). An Edinburgh Instruments Xe900 
450 W xenon arc lamp was the source of excitation light. The corrected emission spectra were 
calculated by applying a calibration curve supplied with the instrument. Luminescence quantum 
yields (Φ) in solution were calculated by the method of Demas and Crosby72 from the corrected 
spectra on a wavelength scale (nm) using an air-equilibrated solution of quinine sulfate in 1 N 
H2SO4 (Φ = 0.546)73 as reference. Room-temperature emission lifetimes were determined with the 
time correlated single photon counting technique using an IBH spectrometer equipped with a 
NanoLed excitation source at 331 nm; the detector was a red-sensitive (up to 850 nm) Horiba Jobin 
Yvon TBX Picosecond Photon Detection Module. The 77 K luminescence lifetimes were acquired 
using the same Edinburgh FLS920 spectrometer equipped with a µF 920H flash lamp as excitation 
source. The fitting of the experimental data to single or multiple-exponential decays was carried out 
with the software provided by the instrument manufacturer. To record the 77 K luminescence 
spectra, the samples were put in quartz tubes (2 mm inner diameter) and inserted in a special quartz 
Dewar flask filled up with liquid nitrogen. 
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9) New cyclometallating tetrazole ligands for blue-emitting iridium complexes  
 
In recent years, increasing interest has been devoted to phosphorescent metal complexes and their 
application as emitters in electroluminescent devices, i.e. organic light-emitting diodes (OLEDs) or 
light-emitting electrochemical cells (LEECs) for displays and lighting applications.1 
Luminescent complexes are generally based on heavy metals, and compounds based on iridium are 
the most studied due to their relatively short excited-state lifetime, high emission quantum yield, 
and facile color tuning.2 The triplet character of the emission, induced by the strong spin–orbit 
coupling in these complexes, is of great importance, since it allows for harvesting of both the singlet 
and the triplet excitons produced when electrons and holes recombine, reaching up to 100% internal 
efficiency.3  
In order to develop full-color display and lighting technologies, a key factor is the employment of 
molecules that can emit the primary colors (red, green, and blue). One of the advantages of 
cyclometallated Ir(III) complexes is that the emission color can be tuned by an appropriate design 
of the chemical structure and nature of the cyclometallated ligands.4,5 Although efficient red- and 
green-emitting Ir(III) complexes have been described and are now in the commercialization phase 
due to their excellent stability in devices, finding stable and efficient blue emitters is still an issue.6 
Among the cyclometallating ligands employed to prepare Ir(III) complexes, the most widely used 
are those in which a carbon from a phenyl ring acts as a donor and the adjacent fragment involved 
in formation of the metallocycle is an N-heterocycle ring,4 and in fact 2-phenylpyridine (ppy) and 
its derivatives are typical compounds used as C^N ligands. Finally a neutral or anionic appropriate 
ancillary ligand is exploited to form the final complexes. 
Through rational synthetic strategies, the C^N ligands and/or the ancillary ligand can be easily 
substituted with electron-withdrawing or electron-donating groups, so that these substitutions have 
an important effect on the HOMO and LUMO energies of the metal complex and consequently on 
the light emission. In order to obtain blue emitters, several options can be followed. 
One approach to obtain blue-emitting complexes is to stabilize the highest occupied molecular 
orbital (HOMO) on the C^N moieties by introducing electron-withdrawing groups on the aryl 
group, typically fluoride substituents, when arylpyridines are used as cyclometallating ligands; 
otherwise, a more effective strategy could be to raise the LUMO of the complex by switching the 
pyridine moiety to a smaller N-heterocyclic ring having higher reduction potentials than pyridine. In 
fact, blue shifts of the emission maxima have been obtained using pyrazoles,7 N-heterocyclic 
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carbenes (NHC),8 or triazoles.9 Notably, tetrazole containing cyclometallating ligands have not be 
so far reported. 
In our group, we were able to successfully employ 2-methyl-5-phenyl-2H-tetrazole as 
cyclometallating ligand to modify the emission of the Ir (III) complexes. Herein, preliminary results 
on the synthesis and the properties of highly blue-emitting charged Iridium(III) complexes 
containing two identical 2-methyl-5-phenyl-2H-tetrazole as cyclometallating ligands and different 
N^N ancillary ligands or isocyanides are presented, (Figure 1). 
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Figure 1: Iridium complexes 
9.1 - Results and discussion 
9.1.1 - Synthesis and characterization 
The cyclometallating ligand 2-methyl-5-phenyl-2H-tetrazole 3 was synthesized by methylation of 
5-phenyl-2H-tetrazole with methyl iodide under basic conditions in almost 60% yield after careful 
purification from the undesired isomer 1-methyl-5-phenyl-2H-tetrazole.  
Any attempt to obtain the classical cyclometallated Ir(III) -dichloro bridged dimer [{(C^N)2Ir(-
Cl)}2], generally used for the subsequent synthesis of Ir(III) complexes containing ancillary ligand, 
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failed, probably owing to the formation of a IrCl3-tetrazole salt. Therefore, a further step involving a 
reagent able to promote the removal of chloride ion from IrCl3 proved to be necessary. Essentially, 
the methyl tetrazole 3 was reacted with IrCl3·nH2O in a 3:1 mixture of 2-ethoxyethanol/H2O 
overnight at reflux.10 The obtained yellow salt was filtered off and refluxed in CH2Cl2 with AgBF4 
in order to satisfactory obtain the solvate-complex [Ir(C^N)2(CH3CN)2]+BF4- (C^N = 2-methyl-5-
phenyl-2H-tetrazole) 4 in 40% yield after purification, (Scheme 1). 
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Scheme 1 
Crystallization of 4 in CH3CN/Et2O gave crystals suitable for X-rays analysis and the X-rays 
structure is reported in Figure 2. 
 
Figure 2. X-rays structure of 4. 
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The complexes 1a-d were obtained reacting the ancillary ligands with the solvato complex 4 in a 
3:1 mixture of CH2Cl2/EtOH (75-80% yield), (Scheme 2). 
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Scheme 2. Synthesis of complexes 1a-d. 
The X-ray structure of 4b is reported in Figure 3. 
 
Figure 3. X-ray structure of 4b. 
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9.1.2 - Electrochemical properties 
The electrochemical behaviour of 1a-d was investigated by cyclic voltammetry (CV) in deaerated 
ACN vs. SCE (Figure 4).  
-3 -2 -1 0 1 2
-6,0x10-5
-5,0x10-5
-4,0x10-5
-3,0x10-5
-2,0x10-5
-1,0x10-5
0,0
1,0x10-5
2,0x10-5
3,0x10-5
4,0x10-5
5,0x10-5
6,0x10-5
C
ur
re
nt
/A
Potential/E vs Fc+/Fc
 Bipy
 Fen
 triaz
 NC
 
Figure 4: Cyclic voltammograms of 1a (black), 1b (green), 1c (blue) and 1d (yellow) in ACN 
solution with 0.1 M NBu4PF6 at 0.1 V s–1 (concentration about mM). The working electrode was 
glass carbon, the reference electrode was Ag/AgNO3 0.1 M in acetonitrile and the counter electrode 
was a Pt wire. The potential is referred to the E°Fc+/Fc potential 
The CVs recorded for all compound show a catodic and a anodic wave. The reduction of Bipy and 
Fen is a reversible process and the ΔEp is respectively equal to 70 and 76 mV suggesting that only 
electron is involved in the reduction. From these processes the D values for the Bipy and Fen were 
estimate and they was used to calculate the number of exchanged electrone for the other processes. 
The other process showed only forward processes in the employed experimental condition. In order 
to investigate the kinetics of those processes the scan rate was changed in the range 0.01 ÷ 10 V s-1. 
Increasing the scan rate the backward waves of the anodic process of Bipy, Fen and Triaz appeared 
suggesting the presence of reactions that follow the first oxidation processes. From the analysis of 
the current recorded at the electrode at different scan rates we can say that the mechanism of the 
oxidation for these three compounds is ECE (electrochemical reaction, chemical reaction and 
electrochemical reaction). From the analysis of the CV at high scan rate, when the effect of 
following reaction is negligible, the number of the exchanged electron and the formal potentials of 
the first oxidation processes were estimate and these parameter are reported in Table 1. Moreover 
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the reduction processes of Triaz is EC and the number of exchanged electron is one. Finally the all 
processes concerning the NC are irreversible and involve one electrone. Comparing the formal 
potential with literature11 the reduction of Bipy and Fen involve the N-N ligand. 
 First reduction process First oxidation process 
Complex Electrode kinetics 
Ered°(V vs 
Fc+/Fc) ΔEp (V)/nred 
Electrode 
kinetics 
Eox°(V vs 
Fc+/Fc) nox 
1a - Bipy Rev -2.254 (0.070)/1 ECE + 0.687 1* 
1b - Fen Rev -2.238 (0.076)/1 ECE + 0.710 1* 
1c - Triaz EC -2.695 1** ECE + 0.787 1** 
1d - NC Irrev. -2.973 1** Irrev. + 1.100 1** 
* calculated from the peak current and the diffusion coefficient calculated from the cathodic process 
reversible ** calculated from the peak current and the diffusion coefficient calculated for the Bipy 
Table 1 
9.1.3 - Photophysical properties 
In Figure 5 the RT absorption spectra in dichloromethane of all the synthesized complexes and for 
comparison, the absorption spectra of archetypal [Ir(ppy)2(bpy)]+ and [Ir(dfppy)2(bpy)]+ are 
reported. All complexes show bluer absorption onset than the bluest diphenylpyridin 
cyclometallated Ir(III) complex, [Ir(dfppy)2(bpy)]+. 
 
Figure 5. Absorption spectra in DCM of complexes 1a-d and reference compounds. 
In Figure 6 and in Table 2 preliminary photophysical data of the obtained complexes are reported. 
Emission studies were carried out at room temperature both in dichloromethane and acetonitrile, 
and at 77K (DCM glass). Basically, 1a and 1b are strongly emissive and their emission is extremely 
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blue, despite the band shape is indicating a pronounced MLCT character. The emission profile of 1a 
is almost superimposed on the bis-fluorinated-phenylpyridine bipyridine Ir(III) complex emission 
band. On the other hand complex 1c and 1d are substantially not emissive. 
 
Figure 6: Preliminary emission spectra of the Ir(III) tetrazolate complexes. 
Complex Medium max (nm) em (%) s)
4a CH2Cl2 532 67,7 1,27
ACN 544 54,0 1,27
77 K CH2Cl2 485 2,82
4b CH2Cl2 520 71,9 1,56
ACN 536 66,5 1,7
77 K CH2Cl2 462, 495… 13,5
4c CH2Cl2 517 0,2 X
ACN 530 0,1 X
77 K CH2Cl2 410, 436… X
4d CH2Cl2 400,425,450 0,5 X
ACN 440 multi 0,7 X
77 K CH2Cl2 396, 422… X  
Table 2. Preliminary photophysical properties 
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9.2 - Conclusions 
This work is still in progress, and therefore all the reported results are preliminary. However, the 
synthesis of new iridium complexes containing tetrazolated ciclometalated ligands is reported for 
the first time.  
From the obtained photophysical data, the complexes 1a and 1b show very good blue emission and 
the quantum yields, both in solution and in the solid state, are extremely high (about 70%): these 
results are really remarkable considering that these complexes are fluoride-free.  
 
9.3 - Experimental section 
Materials and methods 
1H, 13C, NMR spectra were recorded on a Varian AS 300 or on a Mercury 400 spectrometer. 
Chemical shifts (δ) are reported in ppm relative to residual solvent signals for 1H and 13C NMR (1H 
NMR: 7.26 ppm for CDCl3; 13C NMR: 77.0 ppm for CDCl3). 13C NMR spectra were acquired with 
1H broadband decoupled mode. Mass spectra were recorded on a micromass LCT spectrometer 
using electrospray (ES) ionisation techniques. Analytical grade solvents and commercially available 
reagents were used as received, unless otherwise stated. Chromatographic purifications were 
performed using 70-230 mesh silica. 
Synthesis of 2-methyl-5-phenyl-2H-tetrazole 2:, A solution of 5-phenyl-2H-tetrazole (1.0 g, 6.8 
mmol) in CH3N (70 mL) was treated with K2CO3 (3.8 g, 27.4 Mmol) followed by addition of 
methyl iodide (0.86 mL, 13.6 mmol), according to a described procedure (DOI: 
10.1021/jo00058a061). The reaction was stirred at reflux for 72 h, then it was cooled to room 
temperature, the residual solid was filtered off and the solution was concentrated in vacuo to give a 
dark oil. The oil was then purified by column chromatography on silica eluting with 
CH2C12/petroleum ether= 4/6 and then CH2C12/EtOAc= 98/2. Fractions homogeneous by TLC 
were combined and concentrated in vacuo to give 2 (0.67 g, 59.1% yields, less polar spot) as a pale 
yellow solid [1H NMR (CDCl3) : 4.33 (s, 3H), 7.35-7.50 (m, 3H), 8.05-8.15 (m, 2H); 13C NMR 
(CDCl3) : 39.5 (CH3), 126.8 (CH), 127.3 (C), 128.9 (CH), 130.3 (CH), 165.2 (C)] and 1-methyl-5-
phenyl-2H-tetrazole (0.26 g, 23.7% yields) as a white solid [1H NMR (CDCl3) : 4.18 (s, 3H), 7.55-
7.60 (m, 3H), 7.70-7.75 (m, 2H); 13C NMR (CDCl3) : 35.0 (CH3), 123.8 (C), 128.6 (CH), 129.3 
(CH), 131.3 (CH), 165.9 (C)] 
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Synthesis of Ir(III)-solvato complex 3. The reactions were performed under N2 and in the absence 
of light. The solvents were not dried, but they were deoxygenated by bubbling with N2. The ligand 
2 (48 mg, 0.3 mmol) was dissolved in a 3:1 mixture of ethoxyethanol: water ( 2ml) and then 
IrCl3·xH2O (30 mg) was added. The mixture was stirred overnight at 140 °C under N2. After 
cooling, the obtained yellow solid was filtered, washed with water, dried and dissolved in CH2Cl2 
(8 ml). AgBF4 (40 mg) was added, and the solution was then refluxed for 6 h. After cooling, the 
solution was filtered through a paper filter to remove AgCl and evaporated to dryness. The resulting 
crude Ir(III) solvato complex was dissolved in CH3CN and precipitated with Et2O to give 3 (25 mg 
40% yield). 1H NMR (CDCl3) : 4.65 (s, 3H), 6.14 (d, 1H, JHH=7.5), 6.80 (dt, 1H, JHH=7.5, 
JHH=1.4), 6.92 (dt, 1H, JHH=7.5, JHH=1.2), 7.64 (d, 1H, JHH=7.5, JHH=1.4) ; 13C NMR (CDCl3) : 
40.8 (CH3), 122.8 (CH), 123.6 (CH), 129.8 (CH), 130.0 (C), 130.1 (C), 133.6 (CH), 174.3 (C)] 
ESI-MS+: 593 (M++2ACN); 552 (M++ACN) 
Synthesis of Ir(III) Complexes 4a-c. The solvato-complex 3 (10 mg, 0.015 mmol) was dissolved 
in a 3:1 mixture of CH2Cl2/EtOH (2 ml) and the bidentate ligand (0.027 mmol) was added. The 
mixture was left to stir overnight at r.t., and then the solvent was evaporated. The solid was 
dissolved in acetone, precipitated with Et2O and the obtained solid purified by column 
chromatography (DCM/MeOH=98/2) to give pure complexes 4a-c. 
Complexes 4a (9.1 mg, 80 % yields). 1H NMR (CD2Cl2) : 4.27 (s, 6H), 6.24 (d, 2H, JHH=8.8), 
6.98 (t, 2H, JHH=8.8), 7.05 (t, 2H, JHH=8.8), 7.36 (t, 2H, JHH=7.0), 7.70 (d, 2H, JHH=7.0), 8.00-8.10 
(m, 4H), 8.51 (d, 2H, JHH=7.0); 13C NMR (CD2Cl2) : 42.1 (CH3), 123.6 (CH), 124.8 (CH), 127.7 
(CH), 129.2 (C), 131.5 (CH), 132.6 (CH), 140.2 (2CH), 145.6 (C), 151.7 (CH), 156.7 (C), 174.6 
(C)] 
Complexes 4b (77 % yields). 1H NMR (CD2Cl2) : 4.17 (s, 6H), 6.35 (d, 2H, JHH=7.6), 7.02 (dt, 
2H, JHH=7.5, JHH=1.6), 7.08 (dt, 2H, JHH=8.8, JHH=1.9), 7.36 (t, 2H, JHH=7.0), 7.70-7.75 (m, 4H), 
8.02 (s, 2H), 8.33 (dd, 2H, JHH=5.5, JHH=1.9), 8.57 (dd, 2H, JHH=8.5, JHH=1.6); 13C NMR (CD2Cl2) 
: 41.5 (CH3), 123.7 (CH), 124.8 (CH), 126.0 (CH), 128.7 (CH), 129.4 (C), 131.1 (C), 131.4 (CH), 
132.7 (CH), 138.7 (CH), 144.9 (C), 147.7 (C), 156.7 (C), 152.0 (C), 174.6 (C)] 
Complexes 4c (75 % yields). 1H NMR (CD2Cl2) : 4.29 (s, 3H), 4.30 (s, 3H), 6.27 (d, 2H, 
JHH=7.5), 6.90-7.10 (m, 4H), 7.22 (bt, 1H, JHH=6.7), 7.40-7.50 (m, 3H), 7.69 (dd, 2H, JHH=7.1, 
JHH=11.3), 7.78 (bd, 1H, JHH=7.1), 7.89 (d, 1H, JHH=5.2), 8.0 (bs, 1H), 8.5 (bs, 2H), 9.5 (s, 2H); 13C 
NMR (CD2Cl2) : 41.6 (CH3), 41.7 (CH3), 120.7 (CH), 123.2 (CH), 123.5 (CH), 123.6 (CH), 124.1 
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(C), 124.3 (CH), 124.7 (CH), 126.0 (CH), 129.3 (C), 129.35 (C), 130.0 (CH), 130.2 (CH), 130.6 
(CH), 131.3 (CH), 132.5 (CH), 133.0 (CH), 136.1 (CH), 140.0 (CH), 151.0 (CH), 141.8 (C), 145.1 
(C), 150.2 (C), 150.3 (C), 174.4 (C), 174.8 (C)] 
Synthesis of Ir(III) Complex 4d. Caution! tert-Butyl isocyanide is a foul-smelling volatile liquid, 
therefore ensure adequate ventilation. The solvato-complex 3 (10 mg, 0.015 mmol) was dissolved in 
a 3:1 mixture of CH2Cl2/EtOH (2 ml) and t-butyl isocyanide (0.027 mmol) was added. The mixture 
was left to stir overnight at 30 °C, and then the solvent was evaporated. The solid was dissolved in 
acetone and the product was precipitated with Et2O to give pure complex 4d (75 % yields). 1H 
NMR (CD2Cl2) : 1.44 (s, 18H), 4.70 (s, 6H), 6.15 (d, 2H, JHH=7.5), 7.01 (dt, 1H, JHH=7.5, 
JHH=1.6), 7.09 (dt, 2H, JHH=7.5, JHH=1.4), 7.76 (d, 2H, JHH=7.5); 13C NMR (CD2Cl2) : 30.0 (CH3), 
42.2 (CH3), 65.6 (C), 124.2 (CH), 124.8 (CH), 128.3 (C), 131.2 (CH), 131.3 (CH), 149.1 (C), 157.6 
(C), 174.8 (C)] 
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